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                      Summary 
 
The development of efficient and economical processes for the preparation of 
valuable nitrogen heterocycles remains an important goal in synthetic organic and 
medicinal chemistry. Along these lines, activated isocyanides (or α-acidic isocyanides) 
have proven to be a versatile functionality to react with carbonyls, imines, activated 
alkenes/alkynes, etc. to produce a wide range of heterocyclic compounds. The main 
theme of my Ph.D. studies has been the development of new transformations of 
activated isocyanides to access diverse heterocyclic structures, with a focus on the 
development of catalytic asymmetric variants. 
In chapter 1, the catalytic asymmetric reactions of activated isocyanides with 
various electrophiles, including carbonyl compounds, imines, activated alkenes, and 
azodicarboxylates were summarized to give a general background of this field. 
In chapter 2, we reported for the first time that aryl esters could react with 
isocyanoacetates to yield oxazoles. Based on this discovery, we developed a novel 
complexity-generating method: both functionalities in readily available α-imino esters 
undergo [3+2] cyclization reaction with isocyanoacetates to give directly linked 
oxazole-imidazolines under silver catalysis. The asymmetric variant has also been 
realized with the Dixon-type ligand to produce these compounds in high diastereo- 
and enantiopurity. 
In chapter 3, the divergent [3+2] cyclization reaction of activated isocyanides 
with allenoates was described for the first time. Under different catalytic systems, we 
XI 
 
realized the cycloaddition using either of the two C=C bonds in the allene structure. 
While Ag catalysis led to an unprecedented enantioselective synthesis of 3H pyrroles 
and related N-heterocycles, a simple procedure using catalytic amount of PPh3 
produced a wide range of polysubstituted 1H pyrroles in high efficiency. 
In chapter 4, we presented an unexpected Ag-catalyzed three-component reaction 
of 3-formylchromones, amines and isocyanoacetates, leading to the formation of 
1,2,4-trisubstituted pyrroles. Importantly, mechanistic studies revealed that this 
unusual transformation was initiated by 1,4-conjugate addition of amine to 3-formyl 
chromone instead of imine condensation, representing a new reaction pathway in 
isocyanoacetate-based multicomponent reactions. 
In chapter 5, an interesting and effective catalyst-controlled chemo-divergent 
cascade reaction of para-quinone methide-aryl esters with activated isocyanides was 
developed for the first time. While Ag catalysis led to the formation of tricyclic ketals 
with three continuous stereogenic centers in pure form, structurally diverse 
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1.1 Introduction  
Heterocyclic compounds, in particular nitrogen heterocycles are one of the most 
abundant and useful classes of chemical substances, which are commonly presented in 
natural products, biologically active structures as well as drug related compounds.[1] 
As a result of the importance of these molecules, their preparation has always been a 
hot topic in organic synthesis. Along these lines, activated isocyanides (or α-acidic 
isocyanides) have been identified as irreplaceable building blocks to deliver a wide of 
nitrogen heterocycles, such as oxazolines, imidazolines and 1,2,4-triazolines. The 
divergent reactivity of activated isocyanides is resulted from the unique divalent 
properties of the isocyanide group, which could serve both as an electrophile and a 
nucleophile. 
 





Over the past few decades, great efforts have been made to develop highly 
efficient methods for the construction of nitrogen heterocycles by employing activated 
isocyanides.[2] In this review, we will summarize the catalytic asymmetric reactions of 
activated isocyanides with various electrophiles, including carbonyl compounds, 
imines, activated alkenes and azodicarboxylates. A general mechanism is described in 
Scheme 1.1. Typically, all these reactions start with the formation of α-carbanion I 
from the deprotonation of activated isocyanide. The nucleophilic addition of this 
carbanion to the electrophile takes place to generate intermediate II. After the 
formation of II, there are two possibilities: 1) Direct protonation of II gives the 
acyclic product with regeneration of the catalyst (pathway a); 2) Addition of the 
newly formed anion in II to the isocyanide generates intermediate III followed by 
protonation to give the [3+2] cyclization product (pathway b). The selectivity of these 
two pathways depends on the nature of substrates used as well as the reaction 
conditions. The content of this review is organized based on the different types of 
electrophiles. 
 
1.2 Reaction with Carbonyl Compounds 
Typically, only [3+2] cycloaddition products (in this case, oxazolines) could be 
obtained from the reaction of activated isocyanides with carbonyl compounds, as the 





1.2.1 Transition-Metal Catalysis 
1.2.1.1 Gold(I) Catalysis 
In 1986, Ito and co-workers reported the first enantioselective synthesis of 
oxazoline from the reaction of isocyanoacetate with aldehydes, catalyzed by a chiral 
ferrocenylphosphine-Au(I) complex (Scheme 1.2).[3] Since then, this Au(I)-catalyzed 
aldol reaction has been thoroughly investigated and become a valuable method for the 
preparation of chiral oxazolines and their β-hydroxyamino acids derivatives.[4] 
 








In an effort to expand the scope of this catalytic system, various chiral 
ferrocenylphosphine ligands were synthesized and evaluated, for which 1.1a-e were 
proved to be highly effective (Figure 1.1). 
Detailed studies were performed to explain the origin of stereoselectivity of this 
Au(I)-system.[5] In addition to isocyanoacetates, other types of substrates, such as 
isocyanoacetamides[4f, 6] and (isocyanomethyl)phosphonates[7] were also employed in 
this reaction. 
Notably, this catalytic system could be applied to ketones as well (Scheme 1.3).[8] 
However, the level of stereoselectivity (both diastereo- and enantioselectivity) was 
generally lower than the reaction with aldehydes. Furthermore, it was limited to 
activated ketone substrates, such as α-ketoesters and α-diketones. 
 







1.2.1.2 Silver(I) Catalysis 
Except for gold, other transition metals such as silver has also been investigated 
in the asymmetric aldol reaction of activated isocyanides with aldehydes. The pioneer 
work was reported by Ito and co-workers using tosylmethyl isocyanide in 1990 
(Scheme 1.4).[9] In this reaction, the chiral ferrocenylphosphine ligand 1.1d or 1.1e 
was introduced to give the corresponding oxazolines in up to 86% ee. Aromatic, 
aliphatic as well as α,β-unsaturated aldehydes were all tolerated. This catalytic system 
was also applicable to the aldol reaction of isocyanoacetates.[10] 
 
Scheme 1.4 Ag(I)-Catalyzed Aldol Reaction of Tosylmethyl Isocyanide (Ito, 1990) 
 
 
In 2011, a new class of chiral amino phosphine ligands derived from cinchona 
alkaloids was developed by the Dixon group.[11] In combination with Ag2O, these 
ligands performed as effective catalysts for the synthesis of enantiomerically enriched 
oxazolines. Both mono-and disubstituted isocyanoacetates were tested to give the 




Scheme 1.5 Ag(I)-Catalyzed Aldol Reaction of Isocyanoacetates (Dixon, 2011) 
 
 
A catalyst activation mode was proposed. As shown in Figure 1.2, the 
coordination of isocyanide to silver (as Lewis acid) enhances the acidity of the 
α-proton thus facilitates the deprotonation by the quinuclidine nitrogen (as Brønsted 
base) to generate enolate; in the meantime, the aldehyde is activated by silver as well 
to promote the nucleophilic addition of the enolate. 
 
Figure 1.2 Proposed Catalyst Activation Mode 
 
 
This Ag(I)-catalyzed asymmetric aldol reaction could be applied to the synthesis 
of complex structures, for instance, biologically active (-)-chloramphenicol.[12] 
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In addition to aldehydes, ketones were also tested in this system by the same 
group.[13] Various alkyl aryl ketones were examined to give the corresponding highly 
functionalized oxazolines in good to excellent stereoselectivities (Scheme 1.6). It is 
noteworthy that this is the first asymmetric aldol reaction of isocyanoacetates with 
unactivated ketones and is complementary to Ito and Hayashi’s work[8]. 
 
Scheme 1.6 Ag(I)-Catalyzed Aldol Reaction of Unactivated Ketones (Dixon, 2015) 
 
 
Functionalized ketones, such as isatins were investigated in the transition-metal 
catalyzed aldol reaction of isocyanoacetates as well. In 2015, a cooperative chiral 
guanidine/silver(I) catalytic system was developed to realize the asymmetric reaction 
of isocyanoacetates with isatins.[14] Series of spirooxindole oxazolines with two 





Scheme 1.7 Asymmetric Aldol Reaction with Isatins (Liu and Feng, 2015) 
 
 
A transition state was proposed, where both of the two substrates were activated 
by the catalysts (Figure 1.3). The coordination of isocyanide coordinates to silver 
increases the acidity of the α-proton. Simultaneously, the guanidinium salt, generated 
in situ from the reaction of guanidine catalyst 1.10 with the Brønsted acid, activates 
isatin through organized multiple hydrogen-bonding interactions. This transition state 
results in the attack of isocyanoacetate from its Re-face to the Si-face of isatin, leading 
to the construction of two adjacent stereocenters. Subsequent intramolecular 
cyclization affords the spriocyclic skeletons. 
 




1.2.1.3 Palladium(II) and Platinum(II) Catalysis 
Other than gold and silver complexes, chiral palladium and platinum complexes 
have also been evaluated in the asymmetric aldol reaction of isocyanoacetates with 
aldehydes. 
The first example was described by Pregosin and co-workers in 1993.[15] In this 
study, chiral Pd(II) and Pt(II)-complexes 1.12a-c were tested in the reaction of methyl 
isocyanoacetate with benzaldehyde. All these complexes showed high efficiency but 
with poor stereoselectivity (Scheme 1.8). 
 






From then on, a variety of chiral Pd(II)- and Pt(II)-complexes[16] have been 
examined in this reaction (Scheme 1.8). Typically, high yields could be obtained, 
suggesting that Pd(II) and Pt(II) might be alternatives to Au(I) and Ag(I) and worth 
consideration in the future. The formation of trans-diastereomers was preferred. 
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However, no catalyst achieved acceptable level of diastereo- and enantioselectivity. 
The poor stereoselectivity probably resulted from the displacement of the chiral 
ligand from the metal with isocyanoacetate.[17] Hence, the development of an effective 
chiral Pd(II) or Pt(II)-complex regarding to high stereoselcvity is extremely desired. 
 
1.2.1.4 Cobalt(II) catalysis 
In 2011, the Oh group developed a cooperative catalytic system involving a chiral 
Co(II)-catalyst and an achiral thiourea co-catalyst for the asymmetric aldol reaction of 
isocyanoacetates (Scheme 1.9).[18] Aryl, heteroaryl, and alkyl aldehydes were all 
tolerated to give the corresponding oxazolines in good to excellent stereoselectivities. 
 




It is worth noting that in this system, isocyanide does not coordinate to metal 
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(different from Au and Ag); instead, it is activated by the thiourea 1.27 through a 
strong anion-bonding interaction. This interaction potentially disturbs the intrinsic 
metal-isocyanide complexation and might be critical to the stereocontrol.[18] To be 




In contrast to transition-metal catalyzed asymmetric aldol reactions of activated 
isocyanides, only a few organocatalytic variations have been developed. 
 




In 2009, Gong and co-workers reported the first organocatalytic stereoselective 
synthesis of oxazolines by employing a cinchona alkaloid derivative as catalyst 
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(Scheme 1.10).[19] Generally, electron-poor benzaldehydes worked fairly well, 
whereas electron-neutral as well as aliphatic aldehydes resulted in low yields even 
with prolonged reaction time. Monosubstituted isocyanoacetate could also be used to 
give the desired product, albeit with moderate enantioselectivity. 
In addition to aldehydes, ketones have also been applied in organocatalytic 
asymmetric aldol reaction of activated isocyanides. In 2013, Zhao and co-workers 
described a stereoselective [3+2] cycloaddition reaction of isocyanoacetates with 
isatins catalyzed by a cinchona alkaloid-derived thiourea catalyst.[20] Spirooxindole 
oxazolines with two adjacent quaternary stereocenters were obtained in good yields 
with good to excellent stereoselectivities (Scheme 1.11). 
 
Scheme 1.11 Organocatalytic Asymmetric Reaction of Isocyanoacetates with Isatins 
(Zhao and Shi, 2013) 
 
 
In this system, isocyanoacetate was deprotonated by the quinuclidine nitrogen of 
catalyst 1.31, leading to the formation of hydrogen-bonding interaction between the 
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enolate and the tertiary amine. In the meantime, isatin was activated through multiple 
hydrogen bonds formed between the two carbonyl groups of isatin and the 
hydrogen-bonding donor moiety of 1.31. Other than hydrogen-bonding interactions, 
concurrent π-π stacking between the two substrates might be responsible for the 
stereoselectivity as well.[20] 
 
1.3 Reaction with Imines 
In most cases, [3+2] cycloaddition products (in this case, imidazolines) were 
obtained from the reaction of activated isocyanides with imines (refer to pathway b, 
Scheme 1.1). However, acyclic adducts (refer to pathway a) could also be generated 
depending on the specific reaction environment. 
 
1.3.1 Transition-Metal Catalysis 
 
Scheme 1.12 Au(I)-Catalyzed Enantioselective Synthesis of Imidazolines (Lin, 1999) 
 
 
The first transition-metal catalyzed enantioselective synthesis of imidazolines 
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from isocyanoacetates and imines was described in 1999 by Lin and co-workers, 
employing a chiral ferrocenylphosphine-Au(I) complex similar to Ito and Hayashi’s 
system (Scheme 1.12).[21] However, only moderate enantioselectivities were obtained. 
Palladium(II)-pincer complexes 1.34a-d were identified as efficient catalysts for 
the reaction of isocyanoacetates with imines as well (Scheme 1.13).[22] In contrast to 
Lin’s report, this system showed a tendency for the selective formation of 
trans-diastereomer (up to 4:1 trans/cis). 
 





In 2014, the Dixon group reported the asymmetric reaction of isocyanoacetates 
with ketimines by employing their own catalytic system[11, 13] (Scheme 1.14).[23] In 
this study, various N-diphenylphosphinoyl (DPP)-protected ketimines and 
isocyanoacetates were evaluated to give trans-imidazolines in high yields with good 
to excellent stereoselectivities. Moreover, the cleavage of DPP group was realized by 
using a 1.0 M solution of HCl in dichloromethane at room temperature without any 
loss of the stereoselectivity. 
 




Alternatively, this Mannich-type reaction could be realized by introducing a 
chiral Cu(II) catalyst (Scheme 1.15).[24] In general, this catalytic system offered a 
cis-selective synthesis of imidazolines, which is different from Dixon’s work[23]. 
However, when dialkyl substituted ketimines were applied, the corresponding 
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trans-diastereomers were produced preferably. 
 




Scheme 1.16 Asymmetric Reaction of Isocyanoacetates with Cyclic Trifluoromethyl 
Ketimines (Zhao and Shi, 2014) 
 
 
Cyclic ketimines have also been investigated in this filed. In 2014, Zhao and 
co-workers reported an asymmetric reaction of isocyanoacetates with cyclic 
trifluoromethyl ketimines cooperatively catalyzed by a hydrogen-bonding donor 
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catalyst and silver acetate.[25] A variety of tetrahydroimidazo-[1,5-c]quinazoline 
derivatives were constructed in excellent yields with good to excellent 
stereoselectivities (Scheme 1.16). However, this reaction was limited to 
trifluoromethyl-substituted substrates. The replacement of the trifluoromethyl group 
with a methyl group resulted in no reaction under the optimal conditions. 
 




Except for ketimines, the reaction of isocyanoacetates with aldimines was 
investigated as well. In 2014, Zhao and co-workers developed a Ag(I)-catalyzed 
reaction of isocyanoacetates with α-imino esters (Scheme 1.17).[26] In this reaction, 
both functionalities of α-imino esters underwent [3+2] cyclization with 
isocyanoacetates to produce directly linked oxazole-imidazolines. The asymmetric 
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variant of this transformation was realized by introducing a Dixon-type chiral 
ligand[11, 13, 23] 1.41. Generally, α-imino esters with different substituents on the aryl 
ring were well tolerated, while ketimines turned out to be difficult substrates for the 
enantiocontrol. 
In order to better understand the mechanism, kinetic studies were performed, 
showing that the two cyclization reactions were stepwise (imine reacted first) and the 
enantioselectivity was determined in the first step. Based on this finding, this catalytic 
system was applied to the preparation of mono [3+2] cyclization adducts. Additionally, 





Scheme 1.18 Chiral Brønsted Base-Catalyzed Reaction of Isocyanoacetates with 




The first organocatalytic asymmetric reaction of isocyanoacetate with 
N-sulfonylimines was reported by Lu and co-workers in 2010 (Scheme 1.18).[27] A 
variety of cinchona alkaloid-derived Brønsted bases were examined in this reaction 
and 1.43 was determined to be the optimal choice. However, only moderate yields and 
enantioselectivities were obtained. 
In 2012, Nakamura and co-workers achieved the highly enantioselective 
synthesis of trans-imidazolines (up to 96% ee) by employing a chiral thiourea catalyst 
(Scheme 1.19).[28] In this study, the pyridinesulfonyl group in the imine substrates 
proved to be essential for the high stereoselectivity through hydrogen-bonding 
interaction towards the catalyst. The removal of this group could be realized by using 
magnesium in methanol without compromising stereoselectivity. 
 
Scheme 1.19 Chiral Thiourea-Catalyzed Reaction of Isocyanoacetates with 





In an effort to expand the substrate scope, isatin-derived ketimines were 
employed in the reaction with isocyanoacetates (Scheme 1.20).[29] In this study, a 
chiral thiourea 1.47 was used as the catalyst to achieve the stereoselective synthesis of 
Mannich adducts. Furthermore, these products could be transformed to functionalized 
spirooxindole imidazolines in high yields and without any loss of stereoselectivities 
by introducing another chiral thiourea catalyst 1.45. 
 
Scheme 1.20 Chiral Thiourea-Catalyzed Reaction of Isocyanoacetates with 
Isatin-Derived Ketimines (Zhao, 2015) 
 
 
1.4 Reaction with Activated Alkenes 
In general, the reaction of activated isocyanides with activated alkenes affords 
acyclic Michael addition adduct (refer to pathway a, Scheme 1.1) or [3+2] 
cycloaddition product (refer to pathway b, Scheme 1.1) depending on the nature of 
substrates used and the reaction conditions. This section is organized according to the 
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two reaction pathways. 
 
1.4.1 Michael Addition 
1.4.1.1 Transition-Metal Catalysis 
In 1987, Ito and co-workers reported the first palladium-catalyzed 
enantioselective allylation of isocyanoacetates with allylic acetates (Scheme 1.21).[30] 
By employing a chiral ferrocenylphosphine ligand 1.48, up to 39% ee was obtained. 
To be noted, this is the only example of transition-metal catalyzed asymmetric 
Michael addition of activated isocyanides. 
 
Scheme 1.21 Palladium-Catalyzed Enantioselective Allylation of Isocyanoacetates 




In 2012, Xu and co-workers presented the first organocatalytic asymmetric 
Michael addition of isocyanoacetates to maleimides catalyzed by a bifunctional 
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tertiary amine thiourea catalyst (Scheme 1.22).[31] Generally, the use of 
N-arylmaleimides resulted in better stereoselectivities than N-alkyl substituted 
substrates. In addition, the α-substituent of isocyanoacetates was essential to the 
stereoselectivity. When changing from phenyl to benzyl or methyl, only moderate 
diastereo- and enantioselectivities were obtained even with higher catalyst loading. 
This reaction could also be catalyzed by cinchona alkaloid or 
cyclohexane-1,2-diamine derived squaramide catalysts.[32] 
 
Scheme 1.22 Asymmetric Michael Addition of Isocyanoacetates to Maleimides (Xu 
and Wang, 2012) 
 
 
Complementary to cyclic substrates, acyclic activated alkenes were investigated. 
In 2013, Zhu and co-workers developed a chiral Brønsted base catalyzed 
enantioselective alkylation of isocyanoacetates with vinyl phenylselenone, affording 
enantioenriched α,α-disubstituted isocyanoacetates (Scheme 1.23).[33] Both aryl- and 
heteroaryl-substituted isocyanoacetates were well tolerated in this reaction. The 
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resulting Michael adduct 1.53b was used as a starting material to complete the total 
synthesis of (+)-trigonoliimine A. Moreover, this catalytic system was applied to the 
one-pot enantioselective synthesis of 1,3-oxazinan-2-ones.[34] 
 




Scheme 1.24 Asymmetric Michael Addition of Isocyanoacetates to 




In 2015, Zhao and Shi employed a cinchona alkaloid-derived squaramide catalyst 
to achieve the asymmetric Michael addition of isocyanoacetates to 
β-trifluoromethylated enones, affording the corresponding structures in excellent 
stereoselectivities (Scheme 1.24).[35] These adducts could be easily transformed into 
highly functionalized pyrrolines. Alternatively, these pyrrolines could be prepared 
directly from isocyanoacetates and β-trifluoromethylated enones through a one-pot 
procedure. 
 
Scheme 1.25 Asymmetric Michael Addition of Isocyanoacetates to Styrylisoxazoles 
and Subsequent Cyclization (Adamo, 2015) 
 
 
Phase-transfer catalysts have also been employed in the asymmetric Michael 
addition of isocyanoacetates to activated alkenes. In 2015, Adamo and co-workers 
described an asymmetric reaction of styrylisoxazoles and ethyl isocyanoacetate under 
phase-transfer catalysis, affording enantiomerically enriched Michael addition adducts 
in high enantioselectivities (Scheme 1.25).[36] Subsequent cyclization of these 
27 
 
compounds led to the formation of 2,3-dihydro-pyrroles in perfect diastereo- 
selectivities. 
A similar catalytic system was developed by the same research group to 
accomplish the asymmetric Michael addition of ethyl isocyanoacetate to 
(Z)-3-substituted-2-(4-pyridyl)-acrylonitriles.[37] 
 
1.4.2 [3+2] Cycloaddition 
1.4.2.1 Transition-Metal Catalysis 
In 2011, Escolano and co-workers reported the first asymmetric [3+2] cyclization 
reaction of isocyanoacetates with α,β-unsaturated ketones, leading to the construction 
of 2,3-dihydropyrroles (Scheme 1.26).[38] However, only moderate yields and 
enantioselectivities were achieved. 
 
Scheme 1.26 Asymmetric [3+2] Cycloaddition of Isocyanoacetates with 





Scheme 1.27 Asymmetric [3+2] Cycloaddition of Isocyanoacetates with 
2-Oxobutenoate Esters (Gong, 2011) 
 
 
At almost the same time, the Gong group presented an asymmetric [3+2] 
cycloaddition of isocyanoacetates with 2-oxobutenoate esters catalyzed by a chiral 
silver complex (Scheme 1.27).[39] Various 2-oxobutenoate esters and α-aryl substituted 
isocyanoacetates were tested in this reaction. Generally, the corresponding 
2,3-dihydropyrroles were formed in high yields and enantioselectivities with moderate 
diastereoselectivities. It is noteworthy that a crystal structure of this Ag-complex was 
obtained, in which the phosphorus coordinates to silver, while the hydroxyl proton 
forms a hydrogen-bond with one of the acetate oxygens. 
 
Scheme 1.28 Au(I)-Catalyzed [3+2] Cycloaddition of Isocyanoacetates with 





Instead of acyclic alkenes, cyclic substrates such as maleimides (previously 
recognized as Michael acceptors)[31-32] have also been applied in the asymmetric [3+2] 
cyclization reaction with isocyanoacetates.[40] In the presence of Au(I)-complex 1.60, 
the corresponding bicyclic pyrrolines were generated in high stereoselectivities 
(Scheme 1.28). In general, the use of disubstituted isocyanoacetates resulted in higher 
enantioselectivities than monosubstituted substrates. This reaction could also be 
realized by using a cooperative catalytic system.[41] 
In 2015, Zhao and co-workers reported the cyclization of allenoates with 
isocyanoacetates for the first time, affording a wide range of nitrogen heterocycles 
under silver catalysis (Scheme 1.29).[42] The asymmetric variant was also developed 
by employing a Dixon-type chiral ligand[11, 13, 23, 26] 1.35. In general, the use of 
monosubstituted isocyanoacetates resulted in the formation of highly substituted 3H 
pyrroles 1.62 in high yields with good to excellent enantioselectivities. It is worth 
noting that this is the first enantioselective synthesis of this class of heterocycles. In 
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contrast, highly functionalized pyrrolines 1.63 possessing an exocyclic olefin were 
constructed when disubstituted isocyanoacetates were employed. The formation of 
1.63 not only expanded the scope of this catalytic system but also provided strong 
support for the formation of 3H pyrroles through a [3+2] cyclization/1,3-H shift 
sequence. 
 
Scheme 1.29 Ag(I)-Catalyzed [3+2] Cycloaddition of Isocyanoacetates with 
Allenoates (Zhao, 2015) 
 
 
Very recently, an asymmetric cascade reaction of isocyanoacetates was developed 
by introducing a Dixon-type chiral ligand[11, 13, 23, 26, 42] 1.64 with AgNO3.
[43] A variety 
of cis-3a,8a-hexahydropyrrolo[2,3-b]indoles (HPIs) were obtained from the reaction 
of activated isocyanides with 2-(2-amidophenyl)acrylates (Scheme 1.30). 
Isocyanoacetates and isocyanoacetamides were employed in this reaction. Generally, 
good overall yields could be obtained but with moderate stereoselectivities. In terms 
of reaction mechanism, this reaction starts with the generation of cyclic imine 
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intermediates through [3+2] cyclization of activated isocyanides with the olefin 
moiety. Subsequent intramolecular nucleophilic addition of the amino group to the 
newly formed imines results in the formation of tricyclic frameworks. 
 
Scheme 1.30 Ag(I)-Catalyzed Asymmetric Cascade Reaction of Activated 




The first organocatalytic asymmetric [3+2] cyclization reaction of 
isocyanoacetates with nitroolefins was developed by the Gong group in 2008 (Scheme 
1.31).[44] Various cinchona alkaloid-derived Brønsted bases were evaluated in this 
reaction and 1.66 was determined to be optimal choice. Under the standard conditions, 
a number of highly functionalized 2,3-dihydropyrroles were generated with high 




Scheme 1.31 Chiral Brønsted Base Catalyzed [3+2] Cycloaddition of 
Isocyanoacetates with Nitroolefins (Gong, 2008) 
 
 
Isatin-derived alkenes have also been studied in the [3+2] cycloaddition reactions. 
In 2012, Xu and co-workers described a stereoselective cyclization reaction of 
isocyanoacetates with methyleneindolinones by introducing a quinine-derived 
bifunctional thiourea-tertiary amine catalyst (Scheme 1.32).[45] Various 
3,3’-pyrrolidinyl spirooxindoles were obtained in moderate diastereoselectivities with 
excellent enantioselectivities. Notably, only by changing the protecting groups on the 
alkene substrates, different diastereomers could be generated. The use of N-phenyl 
amide protected methyleneindolinones resulted in the selective formation of 
anti-diastereomers, whereas syn-isomers were generated preferably by employing 
N-tert-butoxycarbonyl (N-Boc) protected substrates. This method represents a new 
entry to substrate-induced diastereodivergent reactions. However, the origin of this 
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selectivity is not clear. 
 
Scheme 1.32 Diastereodivergent Cyclization of Isocyanoacetates with 
Methyleneindolinones (Xu and Wang, 2012) 
 
 
In the same year, an asymmetric three-component reaction of isatins, 
malononitrile and isocyanoacetates was developed by Yan and co-workers (Scheme 
1.33).[46] A variety of enantioenriched 3,3’dihydropyrryl spirooxindoles were obtained. 
The N-protecting group and α-substituent of isocyanoacetates proved to be crucial to 
the reactivity and stereoselectivity. Except for malononitrile, other analogous 
nucleophiles such as methyl cyanoacetate, diethyl malonate and ethyl nitroacetate, 
were also evaluated in this reaction. However, no desired product was observed. This 
three-component reaction proceeds through the formation of isatylidene malononitrile 
via the Knoevenagel condensation of isatin and malononitrile, followed by [3+2] 
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cycloaddition with isocyanoacetates. 
 
Scheme 1.33 Asymmetric Three-Component Reaction of Isatins, Malononitrile and 
Isocyanoacetates (Yan, 2012) 
 
 
The in situ utilization of the imine functionality, generated from formal [3+2] 
cyclization of isocyanoacetates with activated alkenes, would not only expand the 
scope of this cycloaddition reaction but also result in the construction of complex 
structures in a single step manner. 
In 2014, the Smith group developed an enantioselective synthesis of 
pyrroloindolines through a cascade reaction of isocyanoacetates under phase-transfer 
catalysis (Scheme 1.34).[47] By incorporating an amino group into the alkene 
substrates, the imine intermediates could be trapped by intramolecular nucleophilic 
addition to give the tricyclic architectures. Interestingly, when treating with 
tetra-n-butyl ammonium bromide (TBAB) and K2CO3, pyrroloindoline 1.70 could be 
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transformed into a spriocyclic scaffold 1.71 without any loss of stereoselectivity. The 
spirocycle 1.71 was probably formed through ring opening of the indoline ring with 
subsequent amide formation from the addition of the urea nitrogen to the benzylic 
ester (Figure 1.4). 
 
Scheme 1.34 Asymmetric Cascade Reaction of Isocyanoacetates under 
Phase-Transfer Catalysis (Smith, 2014) 
 
 
Figure 1.4 Proposed Mechanism for the Formation of Spirocycle 
 
 
1.5 Reaction with Azodicarboxylates 
In addition to carbonyl compounds, imines and activated alkenes, 
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azodicarboxylates have also been investigated in the asymmetric reaction with 
activated isocyanides, leading to the construction of enantioenriched 1,2,4-triazolines 
(refer to pathway b, Scheme 1.1). 
The pioneer work was reported by Jørgensen and co-workers employing a 
cinchonine-derived phase-transfer catalyst (Scheme 1.35).[48] Excellent yields but 
moderate enantioselectivities (only up to 60% ee) were obtained. 
 
Scheme 1.35 Asymmetric [3+2] Cyclization of Isocyanoacetates with 
Azodicarboxylates (Jørgensen, 2011) 
 
 




A chiral N,N’-dioxide/Fe(II) complex was employed to achieve the highly 
enantioselective synthesis of 1,2,4-triazolines (Scheme 1.36).[49] Various 
alkyl-substituted isocyanoacetates and azodicarboxylates bearing different esters were 
examined, affording the corresponding adducts in high yields and enantioselectivities. 
However, the absolute configuration of the products was not assigned. 
 
Scheme 1.37 Asymmetric Synthesis of 1,2,4-Triazolines (Zhao and Shi, 2013) 
 
 
Alternatively, this reaction cloud be realized by using a cinchona alkaloid-derived 
squaramide catalyst (Scheme 1.37).[50] In contrast to Liu and Feng’s report, the use of 
alkyl-substituted isocyanoacetates resulted in low yields or no reaction under the 
standard conditions. Moreover, cyclic substrate was investigated in this reaction, but 
with no desired product formation. 
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1.6 Conclusion and Outlook 
In summary, in the past few decades, catalytic asymmetric reactions of activated 
isocyanides have been explored with the development of a number of catalytic 
systems. Different types of electrophiles, including carbonyl compounds, imines, 
activated alkenes and azodicarboxylates have been employed, affording a wide range 
of enantiomerically enriched molecules. 
Despite of these great achievements, limitations still remained. For instance, only 
five-membered ring structures could be accessed through the cyclization reactions. 
The development of new catalytic system for the stereoselective synthesis of medium 
ring (such as 6 or 7-membered) skeletons is in high demand. Although 
multicomponent reactions (MCRs) and cascade reactions have proven to be the most 
useful strategies for the construction of complex scaffolds, only a few examples of 
these types[26, 43, 46-47] are presented in this filed. Future studies should focus on the 
exploration of new reactivities of activated isocyanides in order to address these 
limitations. Additionally, the application of these existing methods in the synthesis of 















Chapter 2 Highly Diastereo- and Enantioselective 















The generation of complexity and diversity in molecular structure in an efficient 
and economical fashion is an important goal in organic synthesis and chemical 
biology,[51] for which cascade reactions[52] and multicomponent reactions (MCRs)[53] 
have proven to be the most powerful approaches. Along these lines, isocyanoacetates 
(as functionalized isocyanides)[2, 54] have found wide application not only in classical 
Passerini and Ugi type MCRs, but also proven to be a versatile functionality to react 
with various electrophiles, such as carbonyls,[3, 8, 10-11, 18-19] imines,[21, 27-28, 55] 
α,β-unsaturated carbonyls,[31, 39-40, 44] activated alkenes/alkynes,[56] etc. to deliver a 
wide range of nitrogen heterocycles. The combination of these reactions with further 
functionalization of the products in a tandem fashion has also been thoroughly studied, 
in particular by the Zhu Group to produce more complex scaffolds.[57] 
 
Scheme 2.1 Double Cyclization with Both Imine and Ester Functionalities 
 
 
We present here a conceptually different complexity-generating method, i.e., both 
functionalities in α-imino esters (previsouly recognized as activated imines only) 
undergo cyclization with isocyanoacetate to give directly linked 
oxazole-imidazolines[58] under silver catalysis (Scheme 2.1). The asymmetric variant 
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has also been developed by employing Dixon-type catalyst[11] to produce these 
compounds in high diastereo- and enantiopurity, which can be further converted to 
other valuable, highly functionalized entities. 
 
2.2 Project Design 
Our attention was drawn to this possibility of double cyclization during our initial 
attempts of oxazole formation from the reaction between isocyanoacetates and esters, 
which should be more functional group tolerant and easier to handle than the use of 
strong acylating reagents such as acid chlorides (Scheme 2.2).[2] Such a combination, 
however, was known to fail to react even under harsh conditions, due to the low 
reactivity of the enolate derived from isocyanoacetate towards ester.[59] We argued that 
the use of aryl esters could be beneficial, as the better leaving group of aryloxide 
(compared with simple alkoxide from alkyl esters) should facilitate the addition of the 
enolate to the ester. 
 




Indeed, this led to the efficient synthesis of oxazole from different aryl esters 2.1 
and activated isocyanides 2.2 (methyl isocyanoacetate or toluenesulfonylmethyl 
isocyanide) by the use of stoichiometric strong base (71-99% yield for 2.3a-2.3c with 
the use of 2 equiv of NaH). For oxalate 2.4, interestingly, the bis-oxazole 2.5 could be 
generated with excellent yield by using a much milder Ag-catalyzed procedure, which, 
on the other side, failed to yield 2.3a-2.3c at all. Clearly there is a synergetic effect 
between the ester functionalities in 2.4, which led us to consider substrates bearing 
different functionalities that could mutually activate each other for the reaction with 
isocyanoacetate to give complex molecules. 
 
2.3 Results and Discussion 
2.3.1 Optimization of Reaction Conditions 
To demonstrate this idea, the readily available cyclic α-imino ester 2.6a was 
chosen as the model substrate due to its unique α-imino aryl ester structure.[60] 
Notably, the proposed double cyclization with both imine and aryl ester moieties with 
isocyanoacetate will be entirely atom-economical as the product incorporates all 
portions from the starting materials. It is also worth noting that the reaction of 
isocyanoacetates (or isocyanoacetamides) with imines is known to follow divergent 
pathways to produce either imidazoline[21, 27-28, 55d] or oxazole (initiated by isocyanide 
addition to activated imines).[55a-c] These factors, combined with the reaction at the 
aryl ester functionality, could in principle lead to a complex mixture. 
As shown in Table 2.1, a variety of metal salts of different levels of basicity or 
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Lewis acidity was evaluated for the reaction of 2.6a and 2.2a at ambient temperature. 
Gratifyingly, the desired double [3+2] cyclization product 2.7a could be obtained 
cleanly (>20:1 d.r.) when Cu and Ag salts possessing strong basicity were used, with 
Ag2O and Ag2CO3 being the optimal choices (99% yield). In contrast, other Zn or Au 
salts and even strong Lewis acids such as BF3·OEt2 or Sc(OTf)3 failed to promote the 
reaction. This led us to speculate that this may be a base-catalyzed process, in which 
the Mannich reactivity of 2.2a predominates to yield imidazoline with concomitant 
oxazole formation from reaction with the aryl ester moiety. 
 
Table 2.1 Metal Salt Screening for Double [3+2] Cyclization of 2.6a and 2.2a[a-b] 
 
entry metal salt yield (%)[b]  entry metal salt yield (%)[b] 
1 Cu2O 72  7 Ag2O 99 
2 Cu(OAc)2 40  8 Ag2CO3 99 
3 CuCl2 <2  9 AgBF4 <2 
4 ZnCl2 <2  10 AgOTf <2 
5 AuCl3 <2  11 BF3·OEt2 <2 
6 AgOAc 90  12 Sc(OTf)3 <2 




Table 2.2 Ligand Screening for Enantioselective Double [3+2] Cyclization[a-c] 
 
entry 2.8 yield (%)[b] ee (%)[c]  entry 2.8 yield (%)[b] ee (%)[c] 
1 2.8a 95 <2  6 2.8f 99 72 
2 2.8b 98 <2  7 2.8g 99 58 
3 2.8c 67 <2  8 2.8h 95 14 
4 2.8d 99 81  9 2.8i 95 -3 
5 2.8e 99 79  10 2.8j 99 <2 
 
 
[a] Carried out in air for 24 h. [b] Isolated yields. [c] Determined by HPLC analysis. 
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With an efficient reaction in hand, we turned our attention to the development of 
an asymmetric variant by evaluating Cu or Ag complexes supported by various chiral 
ligands. After extensive experimentation, Ag2O turned out to be the most promising 
choice of metal salt, the screening data of which with different chiral ligands is 
summarized in Table 2.2. Initially we focused on simple quinine amides we recently 
disclosed for silicon activation and Cu catalysis,[61] which, to our disappointment, led 
to no asymmetric induction at all (entries 1-3). 
Inspired by the recent report from the Dixon group on enantioselective 
isocyanoacetate aldol reaction catalyzed by Ag complex with a new family of 
cinchona-derived amino phosphine ligands,[11, 23] we tested the related 2.8d-2.8g for 
our reaction. The use of quinine-derived phosphine 2.8d with Ag2O gratifyingly 
yielded 2.7a with a good ee of 81% (entry 4). Modification on the structure of 2.8d as 
reported by the Dixon group (reduction to 2.8e or use of cinchonidine-derived 
2.8f-2.8g)[11] unfortunately all led to lower ee (entries 5-7). The structurally related 
imine 2.8h was also tested, which proved to be much less selective (entry 8). The 
simple chiral phosphine-containing amide 2.8i was not enantioselective at all, 
implying the importance of quinuclidine moiety for the asymmetric induction in 
addition to the phosphine amide moiety (entry 9). Finally, the use of 
pyridyl-containing 2.8j[62]yielded racemic product (entry 10).  
Further optimization of reaction conditions was carried out (Table 2.3). With the 
optimal ligand identified, the use of Ag2CO3 instead of Ag2O resulted in a lower 67% 
ee (entry 1). Various solvents were examined next (entries 2-6) and THF was proved 
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to be the optimal choice. To our delight, lowering the reaction temperature led to a 
dramatic increase in the enantioselectivity. When the reaction was carried out at -20 
oC, 2.7a was obtained in excellent 99% yield with 98% ee (entry 8). Decreased 
catalyst loading of 5 mol% Ag2O with 10 mol% 2.8d yielded 2.7a in high 97% yield 
but with a lower ee of 90% (entry 9). 
 
Table 2.3 Further Optimization of Reaction Conditions[a-d] 
 
entry Ag salt (x) 2.8d (y) solvent temp (oC) yield (%)[b] ee (%)[c] 
1 Ag2CO3 (10) 20 THF 24 96 67 
2 Ag2O (10) 20 EtOAc 24 85 73 
3 Ag2O (10) 20 TBME 24 <2 n.d.
[d] 
4 Ag2O (10) 20 Et2O 24 <2 n.d.
[d] 
5 Ag2O (10) 20 CH2Cl2 24 65 75 
6 Ag2O (10) 20 toluene 24 <5 n.d.
[d] 
7 Ag2O (10) 20 THF 0 98 83 
8 Ag2O (10) 20 THF -20 99 98 
9 Ag2O (5) 10 THF -20 97 90 
[a] Carried out in air for 24 h. [b] Isolated yields. [c] Determined by HPLC analysis. 
[d] n.d. = not determined. 
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2.3.2 Substrate Scope 
With the optimal reaction conditions in hand, the substrate scope of this system 
was studied next (Scheme 2.3). It is worth noting that in almost all cases perfect 
diastereoselectivity was obtained for product 2.7 with an anti-diamine moiety. 
 
Scheme 2.3 Scope for Enantioselective Double [3+2] Cyclization of 2.6 and 2.2[a-d] 
 
[a] -20 °C. [b] 24 oC. [c] -20 oC for 12 h, then 0 oC for 12 h. [d] 0 oC. 
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As shown, isocyanoacetates bearing different ester groups were all suitable 
substrates to produce 2.7a-2.7e in uniformly high yields and excellent ee (91-99%). 
Different substitution patterns on the aryl ring (para-, meta- and ortho-) could be 
well-tolerated to form highly functionalized imidazolines with different phenol units 
with excellent enantioselectivity (2.7f-2.7l). Ketimines turned out to be difficult 
substrates for the double cyclization. A mixture of mono [3+2] cycloaddition product 
(with imine) and the desired product 2.7m was obtained for methyl substituted 
ketimine. Surprisingly a different syn-diastereomer was formed, with a lower ee of 
37%. 
It is noteworthy that the current catalytic system is simple to perform with 
catalysts that can be easily prepared from inexpensive starting materials. The 
reactions were set up open to air with no need for exclusion of air or moisture. The 
level of diastereo- and enantioselectivity compares favorably with previously reported 
Mannich reaction of isocyanoacetate with imines,[27-28, 55d] with the additional 
advantage of complexity generation from concomitant imidazoline and oxazole 
formation. 
 
2.3.3 Mechanistic Study 
In an effort to better understand the mechanism of the system, the kinetics of the 
reaction between 2.6a and 2.2a was monitored by NMR (Scheme 2.4). With a lower 
catalyst loading and in turn decreased reaction rate, the two cyclization reactions were 
identified to be stepwise. Strikingly, an essentially full conversion of 2.6a to mono 
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cyclization product 2.9a was observed within 60 min at 21 °C before the formation of 
2.7a started to expedite. As expected, the enantioselectivity was determined at the first 
step; 2.9a and 2.7a were obtained with the same 79% ee. 
 




2.3.4 Isolation of Mono [3+2] Cyclization Products and Three-Component 
Reactions 
While the nature of this stepwise reaction profile necessitates further 
investigation, it provided more possibilities for our methodology to produce 
structurally different compounds.  
As shown in Scheme 2.5 (part a), the mono [3+2] cyclization products 2.9a-g 
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could be isolated in high yield with good to excellent ee when the reaction was carried 
out at -20 °C with 2.2 as the limiting reagent. Alternatively, a three-component 
reaction of two different isocyanoacetates with 2.6a could also be realized (part b); 
2.2e and 2.2a were added sequentially to yield 2.7n in 67% yield with 97% ee. In 
addition, the use of disubstituted isocyanoacetates such as 2.2f could lead to a smooth 
[3+2] cycloaddition with 2.6a, which was followed by the cyclization of 2.2a with the 
ester unit in the intermediate to yield 2.7o with 73% yield and a slightly lower ee of 
71%. X-ray analysis of 2.7o further confirmed the directly linked oxazole-imidazoline 
structure of the products. 
 









Scheme 2.6 Derivatization of 2.7 to α,β-Diamino Esters and Imidazolinium Salt 
    
 
 
The products of this reaction can be easily transformed into useful entities in 
asymmetric catalysis. The imidazoline moiety could be readily hydrolyzed under 
52 
 
acidic conditions to yield highly functionalized α,β-diamino esters such as 2.10 in 
high yield without any loss of stereoselectivity (part a, Scheme 2.6), X-ray analysis of 
which confirmed the relative and absolute configuration of products 2.7. Formamide 
2.10 has been identified to be highly efficient Lewis base catalyst for the addition of 
allyltrichlorosilane to aliphatic aldehydes, a process that was seriously hampered in 
most previous systems due to chloride addition to aldehyde.[61a] Systematic 
optimization is ongoing with compounds 2.7a-m and related analogs, the results of 
which will be reported in due course. 
Alternatively, 2.7a was converted to the imidazolinium salt 2.11 in high yield 
upon treatment with alkylating reagent such as methyl iodide (part b, Scheme 2.6). 
The application of related compounds as bidentate NHC-phenoxide ligand in 
enantioselective catalysis has been beautifully demonstrated by the Hoveyda group.[63] 
The unique structure bearing multiple functionalities in our products may provide new 
opportunities in asymmetric catalysis. 
 
2.4 Conclusion 
In summary, we reported for the first time that aryl esters could react with 
isocyanoacetates to yield oxazoles. Based on this discovery, we have developed a 
novel complexity-generating method, in which both functionalities of α-imino esters 
undergo stereoselective [3+2] cyclization with isocyanoacetates to produce directly 
linked oxazole-imidazolines and in turn highly functionalized α,β-diamino esters and 
imidazolinium salts in high diastereo- and enantiopurity. 
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2.5 Experimental Section 
2.5.1 General Information 
1H and 13C NMR spectra were recorded on a Bruker AFC 300 (300 MHz) or 
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference: 1H 
(chloroform δ 7.26; DMSO δ 2.50), 13C (chloroform δ 77.0; DMSO δ 39.5). Data are 
reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet, br = broad), coupling constants (Hz) and integration. Melting 
point (MP) was obtained on Buchi B-540. For thin layer chromatography (TLC), 
Merck pre-coated TLC plates (Merck 60 F254) were used, and compounds were 
visualized with a UV light at 254 nm. High resolution mass spectra (HRMS) were 
obtained on a Finnigan/MAT 95XL-T spectrometer. Optical rotations were recorded 
on an mrc AP81 automatic polarimeter. Enantiomeric excesses (ee) were determined 
by HPLC analysis on Agilent HPLC units, including the following instruments: pump, 
LC-20AD; detector, SPD-20A; column, Chiralcel OD-H, Chiralpak AD-H, AS-H and 
IE. 
Unless otherwise noted, all the reactions were carried out in air. Dichloromethane, 
diethyl ether (Et2O), tetrahydrofuran (THF), and toluene were dried over a Pure Solv 
solvent purification system. Deuterated solvents were purchased from Cambridge 
Isotope Laboratories and used as received without further purification. Methyl 
isocyanoacetate (2.2a) and ethyl isocyanoacetate (2.2b) were purchased from Alfa 
Aesar company. tert-Butyl isocyanoacetate (2.2d)[64] and methyl 2-isocyano-3- 
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phenylpropanoate (2.2f)[65] were prepared by literature procedures. Other chemicals 
were purchased from commercial suppliers and used as received without further 
purification. 
 
2.5.2 Synthesis of Ligand 
 
To the solution of 9-amino(9-deoxy) epi-quinine (2.00 g, 6.19 mmol) in 
anhydrous CH2Cl2 (100 mL) was added 2-(diphenylphosphino)benzoic acid (2.10 g, 
6.81 mmol), 4-dimethylaminopyridine (151 mg, 1.20 mmol) and N,N'-dicyclohexyl- 
carbodiimide (1.40 g, 6.81 mmol). The reaction mixture was stirred at ambient 
temperature for 24 h, concentrated and purified by flash chromatography 
(hexanes/ethyl acetate 1:3) to yield 3.4 g (90%) of 2.8d as a white solid. Optical 
Rotation: [α]D25 = -7.2 (c 0.3, CHCl3); 1H NMR (500 MHz, CDCl3): δ 8.65 (d, J = 
4.4 Hz, 1H), 8.02 (d, J = 9.5 Hz, 1H), 7.75 (s, 1H), 7.68-7.66 (m, 1H), 7.38-7.32 (m, 
3H), 7.29-7.24 (m, 9H), 7.19-7.16 (m, 4H), 6.94-6.92 (m, 1H), 5.76-5.69 (m, 1H), 
5.51 (br s, 1H), 4.99-4.95 (m, 2H), 3.96 (s, 3H), 3.17-3.12 (m, 2H), 3.04 (br s, 1H), 
2.67-2.56 (m, 2H), 2.27-2.23 (m, 1H), 1.64-1.63 (m, 1H), 1.60-1.54 (m, 1H), 
1.46-1.42 (m, 1H), 0.92-0.89 (m, 1H); 13C NMR (125 MHz, CDCl3) (C-P coupling 
not removed): δ 168.6, 157.5, 147.3, 144.5, 141.3, 141.2, 141.1, 137.1, 137.0, 136.8, 
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136.7, 135.4, 135.3, 134.0, 133.5, 133.4, 133.4, 133.3, 131.3, 129.9, 128.5, 128.5, 
128.3, 128.3, 128.3, 128.2, 128.2, 128.1, 121.4, 114.2, 102.1, 55.7, 55.5, 40.8, 39.3, 
27.7, 27.2, 26.0; 31P NMR (202 MHz, CDCl3): δ -10.2; MP: 172-173 °C; HRMS 
(ESI): m/z calcd. for [C39H39N3O2P, M+H]
+: 612.2774; found: 612.2801. 
 
 
To the solution of 2.8d (0.60 g, 0.98 mmol) in EtOH (30 mL) was added 10% 
Pd/C (60 mg). The reaction mixture was stirred under a hydrogen atmosphere for 12 h 
at ambient temperature, and then filtered through celite washing with EtOH (3×20 
mL). The filtrate was concentrated and purified by flash chromatography 
(hexanes/ethyl acetate 1:3) to yield 540 mg (90%) of 2.8e as a white solid. Optical 
Rotation: [α]D25 = -13.9 (c 0.3, CHCl3); 1H NMR (500 MHz, CDCl3): δ 8.66 (d, J = 
4.5 Hz, 1H), 8.03 (d, J = 8.8 Hz, 1H), 7.72 (d, J = 2.5 Hz, 1H), 7.67-7.65 (m, 1H), 
7.40-7.36 (m, 2H), 7.32-7.25 (m, 10H), 7.22-7.15 (m, 4H), 6.95-6.92 (m, 1H), 5.43 
(br s, 1H), 3.99 (s, 3H), 3.14-3.09 (m, 2H), 2.96 (br s, 1H), 2.63-2.58 (m, 1H), 
2.27-2.24 (m, 1H), 1.63-1.57 (m, 2H), 1.51-1.46 (m, 1H), 1.42-1.39 (m, 1H), 
1.37-1.32 (m, 1H), 1.26-1.20 (m, 2H), 0.92-0.88 (m, 1H), 0.82 (t, J = 7.3 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) (C-P coupling not removed): δ 168.8, 157.6, 147.4, 144.6, 
141.6, 141.3, 137.3, 137.2, 136.9, 136.8, 135.5, 135.4, 134.1, 133.7, 133.6, 133.5, 
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133.4, 131.4, 130.0, 128.6, 128.6, 128.4, 128.4, 128.3, 128.3, 128.2, 121.4, 102.2, 
57.5, 55.6, 41.0, 37.2, 28.5, 27.3, 25.9, 25.1, 11.9; 31P NMR (202 MHz, CDCl3): δ 





To the solution of 9-amino(9-deoxy) epi-quinine (323 mg, 1.00 mmol) in 
anhydrous CH2Cl2 (50 mL) were added 2-(diphenylphosphino)benzaldehyde (290 mg, 
1.00 mmol) and molecular sieves (4 Å) (1.00 g). The reaction mixture was stirred at 
ambient temperature for 24 h, concentrated and purified by flash chromatography 
(hexanes/ethyl acetate 1:1) to yield 488 mg (82%) of 2.8h as a pale yellow solid. 
Optical Rotation: [α]D25 = -23.2 (c 0.3, CHCl3); 1H NMR (500 MHz, CDCl3): δ 9.04 
(d, J = 5.7 Hz, 1H), 8.70 (d, J = 4.4 Hz, 1H), 8.12-8.10 (m, 1H), 8.04 (d, J = 9.5 Hz, 
1H), 7.76 (s, 1H), 7.43-7.34 (m, 6H), 7.30-7.25 (m, 3H), 7.21-7.21 (m, 5H), 6.85-6.83 
(m, 1H), 5.80-5.73 (m, 1H), 5.00-4.94 (m, 2H), 4.82 (d, J = 9.5 Hz, 1H), 4.02 (s, 3H), 
3.53-3.48 (m, 1H), 3.11-3.06 (m, 1H), 2.98-2.92 (m, 1H), 2.68-2.64 (m, 1H), 
2.47-2.42 (m, 1H), 2.23-2.18 (m, 1H), 1.61-1.59 (m, 1H), 1.49-1.46 (m, 2H), 
1.37-1.32 (m, 1H), 0.84-0.80 (m, 1H); 13C NMR (125 MHz, CDCl3) (C-P coupling 
not removed): δ 159.9, 159.7, 157.4, 147.6, 145.4, 144.8, 141.9, 139.2, 139.1, 137.3, 
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137.2, 136.4, 136.3, 136.2, 134.1, 134.0, 133.9, 133.7, 133.1, 131.6, 130.4, 128.7, 
128.7, 128.6, 128.6, 128.5, 128.4, 128.3, 128.0, 128.0, 127.9, 121.4, 121.2, 114.1, 
102.5, 60.1, 56.3, 55.6, 40.5, 39.8, 28.2, 27.9, 25.8; 31P NMR (202 MHz, CDCl3): δ 





To the solution of (S)-1-(naphthalen-1-yl)ethanamine (342 mg, 2.00 mmol) in 
anhydrous CH2Cl2 (10 mL) were added 2-(diphenylphosphino)benzoic acid (765 mg, 
2.50 mmol), 4-dimethylaminopyridine (24.4 mg, 0.20 mmol) and N,N'-dicyclohexyl- 
carbodiimide (618 mg, 3.00 mmol). The reaction mixture was stirred at ambient 
temperature for 12 h, concentrated and purified by flash chromatography 
(hexanes/ethyl acetate 4:1) to yield 910 mg (99%) of 2.8i as a white solid. Optical 
Rotation: [α]D25 = + 43.7 (c 0.3, CHCl3); 1H NMR (500 MHz, CDCl3): δ 8.22 (d, J = 
8.8 Hz, 1H), 7.89 (d, J = 8.2 Hz, 1H), 7.81 (d, J = 8.2 Hz, 1H), 7.59-7.56 (m, 2H), 
7.53 (t, J = 7.3 Hz, 1H), 7.42 (t, J = 7.6 Hz, 1H), 7.38-7.29 (m, 11H), 7.25-7.21 (m, 
2H), 6.97-6.95 (m, 1H), 6.26 (d, J = 7.6 Hz, 1H), 6.08-6.02 (m, 1H), 1.60 (d, J = 7.0 
Hz, 3H); 13C NMR (125 MHz, CDCl3) (C-P coupling not removed): δ 167.9, 141.7, 
141.5, 138.0, 137.1, 137.0, 136.7, 136.6, 135.6, 135.4, 134.1, 133.9, 133.8, 133.8, 
133.7, 131.1, 130.1, 128.8, 128.7, 128.7, 128.6, 128.6, 128.6, 128.5, 128.2, 128.0, 
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127.9, 126.5, 125.8, 125.1, 123.7, 122.6, 45.3, 20.4; 31P NMR (202 MHz, CDCl3): δ 




2.5.3 Synthesis of Isocyanoacetate 2.2 
2.2c and 2.2e were synthesized according to the procedure reported by Zhu.[66] 
 
Isopropyl isocyanoacetate (2.2c, known compound[67]) 
 
Pale yellow oil, 67% yield. 1H NMR (500 MHz, CDCl3): δ 5.13-5.06 (m, 1H), 4.17 (s, 
2H), 1.28 (d, J = 6.3 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 163.3, 160.9, 70.9, 
43.7, 21.5. 
 
Phenyl isocyanoacetate (2.2e) 
 
Brown wax, 49% yield. 1H NMR (500 MHz, CDCl3): δ 7.41 (t, J = 8.2 Hz, 2H), 7.29 
(t, J = 7.3 Hz, 1H), 7.15-7.13 (m, 2H), 4.47 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 
162.5, 162.0, 149.9, 129.6, 126.6, 120.9, 43.5. HRMS (EI), m/z calcd. for [C9H7NO2, 





2.5.4 Synthesis of α-Imino Esters 2.6 
 
General Procedure. The mixture of o-aminophenol (15 mmol), ethyl glyoxalate 
(6.0 mL, 30 mmol) and 4 Å MS (4 g) in toluene (100 mL) was refluxed for 24 h, and 
filtered through Celite washing with ethyl acetate. The filtrate was concentrated, 
purified by flash chromatography (hexanes/ethyl acetate 10:1) to afford 2.6. 
 
2H-Benzo[b][1,4]oxazin-2-one (2.6a, known compound[60]) 
 
Yellow solid, 56% yield, 1H NMR (500 MHz, CDCl3): δ 8.11 (s, 1H), 7.81 (dd, J = 
8.2 Hz, 1.9 Hz, 1H), 7.57-7.54 (m, 1H), 7.41-7.37 (m, 1H), 7.32 (dd, J = 8.2 Hz, 







Yellow solid, 44% yield. 1H NMR (CDCl3, 500 MHz): δ 8.08 (s, 1H), 7.59 (d, J = 1.3 
Hz, 1H), 7.35 (dd, J = 8.9 Hz, 1.9 Hz, 1H), 7.20 (d, J = 8.8 Hz, 1H), 2.45 (s, 1H); 13C 
NMR (125 MHz, CDCl3): δ 152.5, 146.2, 144.1, 135.6, 132.9, 130.9, 129.4, 116.3, 





Yellow solid, 84% yield. 1H NMR (CDCl3, 500 MHz): δ 8.15 (s, 1H), 8.02 (d, J = 2.5 
Hz, 1H), 7.78 (dd, J = 8.2 Hz, 1.9 Hz, 1H), 7.63-7.61 (m, 2H), 7.49 (t, J = 7.6 Hz, 2H), 
7.43-7.38 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 152.2, 146.6, 145.5, 139.1, 138.8, 
131.3, 130.7, 129.1, 128.0, 127.7, 127.0, 117.0; MP: 108-109 °C; HRMS (EI), m/z 




Yellow solid, 76% yield. 1H NMR (CDCl3, 500 MHz): δ 8.13 (s, 1H), 7.29-7.28 (m, 
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2H), 7.17-7.15 (m, 1H), 3.91 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 157.0, 152.5, 
146.6, 140.3, 131.5, 119.9, 117.3, 111.5, 55.9; MP: 132-133 °C; HRMS (EI), m/z 




Yellow solid, 27% yield. 1H NMR (CDCl3, 300 MHz): δ 8.13 (s, 1H), 7.80 (d, J = 3.6 
Hz, 1H), 7.52 (dd, J = 14.5 Hz, 3.8 Hz, 1H), 7.27 (d, J = 14.6 Hz, 1H); 13C NMR (75 
MHz, CDCl3): δ 151.6, 147.4, 144.8, 131.9, 131.6, 130.8, 129.0, 117.9; MP: 





Yellow solid, 91% yield. 1H NMR (CDCl3, 500 MHz): δ 8.09 (d, J = 2.6 Hz, 1H), 
7.65 (dd, J = 8.9 Hz, 3.2 Hz, 1H), 7.51-7.47 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 
151.4, 146.5, 146.3, 130.5, 130.1, 129.1, 125.8, 120.0; MP: 139-140 °C; HRMS (EI), 





Yellow solid, 62% yield. 1H NMR (CDCl3, 500 MHz): δ 8.09 (s, 1H), 7.77-7.75 (m, 
2H), 7.28 (t, J = 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 151.4, 146.7, 143.7, 
135.5, 132.1, 128.9, 126.1, 110.0; MP: 115-116 °C; HRMS (EI), m/z calcd. for 




Yellow solid, 59% yield. 1H NMR (CDCl3, 500 MHz): δ 8.11 (s, 1H), 7.39 (d, J = 
8.2 Hz, 1H), 7.30 (t, J = 8.2 Hz, 1H), 7.11 (d, J = 8.2 Hz, 1H), 3.97 (s, 3H); 13C 
NMR (125 MHz, CDCl3): δ 151.8, 147.1, 146.6, 136.1, 131.8, 125.0, 121.0, 114.1, 
56.5; MP: 144-145 °C; HRMS (EI), m/z calcd. for [C9H7NO3, M]: 177.0426; found: 
177.0421. 
 




The general procedure outlined above was followed (using ethyl pyruvate). Yellow 
solid, 59% yield. 1H NMR (CDCl3, 500 MHz): δ 7.71 (dd, J = 8.2 Hz, 1.3Hz, 1H), 
7.48-7.45 (m, 1H), 7.36-7.33 (m, 1H), 7.28 (t, J = 7.9 Hz, 1H), 2.57 (s, 3H); 13C 
NMR (125 MHz, CDCl3): δ 155.1, 153.1, 146.5, 131.1, 130.4, 128.5, 125.4, 116.3, 
21.2. 
 
2.5.5 Oxazole Formation from Aryl Esters 
 
General procedure. To a 10 mL vial charged with 2.1a (19.8 mg, 0.1 mmol) 
were added anhydrous DMF (1 mL) and 2.2a (14 µL, 0.15 mmol). NaH (60% 
dispersion in mineral oil) (8 mg, 0.2 mmol) was added at 0 oC. The reaction mixture 
was stirred at ambient temperature for 24 h, concentrated and purified by flash 
chromatography (hexanes/ethyl acetate 2:1) to yield 19.3 mg (95%) of 2.3a. 
 
Methyl 5-phenyloxazole-4-carboxylate (2.3a, known compound[69]) 
 
White solid. 1H NMR (500 MHz, CDCl3): δ 8.09-8.07 (m, 2H), 7.91 (s, 1H), 
7.50-7.47 (m, 3H), 3.95 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 162.4, 155.7, 148.9, 




Methyl 5-benzyloxazole-4-carboxylate (2.3b, known compound[70]) 
 
The general procedure outlined above was followed (using phenyl 2-phenylacetate). 
Colorless syrup, 71% yield. 1H NMR (500 MHz, CDCl3): δ 7.75 (s, 1H), 7.33-7.23 
(m, 5H), 4.40 (s, 2H), 3.94 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 162.4, 158.0, 
149.3, 135.8, 128.7, 127.1, 127.0, 52.1, 31.9. 
 
5-Phenyl-4-tosyloxazole (2.3c, known compound[71]) 
 
The general procedure outlined above was followed (using p-toluenesulfonylmethyl 
isocyanide). White solid, >99% yield. 1H NMR (500 MHz, CDCl3): δ 7.99-7.97 (m, 
2H), 7.90 (d, J = 8.2, 2H), 7.85 (s, 1H), 7.52-7.50 (m, 3H), 7.32 (d, J = 8.2, 2H), 2.42 
(s, 3H); 13C NMR (125 MHz, CDCl3): δ 152.7, 149.2, 145.0, 137.1, 135.6, 130.9, 
129.8, 129.0, 128.6, 128.3, 125.5, 21.7. 
 
Dimethyl [5,5'-bioxazole]-4,4'-dicarboxylate (2.5, known compound[72]) 
 
To a 10 mL vial charged with 2.4 (24.2 mg, 0.100 mmol) and Ag2O (2.3 mg, 
0.010 mmol) was added anhydrous THF (1 mL) and 2.2a (36 µL, 0.40 mmol). The 
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reaction mixture was stirred at ambient temperature for 24 h, concentrated and 
purified by flash chromatography (hexanes/ethyl acetate 2:1) to yield 24.5 mg (97%) 
of 2.5 as a white solid. 1H NMR (500 MHz, CDCl3): δ 8.08 (s, 2H), 3.87 (s, 6H); 13C 
NMR (125 MHz, CDCl3): δ 160.6, 151.7, 141.4, 133.0, 52.6. 
 
2.5.6 Metal Salt Screening for Double [3+2] Cyclization of 2.6a and 2.2a 
General procedure. To a 10 mL vial charged with metal salt (0.010 mmol) and 
2.6a (14.7 mg, 0.100 mmol) were added anhydrous THF (1 mL) and 2.2a (18 µL, 
0.200 mmol) at the ambient temperature. The reaction mixture was stirred for 24 h, 
and then concentrated and purified by flash chromatography (hexanes/ethyl acetate) to 
afford the product 2.7a. 
 
2.5.7 Double [3+2] Cyclization of Isocyanoacetate with Cyclic α-Imino Ester 
 
General procedure. To a 10 mL vial charged with 2.8d (12 mg, 0.020 mmol) and 
Ag2O (2.3 mg, 0.010 mmol) was added anhydrous THF (1 mL). The mixture was 
stirred at ambient temperature for 5 min, then cyclic α-imino ester 2.6 (0.1 mmol) and 
isocyanoacetate 2.2 (0.2 mmol) were added at the given temperature. The reaction 
mixture was stirred at the given temperature for the given time, and then concentrated, 
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purified by flash chromatography (hexanes/ethyl acetate) to afford the product 2.7. 
Racemic sample of 2.7 for the standard of chiral HPLC spectra was prepared 
using 10 mol% Ag2O as catalyst. 
 




The general procedure outlined above was followed (2.6a and 2.2a were added in one 
portion, stirred at -20 oC for 24 h). Colorless wax, 99% yield. 1H NMR (500 MHz, 
CDCl3): δ 7.89 (d, J = 1.9 Hz, 1H), 7.85 (s, 1H), 6.99-6.93 (m, 3H), 6.73-6.70 (m, 1H), 
6.45 (d, J = 7.6 Hz, 1H), 4.93 (dd, J = 7.9 Hz, 1.9 Hz 1H), 3.90 (s, 3H), 3.78 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 170.6, 161.4, 156.3, 154.4, 150.7, 150.6, 129.9, 
126.6, 124.8, 122.2, 119.9, 117.1, 72.2, 57.3, 52.9, 52.4; HRMS (ESI): m/z calcd. for 
[C16H16N3O6, M+H]
+: 346.1034; found: 346.1047. 
Optical Rotation: [α]25D = -85.9 (c = 0.2, CHCl3). The absolute configuration of 
2.7a was assigned by analogy to 2.7k. 98% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 










The general procedure outlined above was followed (2.6a and 2.2b were added in one 
portion, stirred at -20 oC for 24 h). Colorless wax, 89% yield. 1H NMR (500 MHz, 
CDCl3): δ 7.93 (s, 1H), 7.84 (s, 1H), 7.01 (d, J = 7.6 Hz, 1H), 6.97-6.92 (m, 2H), 
6.73-6.69 (m, 1H), 6.45 (d, J = 8.2 Hz, 1H), 4.91 (dd, J = 7.6 Hz, 1.3 Hz, 1H), 
4.41-4.36 (m, 2H), 4.30-4.21 (m, 2H), 1.37 (t, J = 7.3 Hz, 3H), 1.25 (t, J = 7.3 Hz, 
3H); 13C NMR (125 MHz, CDCl3): δ 170.1, 161.0, 156.3, 154.2, 150.6, 150.6, 130.2, 
126.5, 124.8, 121.9, 119.8, 117.1, 72.3, 62.2, 61.7, 57.3, 14.1, 13.9; HRMS (ESI): 
m/z calcd. for [C18H20N3O6, M+H]
+: 374.1347; found: 374.1354. 
Optical Rotation: [α]25D = -40.3 (c = 0.2, CHCl3). The absolute configuration of 
2.7b was assigned by analogy to 2.7k. 97% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 
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The general procedure outlined above was followed (2.6a and 2.2c were added in one 
portion, stirred at ambient temperature for 24 h). Colorless wax, 95% yield. 1H NMR 
(500 MHz, CDCl3): δ 7.97 (d, J = 1.9 Hz, 1H), 7.83 (s, 1H), 7.06-7.05 (m, 1H), 
6.99-6.93 (m, 2H), 6.73-6.70 (m, 1H), 6.43 (d, J = 7.6 Hz, 1H), 5.28-5.26 (m, 1H), 
5.13-5.11 (m, 1H), 4.87 (dd, J = 7.6 Hz, 1.9 Hz, 1H), 1.37 (d, J = 3.8 Hz, 3H), 1.36 (d, 
J = 3.8 Hz, 3H), 1.27 (d, J = 6.3 Hz, 3H), 1.24 (d, J = 6.3 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ 169.7, 160.5, 156.2, 153.9, 150.6, 130.5, 126.4, 124.8, 121.9, 119.7, 




+: 402.1660; found: 402.1657. 
Optical Rotation: [α]25D = -69.8 (c = 0.2, CHCl3). The absolute configuration of 
2.7c was assigned by analogy to 2.7k. 92% ee (HPLC condition: Chiralcel OD-H 
column, n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 








The general procedure outlined above was followed (2.6a was added in one portion; 
2.2d in anhydrous THF (1 mL) was added via syringe pump over 2 h at -20 oC, stirred 
at -20 oC for 12 h, and then 0 oC for 12 h). Colorless wax, 85% yield. 1H NMR (500 
MHz, CDCl3): δ 7.89 (d, J = 1.3 Hz, 1H), 7.81 (s, 1H), 7.04-7.02 (m, 1H), 6.98-6.95 
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(m, 2H), 6.73-6.69 (m, 1H), 6.32 (d, J = 7.0 Hz, 1H), 4.80 (dd, J = 7.0 Hz, 1.3 Hz, 
1H), 1.57 (s, 9H), 1.48 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 169.5, 160.0, 156.1, 
153.4, 150.9, 150.5, 131.2, 126.7, 124.9, 122.5, 119.7, 117.2, 83.2, 83.0, 73.0, 57.5, 
28.1, 27.9; HRMS (ESI): m/z calcd. for [C22H28N3O6, M+H]
+: 430.1973; found: 
430.1981. 
Optical Rotation: [α]25D = -38.2 (c = 0.2, CHCl3). The absolute configuration of 
2.7d was assigned by analogy to 2.7k. 91% ee (HPLC condition: Chiralpak AS-H 
column, n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 










The general procedure outlined above was followed (2.6a was added in one portion; 
2.2e in anhydrous THF (1 mL) was added via syringe pump over 2 h at -20 oC, stirred 
at -20 oC for 12 h, and then 0 oC for 12 h). Colorless wax, 86% yield. 1H NMR (500 
MHz, DMSO-d6): δ 10.03 (s, 1H), 8.59 (s, 1H), 7.81 (d, J = 1.9, 1H), 7.46 (t, J = 7.9 
Hz, 2H), 7.39 (t, J = 7.9 Hz, 2H), 7.32 (t, J = 7.3 Hz, 1H), 7.26 (t, J = 7.6 Hz, 1H), 
7.18 (d, J = 7.6 Hz, 2H), 7.07 (d, J = 8.2 Hz, 2H), 7.04-7.02 (m, 1H), 6.99-6.96 (m, 
1H), 6.89-6.87 (m, 1H), 6.77-6.73 (m, 1H), 6.53 (d, J = 7.6 Hz, 1H), 5.27 (dd, J = 6.9 
Hz, 1.9 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 169.1, 159.2, 156.1, 155.1, 
152.3, 150.3, 150.2, 149.7, 129.6, 129.5, 128.1, 126.3, 126.1, 126.0, 125.5, 122.7, 
121.6, 121.4, 119.4, 116.4, 73.8, 56.9; HRMS (ESI), m/z calcd. for [C26H20N3O6, 
M+H]+: 470.1347; found: 470.1357. 
Optical Rotation: [α]25D = -74.9 (c = 0.4, CHCl3). The absolute configuration of 
2.7e was assigned by analogy to 2.7k. 99% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 78:22, flow rate = 1 ml/min, wavelength = 254 nm, tR = 










The general procedure outlined above was followed (2.6b and 2.2b were added in one 
portion, stirred at -20 oC for 24 h). White solid, 87% yield. 1H NMR (500 MHz, 
CDCl3): δ 7.91 (d, J = 1.3 Hz, 1H), 7.84 (s, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.81 (d, J = 
1.3 Hz, 1H), 6.73 (dd, J = 8.2 Hz, 1.3 Hz, 1H), 6.44 (d, J = 7.6 Hz, 1H), 4.90 (dd, J = 
7.6 Hz, 1.9 Hz, 1H), 4.39 (q, J = 7.3 Hz, 2H), 4.30-4.21 (m, 2H), 2.14 (s, 3H), 1.39 (t, 
J = 7.3 Hz, 3H), 1.26 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 170.2, 
161.0, 156.2, 154.3, 150.6, 148.0, 130.2, 129.1, 126.8, 124.4, 122.2, 116.9, 72.3, 62.1, 
61.7, 57.1, 20.3, 14.1, 14.0; MP: 82-33 °C; HRMS (ESI): m/z calcd. for [C19H22N3O6, 
M+H]+: 388.1503; found: 388.1489. 
Optical Rotation: [α]25D = -31.6 (c = 0.3, CHCl3). The absolute configuration of 
2.7f was assigned by analogy to 2.7k. 94% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 85:15, flow rate = 1 ml/min, wavelength = 254 nm, tR = 











The general procedure outlined above was followed (2.6c and 2.2e were added in one 
portion, stirred at -20 oC for 12 h, and then 0 oC for 12 h). Colorless wax, 68% yield. 
1H NMR (500 MHz, DMSO-d6): 10.21 (s, 1H), 8.61 (s, 1H), 7.94 (d, J = 1.9 Hz, 1H), 
7.50 (d, J = 7.6 Hz, 2H), 7.42-7.35 (m, 5H), 7.31-7.26 (m, 5H), 7.11-7.04 (m, 4H), 
6.95 (d, J = 8.9 Hz, 1H), 6.64 (d, J = 7.0 Hz, 1H), 5.30 (dd, J = 7.6 Hz, 1.9 Hz, 1H); 
13C NMR (125 MHz, DMSO-d6): δ 169.1, 159.3, 156.1, 154.8, 152.4, 150.3, 149.6, 
149.5, 139.5, 131.6, 129.5, 129.5, 128.8, 128.3, 126.7, 126.2, 126.1, 125.8, 123.9, 
121.5, 121.4, 120.3, 116.9, 73.7, 56.6; HRMS (ESI): m/z calcd. for [C32H22N3O6, 
M-H]-: 544.1514; found: 544.1500. 
Optical Rotation: [α]25D = -42.8 (c = 0.3, CHCl3). The absolute configuration of 
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2.7g was assigned by analogy to 2.7k. 95% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 








The general procedure outlined above was followed (2.6d was added in one portion, 
2.2e in anhydrous THF (1 mL) was added via syringe pump over 2 h at 0 oC, stirred at 
0 oC for 24 h). Colorless wax, 61% yield. 1H NMR (500 MHz, DMSO-d6): 9.54 (s, 
1H), 8.60 (s, 1H), 7.89 (d, J = 1.9 Hz, 1H), 7.48-7.44 (m, 2H), 7.40-7.37 (m, 2H), 
7.32 (t, J = 7.3 Hz, 1H), 7.26 (t, J = 7.3 Hz, 1H), 7.20-7.18 (m, 2H), 7.08-7.07 (m, 
2H), 6.79-6.77 (m, 1H), 6.63 (d, J = 3.2 Hz, 1H), 6.56-6.54 (m, 2H), 5.26 (dd, J = 7.6 
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Hz, 1.9 Hz, 1H), 3.61 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 169.0, 159.3, 156.0, 
154.6, 152.3, 152.2, 150.3, 149.7, 143.3, 129.6, 129.5, 128.2, 126.3, 126.1, 125.9, 
121.6, 121.4, 116.9, 110.2, 107.6, 73.6, 56.6, 55.3; HRMS (ESI): m/z calcd. for 
[C27H20N3O7, M-H]
-: 498.1307; found: 498.1291. 
Optical Rotation: [α]25D = -88.8 (c = 0.2, CHCl3). The absolute configuration of 
2.7h was assigned by analogy to 2.7k. 94% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 88:12, flow rate = 1 ml/min, wavelength = 254 nm, tR = 











2.6e in anhydrous THF (1 mL) was added via syringe pump over 2 h at 0 oC, stirred at 
0 oC for 24 h). Colorless wax, 94% yield. 1H NMR (500 MHz, DMSO-d6): 10.38 (s, 
1H), 8.61 (s, 1H), 7.93 (d, J = 1.9 Hz, 1H), 7.48-7.45 (m, 2H), 7.40-7.37 (m, 2H), 
7.34-7.31 (m, 1H), 7.28-7.25 (m, 1H), 7.22-7.20 (m, 2H), 7.16 (d, J = 2.5 Hz, 1H), 
7.09-7.07 (m, 2H), 7.01-6.99 (m, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.59 (d, J = 7.0 Hz, 
1H), 5.31 (dd, J = 7.6 Hz, 1.9 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 168.9, 
159.3, 155.7, 154.2, 152.4, 150.3, 149.7, 148.6, 129.6, 129.5, 128.3, 126.8, 126.3, 
126.1, 125.0, 122.5, 121.6, 121.4, 121.3, 117.6, 73.8, 56.5; HRMS (ESI): m/z calcd. 
for [C26H19ClN3O6, M+H]
+: 504.0957; found: 504.0954. 
Optical Rotation: [α]25D = -81.9 (c = 0.3, CHCl3). The absolute configuration of 
2.7i was assigned by analogy to 2.7k. 91% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 










The general procedure outlined above was followed (2.6f added in one portion; 2.2a 
in anhydrous THF (1 mL) was added via syringe pump over 2 h at -20 oC, stirred at 
-20 oC for 12 h, and then 0 oC for 12 h). Colorless wax, 61% yield. 1H NMR (500 
MHz, DMSO-d6): 10.51 (s, 1H), 8.43 (s, 1H), 7.74 (s, 1H), 6.97 (s, 1H), 6.88 (s, 2H), 
6.25 (d, J = 7.6 Hz, 1H), 4.86 (d, J = 7.6 Hz, 1H), 3.80 (s, 3H), 3.72 (s, 3H); 13C 
NMR (125 MHz, DMSO-d6): δ 170.7, 161.1, 154.7, 154.0, 151.9, 150.9, 128.5, 125.3, 
123.3, 122.0, 118.8, 116.7, 73.5, 56.5, 52.4, 52.0; HRMS (ESI): m/z calcd. for 
[C16H15BrN3O6, M+H]
+: 424.0139; found: 424.0144. 
Optical Rotation: [α]25D = -37.4 (c = 0.3, CHCl3). The absolute configuration of 
2.7j was assigned by analogy to 2.7k. 99% ee (HPLC condition: Chiralpak AD-H 
column, n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 










The general procedure outlined above was followed (2.6g was added in one portion; 
2.2e in anhydrous THF (1 mL) was added via syringe pump over 2 h at 0 oC, stirred at 
0 oC for 24 h). Colorless wax, 76% yield. 1H NMR (500 MHz, DMSO-d6): 9.76 (brs, 
1H), 8.60 (s, 1H), 7.75 (d, J = 1.9 Hz, 1H), 7.45 (t, J = 7.9 Hz, 2H), 7.39 (t, J = 7.9 Hz, 
2H), 7.35-7.30 (m, 2H), 7.26 (t, J = 7.6 Hz, 1H), 7.18-7.16 (m, 2H), 7.09-7.04 (m, 
3H), 6.77 (t, J = 7.9 Hz, 1H), 6.50 (d, J = 7.6 Hz, 1H), 5.34 (dd, J = 7.0 Hz, 1.9 Hz, 
1H); 13C NMR (125 MHz, DMSO-d6): δ 168.9, 159.2, 155.5, 154.9, 152.4, 150.3, 
149.6, 147.6, 129.8, 129.6, 129.5, 128.6, 128.4, 126.2, 126.0, 123.0, 121.7, 121.4, 
121.4, 112.6, 73.8, 56.9; HRMS (ESI): m/z calcd. for [C26H17BrN3O6, M-H]
-: 
546.0306; found: 546.0305. 
Optical Rotation: [α]25D = -74.1 (c = 0.3, CHCl3). The absolute configuration of 
2.7k was assigned by conversion to 2.10 followed by X-ray analysis. 95% ee (HPLC 
condition: Chiralpak AD-H column, n-hexane/i-PrOH = 70:30, flow rate = 1 ml/min, 











The general procedure outlined above was followed (2.6h was added in one portion; 
2.2a in anhydrous THF (1 mL) was added via syringe pump over 2 h at -20 oC, stirred 
at -20 oC for 24 h). Colorless wax, 90% yield. 1H NMR (500 MHz, CDCl3): 7.79 (s, 
1H), 7.75 (d, J = 1.9 Hz, 1H), 6.70-6.67 (m, 1H), 6.61-6.59 (m, 2H), 6.42 (d, J = 8.2 
Hz, 1H), 4.87 (dd, J = 7.6 Hz, 1.9 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 3.80 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 170.7, 161.4, 155.0, 154.6, 150.4, 147.5, 138.3, 
129.6, 124.7, 119.7, 113.6, 107.4, 73.6, 56.8, 56.1, 52.8, 52.3; HRMS (ESI), m/z 
calcd. for [C17H18N3O7, M+H]
+: 376.1139; found: 376.1148. 
Optical Rotation: [α]25D = -67.8 (c = 0.5, CHCl3). The absolute configuration of 
2.7l was assigned by analogy to 2.7k. 99% ee (HPLC condition: Chiralpak AD-H 
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column, n-hexane/i-PrOH = 70:30, flow rate = 1 ml/min, wavelength = 254 nm, tR = 








The general procedure outlined above was followed (2.6i was added in one portion; 
2.2a in anhydrous THF (1 mL) was added via syringe pump over 2 h at ambient 
temperature, stirred at ambient temperature for 24 h). Colorless wax, 69% yield. 1H 
NMR (500 MHz, DMSO-d6): 9.88 (s, 1H), 8.49 (s, 1H), 7.25 (d, J = 2.2 Hz, 1H), 
7.05-7.02 (m, 1H), 6.87 (dd, J = 7.9 Hz, 1.3 Hz, 1H), 6.66-6.63 (m, 1H), 6.43 (dd, J = 
7.9 Hz, 1.6 Hz, 1H), 5.23 (d, J = 2.2 Hz, 1H), 3.77 (s, 3H), 3.64 (s, 3H), 1.33 (s, 3H); 
13C NMR (125 MHz, DMSO-d6): δ 169.7, 161.5, 158.6, 155.6, 153.6, 150.5, 127.9, 
127.6, 127.1, 124.5, 119.3, 116.4, 78.5, 68.4, 52.1, 51.7, 16.5; HRMS (ESI), m/z 
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calcd. for [C17H18N3O6, M+H]
+: 360.1190; found: 360.1206. 
Optical Rotation: [α]25D = +29.8 (c = 0.20, CHCl3). 37% ee (HPLC condition: 
Chiralcel OD-H column, n-hexane/i-PrOH = 85:15, flow rate = 1 ml/min, wavelength 












The cis relative configuration of 2.7m was determined by the NOE correlation 
between the H at C-4 and Me group at C-5 (Figure 2.1). The absolute configuration 
was not determined. 
 
2.5.9 NMR Studies Revealed a Stepwise Reaction Profile 
 
To a 50 mL round-bottom flask charged with 2.8d (44 mg, 0.072 mmol) and 
Ag2O (8.3 mg, 0.036 mmol) was added anhydrous THF (18 mL). The mixture was 
stirred at 21oC for 5 min, then 2.6a (265 mg, 1.80 mmol) and 2.2a (324 µL, 3.60 
mmol) were added in one portion. The reaction mixture was stirred at 21 oC for the 
given time. Real time conversion was determined by 1H NMR (500 MHz). 
 
entry time (min) 2.6a (%) 2.9a (%) 2.7a (%) 
1 0 100 0 0 
2 5 67.94 31.99 0.07 
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3 10 51.34 48.59 0.07 
4 15 36.94 62.99 0.07 
5 20 26.12 73.58 0.30 
6 25 19.99 79.69 0.32 
7 30 13.72 85.91 0.38 
8 35 7.22 92.18 0.60 
9 40 1.44 96.53 2.03 
10 55 0.92 96.96 2.12 
11 60 0.23 97.40 2.37 
12 65 0 94.09 5.91 
13 70 0 91.68 8.32 
14 80 0 66.50 33.5 
15 85 0 47.67 52.33 
16 90 0 38.05 61.95 
17 96 0 29.82 70.18 
18 101 0 23.12 76.88 
19 111 0 20.00 80.00 
20 131 0 16.20 83.80 
21 161 0 14.25 87.75 





2.5.10 Mono [3+2] Cyclization of 2.6 and 2.2 
 
General procedure. To a 10 mL vial charged with 2.8d (12 mg, 0.020 mmol) and 
Ag2O (2.3 mg, 0.010 mmol) was added anhydrous THF (1 mL). After the mixture was 
stirred at ambient temperature for 5 min, 2.6 (0.150 mmol) was added. When the 
reaction mixture was cooled to -20 oC, 2.2 (0.100 mmol) in anhydrous THF (1 mL) 
was added via syringe pump over 2 h. The reaction mixture was stirred at the given 
temperature for the given time, and then concentrated, purified by flash 
chromatography (hexanes/ethyl acetate) to afford the product 2.9. 
Racemic sample of 2.9 for the standard of chiral HPLC spectra was prepared 





The general procedure outlined above was followed (stirred at -20 oC for 24 h). 
Colorless wax, 84% yield. 1H NMR (500 MHz, CDCl3): δ 7.27 (d, J = 2.5 Hz, 1H), 
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7.21-7.19 (m, 1H), 7.17-7.13 (m, 3H), 5.27 (dd, J = 7.0 Hz, 1.9 Hz, 1H), 4.85 (d, J = 
7.0 Hz, 1H), 3.83 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 170.1, 163.9, 151.0, 142.5, 
125.5, 125.5, 123.3, 118.3, 117.8, 73.0, 56.9, 53.2; HRMS (ESI), m/z calcd. for 
[C12H11N2O4, M+H]
+: 247.0713; found: 247.0722. 
Optical Rotation: [α]25D = -90.3 (c = 0.2, CHCl3). The absolute configuration of 
2.9a was assigned by analogy. 97% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 15.4 min 








The general procedure outlined above was followed (stirred at -20 oC for 12 h, and 
then 0 oC for 12 h). Colorless wax, 92% yield. 1H NMR (500 MHz, DMSO-d6): δ 
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7.86 (d, J = 2.5 Hz, 1H), 7.55-7.53 (m, 1H), 7.48-7.45 (m, 2H), 7.32-7.29 (m, 1H), 
7.24-7.20 (m, 4H), 7.18-7.15 (m, 1H), 5.33 (dd, J = 6.9 Hz, 1.9 Hz, 1H), 5.25 (d, J = 
7.6 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 168.8, 164.0, 153.0, 150.3, 142.0, 
129.6, 126.2, 125.0, 124.4, 123.9, 121.5, 118.5, 117.1, 72.5, 56.7; HRMS (ESI), m/z 
calcd. for [C17H13N2O4, M+H]
+: 309.0870; found: 309.0879. 
Optical Rotation: [α]25D = -42.6 (c = 0.3, CHCl3). The absolute configuration of 
2.9b was assigned by analogy. 99% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 16.8 min 










The general procedure outlined above was followed (stirred at -20 oC for 24 h). 
Colorless wax, 92% yield. 1H NMR (500 MHz, DMSO-d6): δ 7.74 (t, J = 1.3 Hz, 1H), 
7.32 (d, J = 1.3 Hz, 1H), 7.07 (d, J = 8.2 Hz, 1H), 6.95-6.93 (m, 1H), 5.02-5.01 (m, 
2H), 3.75 (s, 3H), 2.30 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 170.4, 164.3, 
152.3, 139.9, 134.5, 124.7, 123.5, 118.5, 116.7, 72.5, 56.6, 52.6, 20.4; HRMS (ESI), 
m/z calcd. for [C13H12N2NaO4, M+Na]
+: 283.0689; found: 283.0700. 
Optical Rotation: [α]25D = -63.3 (c = 0.2, CHCl3). The absolute configuration of 
2.9c was assigned by analogy. 97% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 12.2 min 










The general procedure outlined above was followed (stirred at -20 oC for 24 h). 
Colorless wax, 86% yield. 1H NMR (500 MHz, DMSO-d6): δ 8.04 (d, J = 1.9 Hz, 
1H), 7.89 (d, J = 2.5 Hz, 1H), 7.73 (d, J = 7.6 Hz, 2H), 7.50-7.44 (m, 5H), 7.39 (t, J = 
7.3 Hz, 1H), 7.33-7.29 (m, 2H), 7.24 (d, J = 7.6 Hz, 2H), 5.39 (dd, J = 7.6 Hz, 1.9 Hz, 
1H), 5.31 (d, J = 7.6 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 168.8, 163.9, 153.0, 
150.3, 141.4, 138.8, 137.2, 129.7, 128.9, 127.7, 126.7, 126.3, 124.2, 122.4, 121.5, 
117.5, 116.5, 72.6, 56.7; HRMS (ESI), m/z calcd. for [C23H16N2NaO4, M+Na]
+: 
407.1002; found: 407.1004. 
Optical Rotation: [α]25D = -47.5 (c = 0.3, CHCl3). The absolute configuration of 
2.9d was assigned by analogy. 93% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR =20.5 min 









The general procedure outlined above was followed (stirred at -20 oC for 24 h). 
Colorless wax, 90% yield. 1H NMR (500 MHz, DMSO-d6): δ 7.91 (d, J = 1.9 Hz, 
1H), 7.73 (d, J = 2.6 Hz, 1H), 7.48-7.45 (m, 2H), 7.33-7.30 (m, 1H), 7.26-7.21 (m, 
3H), 7.19-7.16 (m, 1H), 5.33 (dd, J = 7.6 Hz, 1.9 Hz, 1H), 5.25 (d, J = 7.6 Hz, 1H); 
13C NMR (125 MHz, DMSO-d6): δ 168.7, 163.4, 152.5, 150.3, 140.7, 129.7, 128.7, 
126.3, 125.1, 123.6, 121.5, 118.6, 117.9, 72.6, 56.2; HRMS (ESI), m/z calcd. for 
[C17H12ClN2O4, M+H]
+: 343.0480; found: 343.0492. 
Optical Rotation: [α]25D = -57.9 (c = 0.3, CHCl3). The absolute configuration of 
2.9e was assigned by analogy. 95% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 17.4 min 










The general procedure outlined above was followed (stirred at -20 oC for 12 h, and 
then 0 oC for 12 h). Colorless wax, 84% yield. 1H NMR (500 MHz, DMSO-d6): δ 
7.86 (d, J = 1.9 Hz, 1H), 7.52-7.50 (m, 2H), 7.48-7.45 (m, 2H), 7.42-7.40 (m, 1H), 
7.32-7.29 (m, 1H), 7.22-7.20 (m, 2H), 5.32 (dd, J = 7.6 Hz, 1.9 Hz, 1H), 5.24 (d, J = 
7.6 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 168.7, 163.3, 152.7, 150.2, 142.6, 
129.6, 127.6, 126.3, 123.5, 121.5, 119.9, 115.0, 72.6, 56.4; HRMS (ESI), m/z calcd. 
for [C17H12BrN2O4, M+H]
+: 386.9975; found: 386.9983. 
Optical Rotation: [α]25D = -46.6 (c = 0.3, CHCl3). The absolute configuration of 
2.9f was assigned by analogy. 96% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 34.3 min 









The general procedure outlined above was followed (stirred at -20 oC for 12 h, and 
then 0 oC for 12 h). Colorless wax, 85% yield. 1H NMR (500 MHz, DMSO-d6): δ 
7.85 (d, J = 1.9 Hz, 1H), 7.46 (t, J = 8.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 1H), 7.32-7.29 
(m, 2H), 7.17-7.14 (m, 1H), 7.11-7.09 (m, 1H), 6.90-6.88 (m, 1H), 5.33 (dd, J = 6.9 
Hz, 1.9 Hz, 1H), 5.21 (d, J = 7.0 Hz, 1H), 3.86 (s, 3H); 13C NMR (125 MHz, 
DMSO-d6): δ 168.8, 163.6, 152.9, 150.3, 147.6, 131.2, 129.6, 126.3, 124.8, 124.7, 
121.5, 110.2, 107.8, 72.4, 56.5, 56.1; HRMS (ESI), m/z calcd. for [C18H15N2O5, 
M+H]+: 339.0975; found: 339.0985. 
Optical Rotation: [α]25D = -58.9 (c = 0.2, CHCl3). The absolute configuration of 
2.9g was assigned by analogy. 96% ee (HPLC condition: Chiralpak AS-H column, 
n-hexane/i-PrOH = 75:25, flow rate = 1 ml/min, wavelength = 254 nm, tR = 21.8 min 
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2.5.11 Three-Component Reaction of Different Isocyanoacetates with 2.6a 
 
To a 10 mL vial charged with 2.8d (12 mg, 0.020 mmol) and Ag2O (2.3 mg, 
0.010 mmol) was added anhydrous THF (1 mL). After the mixture was stirred at 
ambient temperature for 5 min, 2.6a (14.7 mg, 0.100 mmol) was added. When the 
reaction mixture was cooled to -30 oC, 2.2e (16.1 mg, 0.100 mmol) in anhydrous THF 
(1 mL) was added via syringe pump over 2 h. The reaction mixture was stirred for 24 
h at -30 oC, and then 2.2a (9.0 µL, 0.100 mmol) was added in one portion. The 
reaction mixture was stirred for 12 h at 0 oC and another 12 h at ambient temperature, 







Colorless wax, 67% yield. 1H NMR (500 MHz, DMSO-d6) δ 10.0 (s, 1H), 8.48 (s, 
1H), 7.80 (d, J = 3.0 Hz, 1H), 7.46 (t, J = 13.0 Hz, 2H), 7.30 (t, J = 12.2 Hz, 1H), 7.18 
(d, J = 12.6 Hz, 2H), 6.98-6.91 (m, 2H), 6.86-6.83 (m, 1H), 6.73-6.68 (m, 1H), 6.43 
(d, J = 12.9 Hz, 1H), 5.16 (dd, J = 12.6 Hz, 3.1 Hz, 1H), 3.79 (s, 3H); 13C NMR (125 
MHz, DMSO-d6): δ 169.2, 161.3, 155.0, 154.9, 152.0, 150.4, 150.1, 129.6, 128.7, 
126.1, 125.8, 125.4, 122.3, 121.5, 119.4, 116.4, 73.5, 56.6, 52.0; HRMS (ESI): m/z 
calcd. for [C21H18N3O6, M+H]
+: 408.1190; found: 408.1203. 
Optical Rotation: [α]25D = -76.8 (c = 0.3, CHCl3). The absolute configuration of 
2.7n was assigned by analogy to 2.7k. 97% ee (HPLC condition: Chiralcel AD-H 
column, n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 








To a 10 mL vial charged with 2.8d (12 mg, 0.020 mmol) and Ag2O (2.3 mg, 
0.010 mmol) was added anhydrous THF (1 mL). After the mixture was stirred at 
ambient temperature for 5 min, 2.6a (14.7 mg, 0.100 mmol) was added. When the 
reaction mixture was cooled to -20 oC, 2.2f (18.9 mg, 0.100 mmol) in anhydrous THF 
(1 mL) was added via syringe pump over 2 h. The reaction mixture was stirred for 12 
h at -20 oC, and then 2.2a (9.0 µL, 0.100 mmol) was added in one portion. The 
reaction mixture was stirred for 12 h at ambient temperature, concentrated and 





White solid, 73% yield. 1H NMR (500 MHz, DMSO-d6) δ 9.88 (s, 1H), 8.35 (s, 1H), 
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7.68 (s, 1H), 7.31-7.25 (m, 4H), 7.22-7.19 (m, 1H), 6.87-6.84 (m, 1H), 6.77-6.75 (m, 
1H), 6.72-6.71 (m, 1H), 6.64-6.60 (m, 1H), 6.18 (s, 1 H), 3.89 (s, 3H), 3.31 (s, 3H), 
3.29 (d, J = 13.2 Hz, 1H), 3.21 (d, J = 13.2 Hz, 1H); 13C NMR (125 MHz, DMSO-d6): 
δ 170.8, 161.3, 154.2, 153.0, 151.6, 149.7, 135.5, 130.6, 129.2, 127.7, 126.7, 125.5, 
125.3, 121.7, 119.2, 116.2, 82.5, 60.9, 52.0, 51.8, 44.8; MP: 199-200 °C; HRMS 
(ESI), m/z calcd. for [C23H22N3O6, M+H]
+: 436.1503; found: 436.1503. 
Optical Rotation: [α]25D = +61.5 (c = 0.3, CHCl3). 71% ee (HPLC condition: 
Chiralcel OD-H column, n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength 





The cis relative configuration of 2.7o was determined by the NOE correlation 
between the CH2 of benzyl group at C-4 and the H at C-5 (Figure 2.2), and 










2.5.12 Hydrolysis to α,β-Diamino Ester 
 
p-Toluenesulfonic acid monohydrate (21 mg, 0.11 mmol) was added to the 
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mixture of 2.7k (30 mg, 0.055 mmol, 95% ee), CHCl3 (2 mL) and H2O (1 mL). The 
reaction mixture was stirred at ambient temperature for 6 h, concentrated and purified 





White solid. 1H NMR (500 MHz, DMSO-d6) δ 9.37 (d, J = 8.2 Hz, 1H), 9.21 (s, 1H), 
8.62 (s, 1H), 8.16 (s, 1H), 7.50 (t, J = 7.9 Hz, 2H), 7.40 (t, J = 8.2 Hz, 2H), 7.36-7.31 
(m, 3H), 7.27 (t, J = 7.3 Hz, 1H), 6.97 (d, J = 7.6 Hz, 2H), 6.84-6.83 (m, 1H), 
6.67-6.64 (m, 2H), 6.05-5.99 (m, 2H), 5.54 (dd, J = 8.9 Hz, 5.1 Hz, 1H); 13C NMR 
(125 MHz, DMSO-d6): δ 167.4, 161.6, 159.7, 156.4, 152.0, 150.0, 149.8, 141.3, 137.8, 
129.7, 129.7, 127.8, 126.3, 126.3, 122.0, 121.7, 121.4, 121.2, 111.4, 110.3, 53.3, 50.9; 
MP: 185-186 °C; HRMS (ESI), m/z calcd. for [C26H20BrN3NaO7, M+Na]
+: 588.0377; 
found: 588.0372. 
Optical Rotation: [α]25D = -79.3 (c = 0.1, Acetone). 96% ee (HPLC condition: 
Chiralpak IE column, n-hexane/i-PrOH = 85:15, flow rate = 1 ml/min, wavelength = 






2.5.13 Imidazolinium Salt Formation 
 
Methyl iodide (40 µL, 0.650 mmol) was added to the solution of 2.7a (45 mg, 
0.130 mmol) in anhydrous THF (2 mL). The reaction mixture was stirred at 50 
oC for 
24 h and then concentrated. The ratio of isomers (5:1) was determined by 1H NMR. 
The residue was purified by flash chromatography (MeOH/ethyl acetate, 1/5) to give 
56 mg (89%) of 2.11. 
 
1-(2-Hydroxyphenyl)-4-(methoxycarbonyl)-5-(4-(methoxycarbonyl)oxazol-5-yl)-3




Pale yellow solid. 1H NMR (500 MHz, DMSO-d6, major isomer): δ 10.69 (s, 1H), 
9.34 (s, 1H), 8.66 (s, 1H), 7.24-7.16 (m, 2H), 6.93 (dd, J = 8.2 Hz, 1.3 Hz, 1H), 
6.84-6.81 (m, 2H), 5.58 (d, J = 7.0 Hz, 1H), 3.86 (s, 3H), 3.81 (s, 3H), 3.49 (s, 3H); 
13C NMR (125 MHz, DMSO-d6, major isomer): δ 166.5, 160.4, 159.2, 153.0, 151.4, 
149.7, 130.5, 130.3, 125.3, 120.6, 119.4, 116.7, 66.1, 59.4, 53.6, 52.3, 35.1; MP: 
86-88 °C; HRMS (ESI), m/z calcd. for [C17H18N3O6]
+ (cation): 360.1190; found: 
360.1205. The structure of 2.11 was confirmed by HMBC analysis (Figure 2.3). 
 






2.5.14 X-ray Crystallographic Analysis and Determination of Configuration of 
the Products 
The absolute configuration of 2.10 (1R,2R) was assigned by X-ray 
crystallographic analysis of a single crystal of 2.10 (Figure 2.4). The crystal was 
prepared from the solution of 2.10 in ethyl acetate at ambient temperature. The 
absolute configuration of 2.7k (4R,5R) was deduced. The configurations of 2.7a-2.7j, 
2.7l were assigned by analogy. 
 
Figure 2.4 X-ray Structure of 2.10 
 
 
Table 2.4 Crystal Data and Structure Refinement for 2.10 
Identification code 2.10  
Empirical formula C30H28BrN3O9  
Formula weight 654.46  
Temperature 100(2) K  
Wavelength 1.54178 Å  
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Crystal system Orthorhombic  
Space group P 21 21 21  
Unit cell dimensions a = 10.1252(15) Å α = 90° 
 b = 13.217(2) Å β = 90° 
 c = 22.607(4) Å γ = 90° 
Volume 3025.3(8) Å3  
Z 4  
Density (calculated) 1.437 Mg/m3  
Absorption coefficient 2.350 mm-1  
F(000) 1344  
Crystal size 0.290 x 0.190 x 0.080 mm3  
Theta range for data collection 3.874 to 68.196°  
Index ranges -12<=h<=10, -14<=k<=15, -12<=l<=27  
Reflections collected 16789  
Independent reflections 5418 [R(int) = 0.0328]  
Completeness to theta = 67.679° 98.5 %  
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.7531 and 0.6432  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 5418 / 3 / 399  
Goodness-of-fit on F2 1.152  
Final R indices [I>2sigma(I)] R1 = 0.0593, wR2 = 0.1643  
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R indices (all data) R1 = 0.0626, wR2 = 0.1678  
Absolute structure parameter 0.035(8)  
Extinction coefficient n/a  
Largest diff. peak and hole 1.987 and -0.612 e.Å-3  
 
The relative configuration of 2.7o was assigned by X-ray crystallographic 
analysis of a single crystal of 2.7o (Figure 2.5). The crystal was prepared from the 
solution of 2.7o in dimethyl sulfoxide (DMSO) at ambient temperature. 
 
Figure 2.5 X-ray Structure of 2.7o 
 
 
Table 2.5 Crystal Data and Structure Refinement for 2.7o 
Identification code 2.7o  
Empirical formula C23H21N3O6  
Formula weight 435.43  
Temperature 100(2) K  
Wavelength 0.71073 Å  
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Crystal system Monoclinic  
Space group P 21/c  
Unit cell dimensions a = 9.3056(3) Å α = 90° 
 b = 10.5189(3) Å β = 95.9360(11)° 
 c = 21.2002(8) Å γ = 90° 
Volume 2064.05(12) Å3  
Z 4  
Density (calculated) 1.401 Mg/m3  
Absorption coefficient 0.103 mm-1  
F(000) 912  
Crystal size 0.240 x 0.120 x 0.100 mm3  
Theta range for data collection 2.164 to 28.283°  
Index ranges -12<=h<=12, -14<=k<=14, -28<=l<=28 
Reflections collected 43940  
Independent reflections 5123 [R(int) = 0.0302]  
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.7142  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5123 / 0 / 295  
Goodness-of-fit on F2 1.053  
Final R indices [I>2sigma(I)] R1 = 0.0390, wR2 = 0.0910  
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R indices (all data) R1 = 0.0492, wR2 = 0.0958  
Absolute structure parameter 0.035(8)  
Extinction coefficient n/a  












Chapter 3 Catalytic Divergent Synthesis of 3H or 1H 















The development of efficient and atom economical processes for the preparation 
of valuable heterocycles remains an important goal in synthetic organic chemistry. In 
particular, the construction of pyrroles, one of the most abundant and useful classes of 
N-heterocycle,[73] is still under active investigation for which transition 
metal-catalyzed cyclization strategies have proven highly fruitful.[74] In contrast, the 
isomeric non-aromatic 3H pyrroles (A in Scheme 3.1) have been poorly studied due to 
their difficult access, although some of them have been shown to possess anti-tumor 
or anti-microbial activities.[75] The few previously reported syntheses of 3H pyrrole 
were either low yielding to produce mixture of isomers, or required harsh reaction 
conditions and suffered from narrow substrate scope.[76] To the best of our knowledge, 
no enantioselective synthesis of this class of heterocycle has been reported.  
Activated isocyanides such as isocyanoacetates have proven to be a versatile 
functionality to undergo cyclization with various π-systems for heterocycle 
synthesis.[2, 53a, 54] In particular, substituted pyrroles can be obtained from the reaction 
of isocyanoacetate with nitroalkenes (as in Barton-Zard pyrrole synthesis),[77] 
alkynoates (catalyzed by copper reported from the groups of Yamamoto[56a] and de 
Meijere[56b]), and even simple terminal alkynes (catalyzed by silver reported by the 
groups of Bi[78] and Lei[79]). Based on our group’s continuous interest in 
isocyanoacetate chemistry,[26] we became interested in the reaction between 
isocyanoacetate and allenoate,[80] and we envisioned such a combination of two 









As illustrated in Scheme 3.1, the [3+2] cyclization of isocyanoacetate and 
allenoate may proceed with different regioselectivity to generate intermediates C or D 
(or other isomers). Once C is formed, it should undergo facile 1,3-H shift to produce 
3H pyrrole A. While 3H pyrroles without 3,3-disubstitution is known to readily 
rearrange to 1H pyrroles through 1,3-H shift driven by aromatization, compound A 
bearing a quaternary carbon can be produced as a stable compound. Alternatively, 
intermediate D will most likely undergo multiple H-shifts to produce 1H pyrrole B.  
The focus of this study was whether an efficient catalytic method could be 
developed that will allow regio- and stereoselective synthesis of 3H or 1H pyrroles. 
Herein we report operationally simple procedures using silver or phosphine catalysis 
to deliver these products as well as related N-heterocycles from allenoates and 
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activated isocyanides in high efficiency and stereoselectivity. 
 
3.2 Results and Discussion 
3.2.1 Identification of Divergent Reaction Profile 
The readily available allenoate 3.1a and isocyanoacetate 3.2a were chosen as the 
model substrates. Various metal salts with strong basicity that could deprotonate the 
isocyanoacetate to deliver the enolate reactivity of 3.2a were evaluated; selected data 
are summarized in Table 3.1. 
 
Table 3.1 Identification of Divergent Reaction Profile[a-b] 
 
entry metal ligand temp (°C) time (h) 3a:4a yield (%)[b] 
1 Cu2O / 0 12 10: <2 
2 Ag2O / 0 24 24: <2 
3 Ag2CO3 / 0 24 37: <2 
4 Ag2CO3 / 24 3 19: <2 
5 Ag2CO3 PPh3 24 1 55: <2 
6 / PPh3 24 24 <2: 18 




At 0 °C, we were excited to observe that the desired product 3.3a could be 
obtained by using copper or silver salts, albeit with low yield due to the formation of 
other side products (entries 1-3). When the reaction was carried out at ambient 
temperature using Ag2CO3, however, the reaction was messy to yield 3.3a in only 
19% (entry 4). In an effort to modulate the reactivity between 3.1a and 3.2a, the 
addition of ligands such as PPh3 was examined, which to our delight led to a higher 
yield of 3.3a (55%, entry 5). It is noteworthy that under these conditions no product 
corresponding to pathway b (Scheme 3.1) was observed. Inspired by the recent 
advances of phosphine catalysis of allenes with various electrophiles,[81] we also 
tested the control reaction using only PPh3 as the catalyst. Intriguingly, 
2,4-disubstituted pyrrole 3.4a was formed as the exclusive product, albeit in low yield 
(entry 6).[56a] This observation represents an interesting example of catalyst-controlled 
divergent reaction.[82] 
 
3.2.2 Silver-Catalyzed [3+2] Cyclization 
3.2.2.1 Optimization of Reaction Conditions 
The observation of dramatic ligand effect prompted us to examine a wide range 
of ligands and in particular chiral ones aiming towards an efficient as well as 
enantioselective synthesis of 3H pyrroles bearing all-carbon quaternary center.[83] In 
particular, the Dixon group has introduced cinchona alkaloid-based phosphine ligands 
for highly enantioselective Ag-catalyzed aldol and Mannich reactions of 
isocyanoacetates.[11, 23] In our hands, this family of catalysts proved remarkably 
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effective for highly enantioselective double [3+2] cyclization of isocyanoacetate with 
α-imino esters[26] as well as for 3H pyrrole synthesis after extensive screening of 
different catalysts. It is noteworthy that a dramatic ligand acceleration effect was 
observed with this catalytic system so that a lower temperature of -20 °C could be 
employed to produce 3.3a in high yield and ee (Scheme 3.2). 
 
Scheme 3.2 Optimization of Ag-Catalyzed Enantioselective Cyclization 
 
 
3.2.2.2 Substrate Scope 
The scope of this simple catalytic procedure proved to be broad (Scheme 3.3). 
Various allenoates 3.1 underwent smooth reaction with 3.2a in a 1:1 ratio at -20 °C. 
3H Pyrrole 3.3 with different 3-substituents including benzyl derivatives (3.3a-3.3j), 
allyl (3.3k) and alkyl (3.3l, 3.3m) groups were all obtained in high yield (73-94%) 
with good to excellent ee (80-96%). 3H Pyrroles have been utilized as aza-diene for 
Diels-Alder reaction before;[76e] in our studies we have also identified new reactivity 




Scheme 3.3 Enantioselective Synthesis of 3H Pyrrole[a-c] 
 
[a] Carried out at -20 °C for 48 h. [b] Isolated yields. [c] 2 mmol-scale reaction. 
 
To further extend the scope of this catalytic system, the reaction of 3.1a with 
disubstituted isocyanoacetate 3.2b was examined under the same conditions (Scheme 
3.4). Gratifyingly, the direct [3+2] cyclization product 3.6a possessing an exocyclic 
olefin (corresponding to C in Scheme 3.1) was obtained in high yield and 92% ee, 
with a good d.r. of 6:1 (85% isolated major diastereomer). The formation of 3.6a not 
only provided strong support for the mechanism of formation of 3H pyrrole 3.3 
through [3+2] cyclization followed by 1,3-H shift (that is not possible in the case of 
3.6a), but also highlighted the versatility of our method to prepare N-heterocycles 
bearing multiple quaternary stereocenters.[83] 
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Scheme 3.4 Cyclization of Disubstituted Isocyanoacetates[a-c] 
 
[a] The reactions were carried out at -20 °C under ambient atmosphere for 48 h. [b] 
Isolated yields of the major diastereomer. [c] The reaction time was 7 days. 
 
The same set of conditions could be used to produce a wide range of heterocycles 
3.6 (Scheme 3.4). The use of ethyl ester analog of 3.1a led to 3.6b in higher d.r. and 
similar ee. Various substituted benzyl groups (3.6c-3.6i) as well as allyl substituent 
(3.6j) on the allenoate structure could be tolerated to yield the products in high yield 
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and selectivity (82-96% ee; d.r. up to >20:1). Finally, use of methyl-substituted 
isocyanoacetate 3.2c yielded 3.6k in excellent stereoselectivity as well. In all cases, 
the yields refer to that of the isolated major diastereomer. The relative and absolute 
configuration of 3.6a was unambiguously assigned by single crystal X-ray analysis 
and those of other products were assigned by analog. It is also worth noting that all 
the reactions were carried out under ambient atmosphere; exclusion of air or moisture 
was not required. 
 
3.2.2.3 Proposed Mechanism 
 
Scheme 3.5 Proposed Mechanism for the Formation of 3.3 and 3.6 
 
 
This method represents a new entry to Ag-catalyzed reactions of isocyanoacetates. 
As illustrated by the proposed mechanism in Scheme 3.5, intermediate I formed by 
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deprotonation of isocyanoacetate 3.2 would attack allenoate 3.1a to generate II. 
Subsequent intramolecular cyclization and protonation affords formal [3+2] 
cyclization product 3.6. When substituent R is proton, it would undergo facile 1,3-H 
shift to produce 3H pyrrole 3.3. 
 
3.2.3 Phosphine-Catalyzed [3+2] Cyclization 
3.2.3.1 Optimization of Reaction Conditions 
Recognizing the synthetic utility of conversion of readily available allenoates to 
polysubstituted pyrroles, we decided to optimize the PPh3-catalyzed reaction (entry 6, 
Table 3.1); selected data are summarized in Table 3.2. Various trialkylphosphines (e.g. 
PCy3), diarylmonoalkyl-phosphines (e.g. Ph2PCH2PPh2) and triarylphosphines were 
examined (entries 1-4), and the simple and inexpensive PPh3 was determined to be the 
optimal choice. After screening of reaction conditions, a dramatic solvent effect was 
discovered. Chloroform proved superior to all others leading to a highly efficient 
synthesis of 3.4a (entry 5). Decreased catalyst loading of 5 mol% PPh3 resulted in a 
lower yield of 78% (entry 9). It is worth noting that under these conditions no product 
corresponding to pathway a (Scheme 3.1) was observed. 
 





entry catalyst solvent yield (%)[b] 
1 PCy3 CH2Cl2 15 
2 PPh2CH2PPh2 CH2Cl2 52 
3 P(o-tol)3 CH2Cl2 n.r.
[c] 
4 PPh3 CH2Cl2 53 
5 PPh3 CHCl3 90 
6 PPh3 THF 18 
7 PPh3 Et2O 25 
8 PPh3 toluene 17 
9[d] PPh3 CHCl3 78 
[a] The reactions were carried out at ambient temperature in air for 24 h. [b] Isolated 
yields. [c] n.r. = no reaction. [d] 5 mol% PPh3 was used. 
 
3.2.3.2 Substrate Scope 
Using this catalytic protocol, a wide range of di- and tri-substituted pyrroles could 
be accessed (Scheme 3.6). Different substituents on allenoates were well tolerated 
(3.4a-3.4p). Different isocyanoacetates as well as tosylmethylisocyanide could also be 
used to produce 3.4q, 3.4r and 3.4s-3.4w in good to high yield. The high efficiency of 
this process, coupled with the operational simplicity (use of cheap PPh3 as catalyst 
and running reactions open to air), makes it an attractive method for pyrrole synthesis. 
The related 2,4-disubstituted pyrroles such as Pyrrolostatin[84] are important targets in 
medicinal chemistry and the current method provides a rapid access to the core 
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structure of those compounds. 
 
Scheme 3.6 Pyrrole Synthesis by PPh3 Catalysis
[a-f] 
 
[a] Carried out at ambient temperature in air. [b] Isolated yields. [c] 4 mmol-scale 
reaction for 24 h. [d] 20 mol% PPh3. [e] 50 mol% PPh3. [f] 30 mol% PPh3. 
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3.2.3.3 Proposed Mechanism 
This method represents a new entry to phosphine-catalyzed umpolung 
reactions.[85] 
 
Scheme 3.7 Proposed Mechanism for the Formation of 3.4 
 
 
As illustrated by the proposed mechanism in Scheme 3.7, intermediate IV formed 
by addition of PPh3 to 3.1 is reported to be capable of deprotonating Brønsted acidic 
substrates such as malonate to generate analogs of ion pair V and then ylide VI.[85a, 85b] 
With an isocyanide functionality in this case, the ylide is believed to undergo 
cyclization to generate VII. Proton transfer followed by elimination of phosphine then 
yields IX that is eventually transformed to the final product 3.4. 
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3.2.3.4 Mechanistic Study 
In an effort to better understand the reaction profile, deuterium labeling studies 
were carried out. As shown in Scheme 3.8, while the use of D2-isocyanoacetate led to 
surprisingly low deuterium labeling on the pyrrole ring, the use of CDCl3 resulted in 
significant deuterium labeling (49% vs. 7%). This interesting observation suggests 
that proton transfer (VII to VIII in Scheme 3.7) is facilitated by chloroform bearing a 
slightly acidic proton by proton shuffling, which is consistent with the dramatic 
solvent effect (Table 3.2).[86] 
 




In conclusion, we have developed the divergent [3+2] cyclization reaction of 
allenoates with activated isocyanides for the first time. Under different catalytic 
systems, we realized the cycloaddition using either of the two C=C bonds in the allene 
structure. While Ag catalysis led to an unprecedented enantioselective synthesis of 3H 
pyrroles and other related N-heterocycles, a simple procedure using PPh3 produced a 
wide range of polysubstituted 1H pyrroles in high efficiency. Current efforts are 
focused on the application of the current catalytic systems to the preparation of other 
types of N-heterocycles. 
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3.4 Experimental Section 
3.4.1 General Information 
1H and 13C NMR spectra were recorded on a Bruker AFC 300 (300 MHz) or 
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference: 1H 
(chloroform δ 7.26; DMSO δ 2.50; Acetone δ 2.05), 13C (chloroform δ 77.0; DMSO δ 
39.5; Acetone δ 29.8, 206.3). Data are reported as follows: chemical shift, multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, dd = 
doublet of doublets), coupling constants (Hz) and integration. 19F NMR was measured 
at 282 MHz, and CFCl3 (0 ppm) was used as an external standard. Melting point (MP) 
was obtained on Buchi B-540. For thin layer chromatography (TLC), Merck 
pre-coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. High resolution mass spectra (HRMS) were obtained on a 
Finnigan/MAT 95XL-T spectrometer. Optical rotations were recorded on an mrc 
AP81 automatic polarimeter. Enantiomeric excesses (ee) were determined by HPLC 
analysis on Agilent HPLC units, including the following instruments: pump, 
LC-20AD; detector, SPD-20A; column, Chiralcel OD-H, Chiralpak AD-H, AS-H and 
IA, IB, IC, IE. 
Unless otherwise noted, all the reactions were carried out open to air. 
Dichloromethane, diethyl ether (Et2O), tetrahydrofuran (THF), and toluene were dried 
over a Pure Solv solvent purification system. Deuterated solvents were purchased 
from Cambridge Isotope Laboratories and used as received without further 
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purification. Methyl isocyanoacetate (3.2a), ethyl isocyanoacetate and tosylmethyl 
isocyanide isocyanide were purchased from Alfa Aesar company and used without 
further purification. tert-Butyl isocyanoacetate[64] and all allenoates were prepared 
according to literature procedures.[87] Other chemicals were purchased from 
commercial suppliers and used as received without further purification. 
 
3.4.2 Ag-Catalyzed Enantioselective [3+2] Cyclization of 3.1 and 3.2a 
 
General procedure. To a 10 mL vial charged with 3.5b[11] (12 mg, 0.020 mmol) 
and Ag2O (2.3 mg, 0.010 mmol) was added anhydrous CHCl3 (0.5 mL). The mixture 
was allowed to stir at ambient temperature for 5 min, then allenoate 3.1 (0.10 mmol) 
was added in one portion. After the mixture was cooled to -20 oC, isocyanoacetate 
3.2a (0.10 mmol) in anhydrous CHCl3 (0.5 mL) was added via syringe pump over 2 h. 
The reaction mixture was stirred at -20 oC for 48 h, concentrated and purified by flash 







3.4.3 Characterization of Compounds 3.3                                                                                             
(S)-dimethyl 3-benzyl-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3a) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 84% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.21 (s, 1H), 7.21-7.17 (m, 3H), 7.10-7.09 (m, 2H), 3.69 (s, 3H), 3.63 (d, J = 13.9 Hz, 
1H), 3.63 (s, 3H), 3.19 (d, J = 13.9 Hz, 1H), 2.29 (s, 3H); 13C NMR (125 MHz, 
DMSO-d6): δ 170.4, 167.3, 162.7, 148.0, 141.9, 134.3, 129.2, 127.9, 127.0, 74.5, 53.0, 
51.4, 36.5, 11.4; HRMS (ESI): m/z calcd. for [C16H16NO4, M-H]
-: 286.1085; found: 
286.1071. 
Optical Rotation: [α]25D = 86.5 (c = 0.4, CHCl3). The absolute configuration of 
3.3a was assigned by analogy to 3.6a. 92% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 31.6 min 






(S)-dimethyl 4-methyl-3-(4-methylbenzyl)-3H-pyrrole-3,5-dicarboxylate (3.3b) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 92% yield. 1H NMR (500 MHz, DMSO-d6): δ 
7.19 (s, 1H), 7.01-6.96 (m, 4H), 3.69 (s, 3H), 3.63 (s, 3H), 3.58 (d, J = 13.9 Hz, 1H), 
3.13 (d, J = 13.9 Hz, 1H), 2.28 (s, 3H), 2.21 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 
170.5, 167.3, 162.7, 148.1, 141.8, 136.1, 131.2, 129.1, 128.5, 74.6, 53.0, 51.5, 36.2, 
20.6, 11.4; HRMS (ESI): m/z calcd. for [C17H18NO4, M-H]
-: 300.1241; found: 
300.1243. 
Optical Rotation: [α]25D = 82.8 (c = 0.3, CHCl3). The absolute configuration of 
3.3b was assigned by analogy to 3.3a. 94% ee (HPLC condition: Chiralcel IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 33.0 min 






(S)-dimethyl 3-(4-methoxybenzyl)-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3c) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 74% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.19 (s, 1H), 7.01 (d, J = 8.7 Hz, 2H), 6.75 (d, J = 8.7 Hz, 2H), 3.70 (s, 3H), 3.68 (s, 
3H), 3.63 (s, 3H), 3.56 (d, J = 13.8 Hz, 1H), 3.11 (d, J = 13.8 Hz, 1H), 2.28 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 170.5, 167.3, 162.7, 158.1, 148.1, 141.8, 130.3, 
126.1, 113.3, 74.7, 54.9, 53.0, 51.5, 35.8, 11.4; HRMS (ESI): m/z calcd. for 
[C17H18NO5, M-H]
-: 316.1190; found: 316.1191. 
Optical Rotation: [α]25D = 62.2 (c = 0.3, CHCl3). The absolute configuration of 
3.3c was assigned by analogy to 3.3a. 91% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 85:15, flow rate = 1 ml/min, wavelength = 254 nm, tR = 31.7 min 






(S)-dimethyl 3-(4-bromobenzyl)-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3d) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 87% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.22 (s, 1H), 7.38 (d, J = 8.3 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 3.70 (s, 3H), 3.63 (s, 
3H), 3.61 (d, J = 13.8 Hz, 1H), 3.20 (d, J = 13.5 Hz, 1H), 2.28 (s, 3H); 13C NMR (125 
MHz, DMSO-d6): δ 170.3, 167.1, 162.6, 147.8, 142.0, 133.7, 131.5, 130.8, 120.3, 
74.2, 53.1, 51.5, 35.5, 11.4; HRMS (ESI): m/z calcd. for [C16H16BrNNaO4, M+Na]
+: 
388.0155; found: 388.0165. 
Optical Rotation: [α]25D = 64.3 (c = 0.3, CHCl3). The absolute configuration of 
3.3d was assigned by analogy to 3.3a. 88% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 29.3 min 






(S)-dimethyl 3-(4-fluorobenzyl)-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3e) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1.5:1). Colorless syrup, 92% yield. 1H NMR (500 MHz, DMSO-d6): 
δ 8.22 (s, 1H), 7.15-7.12 (m, 1H), 7.03-6.99 (m, 1H), 3.69 (s, 3H), 3.63 (d, J = 13.9 
Hz, 1H), 3.63 (s, 3H), 3.20 (d, J = 13.9 Hz, 1H), 2.28 (s, 3H); 13C NMR (125 MHz, 
DMSO-d6): δ 170.4, 167.2, 162.7, 161.2 (d, J = 241.4 Hz), 147.8, 142.0, 131.2 (d, J = 
8.2 Hz), 130.4 (d, J = 2.7 Hz), 114.6 (d, J = 21.0 Hz), 74.4, 53.0, 51.5, 35.5, 11.4; 19F 
NMR (282 MHz, DMSO-d6): δ -115.52; HRMS (ESI): m/z calcd. for 
[C16H16FNNaO4, M+Na]
+: 328.0956; found: 328.0971.  
Optical Rotation: [α]25D = 39.4 (c = 0.7, CHCl3). The absolute configuration of 
3.3e was assigned by analogy to 3.3a. 96% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 14.4 min 










The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 88% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.26 (s, 1H), 7.57 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 3.73 (d, J = 13.2 Hz, 
1H), 3.69 (s, 3H), 3.64 (s, 3H), 3.32 (d, J = 14.5 Hz, 1H), 2.30 (s, 3H); 13C NMR (125 
MHz, DMSO-d6): δ 170.2, 167.1, 162.6, 147.7, 142.1, 139.2, 130.1, 127.6 (q, J = 31.9 
Hz), 124.7 (q, J = 4.6 Hz), 124.2 (q, J = 270.5 Hz), 74.2, 53.1, 51.5, 35.7, 11.3; 19F 
NMR (282 MHz, DMSO-d6): δ -60.94; HRMS (ESI): m/z calcd. for 
[C17H16F3NNaO4, M+Na]
+: 378.0924; found: 378.0932.  
Optical Rotation: [α]25D = 50.2 (c = 0.3, CHCl3). The absolute configuration of 
3.3f was assigned by analogy to 3.3a. 91% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 35.1 min 






(S)-dimethyl 3-(3-bromobenzyl)-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3g) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 94% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.24 (s, 1H), 7.38-7.33 (m, 2H), 7.16 (t, J = 7.9 Hz, 1H), 7.09 (d, J = 7.6 Hz, 1H), 
3.70 (s, 3H), 3.63 (d, J = 13.9 Hz, 1H), 3.64 (s, 3H), 3.23 (d, J = 13.3 Hz, 1H), 2.28 (s, 
3H); 13C NMR (125 MHz, DMSO-d6): δ 170.2, 167.1, 162.6, 147.7, 142.1, 137.0, 
132.0, 130.0, 128.3, 121.0, 74.2, 53.1, 51.5, 35.5, 11.4; HRMS (ESI): m/z calcd. for 
[C16H16BrNNaO4, M+Na]
+: 388.0155; found: 388.0159. 
Optical Rotation: [α]25D = 48.2 (c = 0.3, CHCl3). The absolute configuration of 
3.3g was assigned by analogy to 3.3a. 87% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 31.5 min 






(S)-dimethyl 4-methyl-3-(2-methylbenzyl)-3H-pyrrole-3,5-dicarboxylate (3.3h) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 84% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.06 (s, 1H), 7.13-7.08 (m, 2H), 7.03 (t, J = 7.6 Hz, 1H), 6.93 (d, J = 7.6 Hz, 1H), 
3.73 (s, 3H), 3.63 (s, 3H), 3.62 (d, J = 14.4 Hz, 1H), 3.07 (d, J = 14.2 Hz, 1H), 2.32 (s, 
3H), 2.25 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 170.1, 167.5, 162.8, 148.2, 
141.6, 136.1, 133.1, 130.4, 129.2, 127.2, 125.5, 74.5, 53.1, 51.5, 33.4, 19.4, 11.5; 
HRMS (ESI): m/z calcd. for [C17H18NO4, M-H]
-: 300.1241; found: 300.1233. 
Optical Rotation: [α]25D = 52.5 (c = 0.3, CHCl3). The absolute configuration of 
3.3h was assigned by analogy to 3.3a. 96% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 80:20, flow rate = 1 ml/min, wavelength = 254 nm, tR = 14.5 min 






(S)-dimethyl 3-(2-bromobenzyl)-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3i) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 90% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.15 (s, 1H), 7.56 (dd, J = 7.8 Hz, 0.9 Hz, 1H), 7.26-7.22 (m, 1H), 7.17-7.14 (m, 1H), 
7.11 (dd, J = 7.6 Hz, 1.7 Hz, 1H), 3.80 (d, J = 14.0 Hz, 1H), 3.72 (s, 3H), 3.65 (s, 3H), 
3.35 (d, J = 14.0 Hz, 1H), 2.34 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 169.1, 
167.0, 162.7, 147.7, 142.0, 134.0, 132.8, 131.0, 129.4, 127.5, 124.4, 74.3, 53.3, 51.6, 
36.0, 11.6; HRMS (ESI), m/z calcd. for [C16H16BrNNaO4, M+Na]
+: 388.0155; found: 
388.0148. 
Optical Rotation: [α]25D = 71.3 (c = 0.4, CHCl3). The absolute configuration of 
3.3i was assigned by analogy to 3.3a. 96% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 35.3 min 
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The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 85% yield. 1H NMR (500 MHz, DMSO-d6): δ 
7.90 (s, 1H), 7.69 (d, J = 7.7 Hz, 1H), 7.52 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 
7.07 (d, J = 7.7 Hz, 1H), 3.82 (d, J = 14.8 Hz, 1H), 3.76 (s, 3H), 3.66 (s, 3H), 3.35 (d, 
J = 14.8 Hz, 1H), 2.32 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 169.5, 167.1, 
162.7, 148.1, 142.3, 133.2, 132.3, 130.3, 127.9, 127.1 (q, J = 29.2 Hz), 126.1 (q, J = 
5.5 Hz), 124.3 (q, J = 272.4 Hz), 73.7, 53.4, 51.6, 31.7, 11.3; 19F NMR (282 MHz, 
DMSO-d6): δ -56.90; HRMS (ESI): m/z calcd. for [C17H16F3NO4, M-H]-: 354.0959; 
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found: 354.0952.  
Optical Rotation: [α]25D = -31.6 (c = 0.3, CHCl3). The absolute configuration of 
3.3j was assigned by analogy to 3.3a. 94% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 19.1 min 





(S)-dimethyl 3-allyl-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3k) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 88% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.11 (s, 1H), 5.30-5.22 (m, 1H), 5.12 (dd, J = 17.0 Hz, 1.2 Hz, 1H), 4.98-4.96 (m, 1H), 
3.76 (s, 3H), 3.61 (s, 3H), 2.99 (dd, J = 13.8 Hz, 6.7 Hz, 1H), 2.61 (dd, J = 13.8 Hz, 
7.6 Hz, 1H), 2.16 (s, 3H); 13C NMR (125 MHz, DMSO-d6): δ 170.4, 167.1, 162.9, 




+: 260.0893; found: 260.0900. 
Optical Rotation: [α]25D = 5.1 (c = 0.2, CHCl3). The absolute configuration of 
3.3k was assigned by analogy to 3.3a. 83% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 31.0 min 





(S)-dimethyl 3-ethyl-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3l) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 73% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.12 (s, 1H), 3.78 (s, 3H), 3.61 (s, 3H), 2.31-2.24 (m, 1H), 2.14 (s, 3H), 1.88-1.81 (m, 
1H), 0.58 (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, DMSO-d6): δ 171.0, 167.7, 162.9, 
148.5, 141.5, 74.3, 52.9, 51.5, 23.9, 10.8, 7.9; HRMS (ESI): m/z calcd. for 
[C11H15NNaO4, M+Na]
+: 248.0893; found: 248.0905. 
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Optical Rotation: [α]25D = 6.5 (c = 0.2, CHCl3). The absolute configuration of 
3.3l was assigned by analogy to 3.3a. 80% ee (HPLC condition: Chiralpak IC column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 32.4 min 





(S)-dimethyl 3-heptyl-4-methyl-3H-pyrrole-3,5-dicarboxylate (3.3m) 
 
The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 1:1). Colorless syrup, 89% yield. 1H NMR (500 MHz, DMSO-d6): δ 
8.14 (s, 1H), 3.78 (s, 3H), 3.61 (s, 3H), 2.24-2.18 (m, 1H), 2.15 (s, 3H), 1.81-1.75 (m, 
1H), 1.25-1.18 (m, 8H), 0.91-0.86 (m, 2H), 0.83 (t, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, DMSO-d6): δ 171.1, 167.6, 162.9, 148.6, 141.3, 73.9, 52.9, 51.5, 31.1, 30.6, 
28.9, 28.2, 23.2, 22.0, 13.8, 10.9; HRMS (ESI), m/z calcd. for [C16H25NNaO4, 
M+Na]+: 318.1676; found: 318.1679. 
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Optical Rotation: [α]25D = +21.1 (c = 0.3, CHCl3). The absolute configuration of 
3.3m was assigned by analogy to 3.3a. 93% ee (HPLC condition: Chiralcel IB column, 
n-hexane/i-PrOH = 95:5, flow rate = 1 ml/min, wavelength = 254 nm, tR = 8.6 min for 





3.4.4 Ag-Catalyzed Enantioselective Cyclization of Disubstituted Isocyanoacetate 
 
General procedure. To a 10 mL vial charged with 3.5b (12 mg, 0.020 mmol) and 
Ag2O (2.3 mg, 0.010 mmol) was added anhydrous CHCl3 (0.5 mL). The mixture was 
allowed to stir at ambient temperature for 5 min, then allenoate 3.1 (0.10 mmol) was 
added in one portion. After the mixture was cooled to -20 oC, isocyanoacetate 3.2b or 
3.2c (0.10 mmol) in anhydrous CHCl3 (0.5 mL) was added via syringe pump over 2 h. 
The reaction mixture was stirred at -20 oC for 48 h, concentrated and purified by flash 
chromatography (hexanes/ethyl acetate) to afford the product 3.6. The pure major 
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diastereomer was isolated and characterized. 
 




6:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). White solid, 85% yield. MP: 87-89 oC; 1H 
NMR (500 MHz, DMSO-d6): δ 7.65 (s, 1H), 7.23-7.18 (m, 3H), 7.17-7.14 (m, 3H), 
7.01-6.98 (m, 4H), 5.65 (s, 1H), 5.60 (s, 1H), 3.36 (s, 3H), 3.32 (s, 3H), 3.31 (d, J = 
15.1 Hz, 1H), 3.26 (d, J = 13.2 Hz, 1H), 3.00 (d, J = 13.9 Hz, 1H), 2.91 (d, J = 13.3 
Hz, 1H); 13C NMR (125 MHz, DMSO-d6): δ 170.9, 170.1, 166.9, 147.3, 135.3, 135.2, 
130.8, 130.0, 128.0, 127.3, 126.7, 126.2, 112.5, 84.9, 66.4, 52.6, 52.4, 44.1, 42.7; 
HRMS (ESI): m/z calcd. for [C23H24NO4, M+H]
+: 378.1700; found: 378.1711. 
Optical Rotation: [α]25D = 51.6 (c = 1.0, CHCl3). 92% ee (HPLC condition: 
Chiralpak IB column, n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 







Figure 3.1 NOESY Spectrum of 3.6a 
 
 
The trans relative configuration of 3.6a was determined by the NOE (Figure 3.1), 
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11:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 90% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.63 (s, 1H), 7.23-7.01 (m, 10H), 5.74 (s, 1H), 5.71 (s, 1H), 3.99-3.88 (m, 
1H), 3.75-3.65 (m, 1H), 3.52 (s, 3H), 3.43 (d, J = 13.5 Hz, 1H), 3.29 (d, J = 13.4 Hz, 
1H), 3.10 (d, J = 13.5 Hz, 1H), 2.92 (d, J = 13.4 Hz, 1H), 1.03 (t, J = 7.1 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 171.6, 170.0, 167.5, 147.5, 135.3, 135.1, 131.2, 130.1, 
128.2, 127.5, 126.9, 126.4, 112.9, 85.3, 66.7, 61.6, 52.7, 45.0, 44.4, 13.7; HRMS 
(ESI): m/z calcd. for [C24H26NO4, M+H]
+: 392.1856; found: 392.1867. 
Optical Rotation: [α]23D = 38.2 (c = 0.5, CHCl3). The absolute configuration of 
3.6b was assigned by analogy to 3.6a. 90% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 7.2 min for 







(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(2-fluorobenzyl)-3-methylene-3,4-dihydro-2 
H-pyrrole-2,4-dicarboxylate (3.6c) 
 
8:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 78% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.69 (d, J = 2.6 Hz, 1H), 7.20-6.90 (m, 9H), 5.78 (s, 1H), 5.71 (s, 1H), 
4.03-3.92 (m, 1H), 3.84-3.73 (m, 1H), 3.46-3.27 (m, 5H), 3.12-2.99 (m, 2H), 1.10 (t, J 
= 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.6, 169.8, 166.9, 161.1 (d, J = 246.2 
Hz), 147.0, 135.3, 132.7 (d, J = 4.1 Hz), 131.1, 129.0 (d, J = 8.3 Hz), 127.6, 126.5, 
123.7 (d, J = 3.7 Hz), 122.3 (d, J = 15.8 Hz), 115.4 (d, J = 22.5 Hz), 113.4, 85.3, 66.7, 
61.8, 52.7, 45.5, 36.3, 13.7; HRMS (ESI): m/z calcd. for [C24H25FNO4, M+H]
+: 
410.1762; found: 410.1777. 
Optical Rotation: [α]25D = 37.6 (c = 0.3, CHCl3). The absolute configuration of 
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3.6c was assigned by analogy to 3.6a. 94% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 7.8 min for 





(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(2-bromobenzyl)-3-methylene-3,4-dihydro-2 
H-pyrrole-2,4-dicarboxylate (3.6d) 
 
7:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 70% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.77 (s, 1H), 7.56-7.43 (m, 1H), 7.16-7.06 (m, 8H), 5.78 (d, J = 3.3 Hz, 2H), 
4.02-3.91 (m, 1H), 3.78-3.66 (m, 1H), 3.52 (s, 3H), 3.45 (dd, J = 13.6, 6.2 Hz, 2H), 
3.24 (d, J = 13.7 Hz, 1H), 3.10 (d, J = 13.5 Hz, 1H), 1.06 (t, J = 7.1 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 171.6, 169.9, 166.8, 147.4, 135.2, 133.1, 132.0, 131.1, 
128.7, 127.5, 127.1, 126.4, 125.4, 113.5, 85.2, 77.2, 66.8, 61.8, 52.6, 45.2, 42.9, 13.7; 
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HRMS (ESI): m/z calcd. for [C24H25BrNO4, M+H]
+: 470.0961; found: 470.0964. 
Optical Rotation: [α]22D = 22.1 (c = 0.3, CHCl3). The absolute configuration of 
3.6d was assigned by analogy to 3.6a. 96% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 8.6 min for 





(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(2-methylbenzyl)-3-methylene-3,4-dihydro-2 
H-pyrrole-2,4-dicarboxylate (3.6e) 
 
>20:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 4:1). Colorless wax, 67% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.52 (s, 1H), 7.22-6.98 (m, 9H), 5.75 (s, 1H), 5.69 (s, 1H), 4.00-3.89 (m, 
1H), 3.72-3.55 (m, 4H), 3.48 (d, J = 13.5 Hz, 1H), 3.30 (d, J = 13.8 Hz, 1H), 3.15 (d, 
J = 13.6 Hz, 1H), 3.02 (d, J = 13.8 Hz, 1H), 2.25 (s, 3H), 1.02 (t, J = 7.1 Hz, 3H); 13C 
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NMR (75 MHz, CDCl3): δ 171.8, 170.3, 168.0, 148.3, 136.6, 135.3, 133.9, 131.3, 
130.6, 130.2, 127.5, 127.2, 126.4, 125.8, 112.7, 85.3, 66.7, 61.6, 52.7, 44.4, 41.3, 19.7, 
13.7; HRMS (ESI): m/z calcd. for [C25H28NO4, M+H]
+: 406.2013; found: 406.2024. 
Optical Rotation: [α]24D = 36.5 (c = 0.3, CHCl3). The absolute configuration of 
3.6e was assigned by analogy to 3.6a. 94% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 6.2 min for 





(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(4-fluorobenzyl)-3-methylene-3,4-dihydro-2 
H-pyrrole-2,4-dicarboxylate (3.6f) 
 
8:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 87% yield. 1H NMR (300 MHz, 
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CDCl3): δ 7.62 (s, 1H), 7.21-6.97 (m, 7H), 6.92-6.86 (m, 2H), 5.75 (s, 1H), 5.69 (s, 
1H), 4.00-3.90 (m, 1H), 3.80-3.66 (m, 1H), 3.52 (s, 3H), 3.42 (d, J = 13.5 Hz, 1H), 
3.26 (d, J = 13.6 Hz, 1H), 3.08 (d, J = 13.5 Hz, 1H), 2.92 (d, J = 13.6 Hz, 1H), 1.06 (t, 
J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.6, 169.9, 167.2, 162.0 (d, J = 
245.5 Hz), 147.3, 135.2, 131.8 (d, J = 8.0 Hz), 131.1, 130.9 (d, J = 3.3 Hz), 127.6, 
126.5, 115.1 (d, J = 21.3 Hz), 113.1, 85.4, 66.8, 61.7, 52.7, 45.3, 43.3, 13.8; HRMS 
(ESI): m/z calcd. for [C24H25FNO4, M+H]
+: 410.1762; found: 410.1769. 
Optical Rotation: [α]25D = 23.1 (c = 0.4, CHCl3). The absolute configuration of 
3.6f was assigned by analogy to 3.6a. 83% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 7.2 min for 










7:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 4:1). Colorless wax, 58% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.63 (s, 1H), 7.19-7.05 (m, 5H), 7.01 (d, J = 7.9 Hz, 2H), 6.93 (d, J = 8.1 
Hz, 2H), 5.73 (s, 1H), 5.70 (s, 1H), 3.99-3.89 (m, 1H), 3.77-3.66 (m, 1H), 3.51 (s, 3H), 
3.42 (d, J = 13.5 Hz, 1H), 3.25 (d, J = 13.5 Hz, 1H), 3.09 (d, J = 13.5 Hz, 1H), 2.88 (d, 
J = 13.5 Hz, 1H), 2.27 (s, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): 
δ 171.7, 170.1, 167.7, 147.6, 136.5, 135.3, 132.0, 131.2, 130.0, 128.9, 127.6, 126.4, 
112.8, 85.3, 66.8, 61.6, 52.7, 45.1, 44.0, 21.0, 13.7; HRMS (ESI): m/z calcd. for 
[C25H28NO4, M+H]
+: 406.2013; found: 406.2020. 
Optical Rotation: [α]24D = 50.1 (c = 0.2, CHCl3). The absolute configuration of 
3.6g was assigned by analogy to 3.6a. 91% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 6.8 min for 







(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(3-bromobenzyl)-3-methylene-3,4-dihydro-2 
H-pyrrole-2,4-dicarboxylate (3.6h) 
 
10:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 74% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.61 (s, 1H), 7.36-7.30 (m, 1H), 7.20-7.19 (m, 1H), 7.17-7.04 (m, 6H), 
7.00-6.97 (m, 1H), 5.75 (s, 1H), 5.70 (s, 1H), 4.02-3.91 (m, 1H), 3.77-3.66 (m, 1H), 
3.56 (s, 3H), 3.44 (d, J = 13.5 Hz, 1H), 3.25 (d, J = 13.5 Hz, 1H), 3.10 (d, J = 13.5 Hz, 
1H), 2.88 (d, J = 13.5 Hz, 1H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): 
δ 171.5, 169.8, 167.0, 147.3, 137.5, 135.2, 133.0, 131.2, 130.2, 129.8, 128.9, 127.6, 
126.5, 122.3, 113.1, 85.4, 66.6, 61.8, 52.8, 45.0, 43.7, 13.8; HRMS (ESI): m/z calcd. 
for [C24H25BrNO4, M+H]
+: 470.0961; found: 470.0974. 
Optical Rotation: [α]22D = 29.8 (c = 0.4, CHCl3). The absolute configuration of 
3.6h was assigned by analogy to 3.6a. 82% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 7.7 min for 







(2R,4S)-4-ethyl 2-methyl 2-benzyl-4-(3,5-dimethoxybenzyl)-3-methylene-3,4-dihy 
dro-2H-pyrrole-2,4-dicarboxylate (3.6i) 
 
11:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 86% yield. 1H NMR (500 MHz, 
CDCl3): δ 7.64 (s, 1H), 7.17-7.12 (m, 3H), 7.10-7.06 (m, 2H), 6.28 (t, J = 2.2 Hz, 1H), 
6.19 (d, J = 2.2 Hz, 2H), 5.74 (s, 1H), 5.72 (s, 1H), 3.98-3.92 (m, 1H), 3.73-3.69 (m, 
7H), 3.58 (s, 3H), 3.44 (d, J = 13.6 Hz, 1H), 3.23 (d, J = 13.4 Hz, 1H), 3.10 (d, J = 
13.6 Hz, 1H), 2.85 (d, J = 13.4 Hz, 1H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3): δ 171.8, 170.0, 167.6, 160.6, 147.8, 137.4, 135.3, 131.2, 127.6, 126.5, 112.9, 
108.0, 99.2, 85.4, 66.6, 61.6, 55.2, 52.7, 45.1, 44.8, 13.8; HRMS (ESI): m/z calcd. for 
[C26H30NO6, M+H]
+: 452.2068; found: 452.2084. 
Optical Rotation: [α]23D = 52.5 (c = 0.2, CHCl3). The absolute configuration of 
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3.6i was assigned by analogy to 3.6a. 88% ee (HPLC condition: Chiralpak IE column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 25.3 min 





(2R,4S)-4-ethyl 2-methyl 4-allyl-2-benzyl-3-methylene-3,4-dihydro-2H-pyrrole- 
2,4-dicarboxylate (3.6j) 
 
4:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 67% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.69 (s, 1H), 7.18-7.09 (m, 5H), 5.71-5.47 (m, 3H), 5.11-5.06 (m, 1H), 
5.04-4.99 (m, 1H), 4.02-3.91 (m, 1H), 3.82-3.64 (m, 4H), 3.46 (d, J = 13.6 Hz, 1H), 
3.16 (d, J = 13.6 Hz, 1H), 2.66 (dd, J = 13.8, 7.1 Hz, 1H), 2.37 (dd, J = 13.8, 7.7 Hz, 
1H), 1.11 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.7, 169.8, 167.7, 
147.4, 135.3, 131.7, 131.2, 127.6, 126.5, 119.5, 112.5, 85.5, 65.5, 61.6, 52.6, 44.7, 
147 
 
42.6, 13.8; HRMS (ESI): m/z calcd. for [C20H24NO4, M+H]
+: 342.1700; found: 
342.1710. 
Optical Rotation: [α]22D = 20.3 (c = 0.2, CHCl3). The absolute configuration of 
3.6j was assigned by analogy to 3.6a. 82% ee (HPLC condition: Chiralpak IB column, 
n-hexane/i-PrOH = 96:4, flow rate = 1 ml/min, wavelength = 254 nm, tR = 6.5 min for 





(2R,4S)-4-ethyl 2-methyl 4-benzyl-2-methyl-3-methylene-3,4-dihydro-2H-pyrrole 
-2,4-dicarboxylate (3.6k) 
 
11:1 d.r. (of crude). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 79% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.62 (s, 1H), 7.32-7.20 (m, 3H), 7.18-7.08 (m, 2H), 5.49 (s, 2H), 4.23-4.03 
(m, 2H), 3.59 (s, 3H), 3.42 (d, J = 13.6 Hz, 1H), 2.99 (d, J = 13.6 Hz, 1H), 1.55 (s, 
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3H), 1.18 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 172.2, 170.4, 166.8, 
150.6, 135.5, 130.2, 128.3, 127.0, 111.1, 81.5, 67.0, 61.7, 52.8, 43.2, 26.2, 13.9; 
HRMS (ESI): m/z calcd. for [C18H22NO4, M+H]
+: 316.1543; found: 316.1550. 
Optical Rotation: [α]23D = -55.8 (c = 0.3, CHCl3). The absolute configuration of 
3.6k was assigned by analogy to 3.6a. 94% ee (HPLC condition: Chiralpak IE column, 
n-hexane/i-PrOH = 90:10, flow rate = 1 ml/min, wavelength = 254 nm, tR = 15.4 min 





3.4.6 X-Ray Crystallographic Analysis and Determination of Configuration of 
3.6a 
The absolute configuration of 3.6a (2R,4S) was assigned by X-ray 
crystallographic analysis of a single crystal of 3.6a (Figure 3.2), which was prepared 





Figure 3.2 X-ray Structure of 3.6a 
 
 
Table 3.3 Crystal Data and Structure Refinement for 3.6a 
Identification code 3.6a  
Empirical formula C23H23NO4  
Formula weight 377.42  
Temperature 100(2) K  
Wavelength 1.54178 Å  
Crystal system Monoclinic  
Space group P 21  
Unit cell dimensions a = 9.2073(5) Å α = 90° 
 b = 8.4035(4) Å β = 90.524(2)° 




Z 2  
Density (calculated) 1.283 Mg/m
3
  





F(000) 400  
Crystal size 0.329 x 0.025 x 0.014 mm
3
  
Theta range for data collection 3.499 to 72.628°  
Index ranges -9<=h<=11, -10<=k<=10, -15<=l<=15 
Reflections collected 12788  
Independent reflections 3778 [R(int) = 0.0558]  
Completeness to theta = 67.679° 99.0 %  
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 3778 / 1 / 323  
Goodness-of-fit on F2 1.074  
Final R indices [I>2sigma(I)] R1 = 0.0516, wR2 = 0.1349  
R indices (all data) R1 = 0.0518, wR2 = 0.1352  
Absolute structure parameter 0.32(9)  




3.4.7 Pyrrole Synthesis by PPh3-Catalyzed [3+2] Cyclization of 3.1 and 3.2 
 
General procedure. To a 4 mL vial charged with PPh3 (3.2 mg, 0.012 mmol) was 
added anhydrous CHCl3 (0.5 mL). Allenoate 3.1 (0.12 mmol, 1.2 equiv) and activated 
isocyanide 3.2 (0.10 mmol, 1.0 equiv) were added in one portion. The reaction 
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mixture was allowed to stir at ambient temperature for the given time and then 
concentrated. The residue was purified by flash chromatography (hexanes/ethyl 
acetate) to afford the product 3.4. 
 




The general procedure outlined above was followed (using 1.0 equiv of allenoate, 24 
h). The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 3:1). Colorless wax, 90% yield. 1H NMR (300 MHz, CDCl3): δ 9.42 
(br s, 1H), 7.28-7.16 (m, 3H), 7.16-7.09 (m, 2H), 6.92-6.86 (m, 1H), 6.81 (dd, J = 2.8, 
1.7 Hz, 1H), 3.86-3.79 (m, 4H), 3.62 (s, 3H), 3.30 (dd, J = 13.6, 8.5 Hz, 1H), 3.01 (dd, 
J = 13.6, 7.0 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 174.1, 161.6, 138.9, 128.8, 
128.3, 126.3, 122.9, 122.5, 121.3, 114.3, 51.9, 51.5, 46.0, 39.8; HRMS (ESI): m/z 
calcd. for [C16H16NO4, M-H]







The general procedure outlined above was followed (17 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 90% yield. 1H NMR (300 MHz, CDCl3): δ 9.17 (br s, 1H), 7.40-7.32 (m, 2H), 
7.02-6.95 (m, 2H), 6.90-6.84 (m, 1H), 6.79 (dd, J = 2.8, 1.7 Hz, 1H), 3.84 (s, 3H), 
3.80-3.73 (m, 1H), 3.62 (s, 3H), 3.24 (dd, J = 13.7, 8.4 Hz, 1H), 2.95 (dd, J = 13.7, 
7.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 173.9, 161.4, 137.9, 131.4, 130.6, 122.7, 
122.6, 121.2, 120.3, 114.2, 52.0, 51.5, 45.8, 39.1; HRMS (ESI): m/z calcd. for 
[C16H15BrNO4, M-H]





The general procedure outlined above was followed (17 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 90% yield. 1H NMR (300 MHz, CDCl3): δ 9.30 (br s, 1H), 7.35-7.25 (m, 2H), 
7.13-7.00 (m, 2H), 6.87 (s, 1H), 6.81 (d, J = 2.2 Hz, 1H), 3.86-3.74 (m, 4H), 3.62 (s, 
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3H), 3.26 (dd, J = 13.7, 8.5 Hz, 1H), 2.96 (dd, J = 13.7, 7.0 Hz, 1H); 13C NMR (75 
MHz, CDCl3): δ 173.8, 161.5, 141.3, 131.9, 129.8, 129.5, 127.6, 122.7, 122.6, 122.3, 
121.2, 114.1, 52.0, 51.5, 45.7, 39.3; HRMS (ESI): m/z calcd. for [C16H15BrNO4, 





The general procedure outlined above was followed (17 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 94% yield. 1H NMR (300 MHz, CDCl3): δ 9.21 (br s, 1H), 7.10-7.02 (m, 2H), 
6.97-6.89 (m, 2H), 6.88-6.84 (m, 1H), 6.82-6.78 (m, 1H), 3.84 (s, 3H), 3.80-3.73 (m, 
1H), 3.62 (s, 3H), 3.25 (dd, J = 13.7, 8.5 Hz, 1H), 2.97 (dd, J = 13.7, 7.1 Hz, 1H); 13C 
NMR (75 MHz, CDCl3): δ 174.0, 161.5 (d, J = 242.7 Hz), 161.4, 134.6 (d, J = 3.2 
Hz), 130.3 (d, J = 7.8 Hz), 122.8, 122.6, 121.2, 115.1 (d, J = 21.3 Hz), 114.2, 52.0, 
51.5, 46.1, 39.0; HRMS (ESI): m/z calcd. for [C16H15FNO4, M-H]








The general procedure outlined above was followed (17 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 91% yield. 1H NMR (300 MHz, CDCl3): δ 9.26 (br s, 1H), 7.10-6.97 (m, 4H), 
6.93-6.86 (m, 1H), 6.82 (dd, J = 2.8, 1.7 Hz, 1H), 3.87-3.75 (m, 4H), 3.62 (s, 3H), 
3.26 (dd, J = 13.7, 8.6 Hz, 1H), 2.97 (dd, J = 13.7, 7.0 Hz, 1H), 2.29 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 174.2, 161.5, 135.8, 129.0, 128.7, 123.1, 122.5, 121.2, 
114.3, 51.9, 51.5, 46.1, 39.4, 21.0; HRMS (ESI), m/z calcd. for [C17H18NO4, M-H]
-: 
300.1241; found: 300.1244. 
 
Methyl 4-(1-ethoxy-1-oxo-3-phenylpropan-2-yl)-1H-pyrrole-2-carboxylate (3.4f) 
 
The general procedure outlined above was followed (18 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 95% yield. 1H NMR (300 MHz, CDCl3): δ 9.16 (br s, 1H), 7.28-7.17 (m, 3H), 
7.17-7.10 (m, 2H), 6.93-6.85 (m, 1H), 6.82 (dd, J = 2.7, 1.7 Hz, 1H), 4.15-3.99 (m, 
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2H), 3.87-3.75 (m, 4H), 3.28 (dd, J = 13.6, 8.7 Hz, 1H), 3.01 (dd, J = 13.6, 7.0 Hz, 
1H), 1.15 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 173.7, 161.5, 139.0, 
128.9, 128.2, 126.3, 123.2, 122.5, 121.2, 114.3, 60.7, 51.5, 46.1, 39.9, 14.1; HRMS 
(ESI): m/z calcd. for [C17H18NO4, M-H]





The general procedure outlined above was followed (16 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 4:1). Colorless 
wax, 93% yield. 1H NMR (300 MHz, CDCl3): δ 9.28 (br s, 1H), 7.29-7.11 (m, 5H), 
6.94-6.87 (m, 1H), 6.83 (dd, J = 2.5, 1.9 Hz, 1H), 5.04-4.80 (m, 1H), 3.88-3.72 (m, 
4H), 3.26 (dd, J = 13.6, 9.0 Hz, 1H), 3.00 (dd, J = 13.6, 6.8 Hz, 1H), 1.13 (d, J = 6.2 
Hz, 3H), 1.08 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 173.2, 161.6, 139.0, 
128.9, 128.2, 126.3, 123.3, 122.4, 121.2, 114.3, 68.0, 51.4, 46.3, 40.0, 21.6, 21.6; 
HRMS (ESI): m/z calcd. for [C18H20NO4, M-H]







The general procedure outlined above was followed (72 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 4:1). Colorless 
wax, 95% yield. 1H NMR (300 MHz, CDCl3): δ 9.20 (br s, 1H), 7.27-7.13 (m, 5H), 
6.92-6.85 (m, 1H), 6.85-6.79 (m, 1H), 3.84 (s, 3H), 3.72 (dd, J = 8.9, 6.8 Hz, 1H), 
3.23 (dd, J = 13.6, 9.0 Hz, 1H), 2.97 (dd, J = 13.7, 6.8 Hz, 1H), 1.33 (s, 9H); 13C 
NMR (75 MHz, CDCl3): δ 172.88, 161.6, 139.2, 129.0, 128.2, 126.2, 123.7, 122.4, 
121.1, 114.3, 80.7, 51.4, 46.9, 40.0, 27.9; HRMS (ESI): m/z calcd. for [C19H22NO4, 





The general procedure outlined above was followed (36 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 4:1). Colorless 
wax, 93% yield. 1H NMR (300 MHz, CDCl3): δ 9.14 (br s, 1H), 7.27-7.12 (m, 5H), 
6.93-6.87 (m, 1H), 6.83 (dd, J = 2.8, 1.6 Hz, 1H), 4.69 (dd, J = 8.2, 4.3 Hz, 1H), 
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3.87-3.73 (m, 4H), 3.27 (dd, J = 13.6, 9.0 Hz, 1H), 3.00 (dd, J = 13.7, 6.8 Hz, 1H), 
1.85-1.55 (m, 5H), 1.36-1.18 (m, 5H); 13C NMR (75 MHz, CDCl3): δ 173.1, 161.5, 
139.1, 128.9, 128.2, 126.3, 123.5, 122.4, 121.1, 114.3, 72.9, 51.5, 46.3, 40.0, 31.3, 
31.3, 25.3, 23.6; HRMS (ESI): m/z calcd. for [C21H24NO4, M-H]
-: 354.1711; found: 
354.1706. 
 
Methyl 4-(1-(benzyloxy)-1-oxopropan-2-yl)-1H-pyrrole-2-carboxylate (3.4j) 
 
The general procedure outlined above was followed (using 2.0 equiv of allenoate, 23 
h). The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 4:1). Colorless oil, 75% yield. 1H NMR (300 MHz, CDCl3): δ 9.21 
(br s, 1H), 7.40-7.27 (m, 5H), 6.87 (d, J = 2.8 Hz, 2H), 5.12 (d, J = 1.9 Hz, 2H), 3.84 
(s, 3H), 3.73 (q, J = 7.2 Hz, 1H), 1.49 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 174.6, 161.5, 136.0, 128.5, 128.1, 128.0, 124.8, 122.4, 120.7, 114.1, 66.4, 
51.4, 38.0, 18.2; HRMS (ESI): m/z calcd. for [C16H16NO4, M-H]
-: 286.1085; found: 
286.1073. 
 




The general procedure outlined above was followed (using 2.0 equiv of allenoate, 23 
h). The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 4:1). Colorless oil, 84% yield. 1H NMR (300 MHz, CDCl3): δ 9.15 
(br s, 1H), 6.96-6.78 (m, 2H), 3.83 (s, 3H), 3.67 (s, 3H), 3.42 (t, J = 7.6 Hz, 1H), 
2.06-1.89 (m, 1H), 1.84-1.72 (m, 1H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 174.9, 161.5, 123.6, 122.5, 121.1, 114.4, 51.9, 51.5, 45.7, 26.8, 12.0; 
HRMS (ESI), m/z calcd. for [C11H14NO4, M-H]
-: 224.0928; found: 224.0922. 
 
Methyl 4-(1-methoxy-1-oxopent-4-en-2-yl)-1H-pyrrole-2-carboxylate (3.4l) 
 
The general procedure outlined above was followed (16 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 4:1). Colorless 
oil, 81% yield. 1H NMR (300 MHz, CDCl3): δ 9.31 (br s, 1H), 6.92-6.83 (m, 2H), 
5.82-5.66 (m, 1H), 5.11-4.97 (m, 2H), 3.83 (s, 3H), 3.70-3.57 (m, 4H), 2.80-2.62 (m, 
1H), 2.56-2.41 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 174.2, 161.5, 135.2, 123.0, 
122.5, 121.1, 117.0, 114.3, 51.9, 51.5, 43.8, 37.6; HRMS (ESI), m/z calcd. for 
[C12H14NO4, M-H]
-: 236.0928; found: 236.0923. 
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Dimethyl 2-(5-(methoxycarbonyl)-1H-pyrrol-3-yl)succinate (3.4m) 
 
The general procedure outlined above was followed (using 2.0 equiv of allenoate, 16 
h). The crude reaction mixture was purified by flash column chromatography 
(hexane/EtOAc 3:1). Colorless wax, 86% yield. 1H NMR (300 MHz, CDCl3): δ 9.27 
(br s, 1H), 6.88 (s, 1H), 6.82 (s, 1H), 4.04 (dd, J = 9.5, 5.8 Hz, 1H), 3.83 (s, 3H), 3.68 
(d, J = 6.7 Hz, 6H), 3.10 (dd, J = 16.9, 9.6 Hz, 1H), 2.68 (dd, J = 16.8, 5.7 Hz, 1H); 
13C NMR (75 MHz, CDCl3): δ 173.6, 172.0, 161.4, 122.8, 122.0, 121.0, 113.9, 52.3, 




Methyl 4-(2-ethoxy-2-oxoethyl)-1H-pyrrole-2-carboxylate (3.4n) 
 
The general procedure outlined above was followed (using 2.0 equiv of allenoate, 20 
mol% PPh3, 43 h). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Pale brown oil, 56% yield. 1H NMR (500 MHz, 
CDCl3): δ 9.15 (br s, 1H), 6.91 (dd, J = 2.1, 1.5 Hz, 1H), 6.84 (d, J = 1.8 Hz, 1H), 
4.15 (q, J = 7.2 Hz, 2H), 3.83 (s, 3H), 3.49 (s, 2H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR 
(126 MHz, CDCl3): δ 171.8, 161.5, 122.6, 121.9, 117.8, 115.7, 60.8, 51.4, 32.8, 14.2; 
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HRMS (ESI), m/z calcd. for [C10H12NO4, M-H]
-: 210.0772; found: 210.0764. 
 
Methyl 4-(2-ethoxy-2-oxoethyl)-3-ethyl-1H-pyrrole-2-carboxylate (3.4o) 
 
The general procedure outlined above was followed (using 1.5 equiv of allenoate, 20 
mol% PPh3, 41 h). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Colorless wax, 59% yield. 1H NMR (300 MHz, 
CDCl3): δ 8.98 (br s, 1H), 6.85 (d, J = 3.0 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.83 (s, 
3H), 3.45 (s, 2H), 2.75 (q, J = 7.5 Hz, 2H), 1.25 (t, J = 7.1 Hz, 3H), 1.11 (t, J = 7.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 172.0, 161.7, 133.1, 121.4, 118.6, 116.7, 60.8, 
51.1, 30.8, 18.0, 15.2, 14.2; HRMS (ESI), m/z calcd. for [C12H16NO4, M-H]
-: 





The general procedure outlined above was followed (using 2.0 equiv of allenoate, 50 
mol% PPh3, 95 h). The crude reaction mixture was purified by flash column 
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chromatography (hexane/EtOAc 3:1). Colorless wax, 39% yield. 1H NMR (300 MHz, 
CDCl3): δ 8.95 (br s, 1H), 7.28-7.11 (m, 5H), 6.95 (d, J = 3.1 Hz, 1H), 4.13-3.94 (m, 
2H), 3.86-3.74 (m, 4H), 3.28 (dd, J = 13.5, 9.2 Hz, 1H), 2.97 (dd, J = 13.6, 6.4 Hz, 
1H), 2.83-2.57 (m, 2H), 1.16-0.98 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 174.1, 
161.6, 139.2, 132.7, 128.9, 128.3, 126.4, 122.3, 120.2, 118.3, 60.7, 51.1, 44.1, 40.4, 
17.8, 15.5, 14.0; HRMS (ESI), m/z calcd. for [C19H22NO4, M-H]
-: 328.1554; found: 
328.1552. 
 
Ethyl 4-(1-ethoxy-1-oxo-3-phenylpropan-2-yl)-1H-pyrrole-2-carboxylate (3.4q) 
 
The general procedure outlined above was followed (20 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 97% yield. 1H NMR (300 MHz, CDCl3): δ 9.28 (br s, 1H), 7.31-7.09 (m, 5H), 
6.95-6.86 (m, 1H), 6.82 (dd, J = 2.8, 1.7 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 4.16-3.98 
(m, 2H), 3.81 (dd, J = 8.7, 6.9 Hz, 1H), 3.29 (dd, J = 13.6, 8.8 Hz, 1H), 3.01 (dd, J = 
13.6, 6.9 Hz, 1H), 1.35 (t, J = 7.1 Hz, 3H), 1.14 (t, J = 7.1 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 173.7, 161.2, 139.0, 128.9, 128.2, 126.3, 123.1, 122.8, 121.0, 114.1, 
60.7, 60.4, 46.1, 39.9, 14.4, 14.0; HRMS (ESI), m/z calcd. for [C18H20NO4, M-H]
-: 







The general procedure outlined above was followed (20 mol %PPh3, 89 h). The crude 
reaction mixture was purified by flash column chromatography (hexane/EtOAc 4:1). 
Colorless wax, 82% yield. 1H NMR (300 MHz, CDCl3): δ 9.07 (br s, 1H), 7.33-7.09 
(m, 5H), 6.92-6.71 (m, 2H), 4.18-3.98 (m, 2H), 3.80 (dd, J = 8.9, 6.7 Hz, 1H), 3.28 
(dd, J = 13.6, 9.0 Hz, 1H), 3.00 (dd, J = 13.6, 6.6 Hz, 1H), 1.56 (s, 9H), 1.13 (t, J = 
7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 173.8, 160.6, 139.1, 128.9, 128.2, 126.3, 
124.3, 123.0, 120.3, 113.5, 80.9, 60.7, 46.2, 40.0, 28.3, 14.0; HRMS (ESI), m/z calcd. 
for [C20H24NO4, M-H]
-: 342.1711; found: 342.1694. 
 
Methyl 3-phenyl-2-(5-tosyl-1H-pyrrol-3-yl)propanoate (3.4s) 
 
The general procedure outlined above was followed (23 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 79% yield. 1H NMR (300 MHz, CDCl3): δ 9.30 (br s, 1H), 7.76 (d, J = 8.2 Hz, 
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2H), 7.33-7.00 (m, 7H), 6.81 (d, J = 2.5 Hz, 1H), 6.77 (d, J = 1.9 Hz, 1H), 3.80-3.73 
(m, 1H), 3.59 (s, 3H), 3.23 (dd, J = 13.5, 8.6 Hz, 1H), 2.94 (dd, J = 13.5, 7.0 Hz, 1H), 
2.41 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 173.7, 143.9, 139.3, 138.6, 129.8, 128.8, 
128.4, 128.3, 126.9, 126.5, 123.7, 121.5, 114.3, 52.0, 46.0, 40.0, 21.6; HRMS (ESI), 
m/z calcd. for [C21H20NO4S, M-H]
-: 382.1119; found: 382.1112. 
 
Ethyl 3-phenyl-2-(5-tosyl-1H-pyrrol-3-yl)propanoate (3.4t) 
 
The general procedure outlined above was followed (18 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 3:1). Colorless 
wax, 83% yield. 1H NMR (300 MHz, CDCl3): δ 9.58 (br s, 1H), 7.77 (d, J = 8.3 Hz, 
2H), 7.32-7.24 (m, 2H), 7.23-7.12 (m, 3H), 7.11-7.02 (m, 2H), 6.87-6.74 (m, 2H), 
4.11-3.95 (m, 2H), 3.76 (dd, J = 8.7, 7.0 Hz, 1H), 3.22 (dd, J = 13.5, 8.8 Hz, 1H), 2.94 
(dd, J = 13.6, 6.9 Hz, 1H), 2.40 (s, 3H), 1.11 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 173.3, 143.9, 139.3, 138.6, 129.8, 128.9, 128.2, 128.1, 126.8, 126.4, 123.7, 
121.7, 114.5, 60.8, 46.1, 40.0, 21.5, 14.0; HRMS (ESI), m/z calcd. for [C22H22NO4S, 
M-H]-: 396.1275; found: 396.1268. 
 




The general procedure outlined above was followed (23 h). The crude reaction 
mixture was purified by flash column chromatography (hexane/EtOAc 4:1). Colorless 
wax, 86% yield. 1H NMR (500 MHz, CDCl3): δ 9.52 (br s, 1H), 7.77 (d, J = 8.3 Hz, 
2H), 7.31-7.04 (m, 7H), 6.89-6.82 (m, 1H), 6.82-6.74 (m, 1H), 5.00-4.82 (m, 1H), 
3.73 (dd, J = 9.0, 6.8 Hz, 1H), 3.21 (dd, J = 13.6, 9.0 Hz, 1H), 2.95 (dd, J = 13.6, 6.8 
Hz, 1H), 2.40 (s, 3H), 1.11 (d, J = 6.3 Hz, 3H), 1.05 (d, J = 6.3 Hz, 3H); 13C NMR 
(126 MHz, CDCl3): δ 172.8, 143.8, 139.4, 138.7, 129.8, 128.9, 128.2, 128.1, 126.8, 
126.4, 123.9, 121.7, 114.5, 68.1, 46.2, 40.0, 21.5; HRMS (ESI), m/z calcd. for 
[C23H24NO4S, M-H]
-: 410.1432; found: 410.1420. 
 
tert-Butyl 3-phenyl-2-(5-tosyl-1H-pyrrol-3-yl)propanoate (3.4v) 
 
The general procedure outlined above was followed (20 mol% PPh3, 47 h). The crude 
reaction mixture was purified by flash column chromatography (hexane/EtOAc 3:1). 
White solid, 71% yield. 1H NMR (500 MHz, CDCl3): δ 9.46 (br s, 1H), 7.77 (d, J = 
8.3 Hz, 2H), 7.28-7.08 (m, 7H), 6.83 (s, 1H), 6.78 (d, J = 1.7 Hz, 1H), 3.68 (dd, J = 
165 
 
8.8, 7.0 Hz, 1H), 3.18 (dd, J = 13.6, 9.0 Hz, 1H), 2.92 (dd, J = 13.6, 6.8 Hz, 1H), 2.41 
(s, 3H), 1.31 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 172.5, 143.8, 139.5, 138.8, 
129.8, 129.0, 128.1, 128.0, 126.8, 126.3, 124.3, 121.6, 114.5, 80.9, 46.9, 40.0, 27.8, 
21.5; HRMS (ESI), m/z calcd. for [C24H26NO4S, M-H]
-: 424.1588; found: 424.1595. 
 
Ethyl 2-(4-ethyl-5-tosyl-1H-pyrrol-3-yl)acetate (3.4w) 
 
The general procedure outlined above was followed (using 2.0 equiv of allenoate, 30 
mol% PPh3, 95 h). The crude reaction mixture was purified by flash column 
chromatography (hexane/EtOAc 3:1). Pale brown wax, 58% yield. 1H NMR (300 
MHz, CDCl3): δ 9.20 (br s, 1H), 7.76 (d, J = 8.3 Hz, 2H), 7.32-7.23 (m, 2H), 6.92 (d, 
J = 3.0 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.38 (s, 2H), 2.62 (q, J = 7.5 Hz, 2H), 2.39 
(s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): 
δ 171.5, 143.7, 139.9, 130.7, 129.7, 126.7, 123.5, 121.8, 117.5, 60.9, 30.8, 21.5, 17.3, 
14.9, 14.1; HRMS (ESI), m/z calcd. for [C17H20NO4S, M-H]
-: 334.1119; found: 
334.1112. 
 
3.4.9 X-Ray Crystallographic Analysis of 3.4v 
The conformation of 3.4v was determined by X-ray crystallographic analysis of a 
single crystal of 3.4v (Figure 3.3). The crystal was prepared from the solution of 3.4v 
in hexanes/ethyl acetate at ambient temperature. 
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Figure 3.3 X-ray Structure of 3.4v 
 
 
Table 3.4 Crystal Data and Structure Refinement for 3.4v 
Identification code 3.4v  
Empirical formula C24H27NO4S  
Formula weight 425.52  
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic  
Space group P21/c  
Unit cell dimensions a = 24.358(3) Å α = 90° 
 b = 8.0579(9) Å β = 100.201(3)° 




Z 4  
Density (calculated) 1.299 Mg/m
3
  
Absorption coefficient 0.179 mm
-1
  
F(000) 904  
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Crystal size 0.260 x 0.200 x 0.100 mm
3
  
Theta range for data collection 1.699 to 27.518°  
Index ranges -31<=h<=27, -10<=k<=10, -13<=l<=14 
Reflections collected 14979  
Independent reflections 4999 [R(int) = 0.0578]  
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6607  
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 4999 / 0 / 279  
Goodness-of-fit on F2 0.990  
Final R indices [I>2sigma(I)] R1 = 0.0581, wR2 = 0.1484  
R indices (all data) R1 = 0.0772, wR2 = 0.1615  
Extinction coefficient n/a  
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The development of efficient and economical methods for the construction of 
valuable heterocyclic compounds remains an important goal in organic synthesis and 
medicinal chemistry, for which multicomponent reactions (MCRs)[53] have emerged 
as powerful strategies due to their potential for introducing structural diversity and 
complexity in only one synthetic step. Along these lines, activated isocyanides (or 
α-acidic isocyanides)[2, 54] such as isocyanoacetates and isocyanoacetamides have 
found wide application in numerious MCRs due to their unique reactivities. In 
particular, three-component reactions of aldehydes, amines and activated isocyanides 
have been extensively studied to deliver a wide range of heterocycles.[55, 57a, 57c, 57d, 88] 
By taking advantage of the α-acidic carbon, Orru and co-workers developed an 
elegant synthesis of imidazolines from three-component reactions of aldehydes, 
amines and α-substituted isocyanoacetates (Scheme 4.1, top).[55d, 88a-e] The reaction 
was initiated by imine condensation, followed by nucleophilic addition of the 
α-carbanion to the generated imine and cyclization. In contrast, Zhu and co-workers 
described a completely different reactivity of activated isocyanides (both α-substituted 
isocyanoacetates and isocyanoacetamides) in the three-component reactions with 
aldehydes and amines, which was initiated by nucleophilic addition of the isocyanide 
carbon to the in situ generated imine/iminium, leading to the formation of oxazole 
scaffolds (Scheme 4.1, middle).[55a-c, 57a, 57c, 57d] Despite of these important 
achievements on this topic, however, the implementation of mechanistically novel 
catalytic transformations to achieve product structural diversity remains a significant 
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challenge in organic synthesis. We present here an intriguing three-component 
reaction of 3-formylchromones, amines and isocyanoacetates to yield highly 
functionalized pyrroles under silver catalysis (Scheme 4.1, bottom). Experimental 
studies revealed that this unusual transformation was initiated by 1,4-conjugate 
addition instead of imine condensation, representing a new reaction mode in 
isocyanide-based MCRs. 
 
Scheme 4.1 Three-Component Reaction of Activated Isocyanides 
 
 
4.2 Project Design 
In contrast to well-established [3+2] cycloaddition reactions, there is no evidence 
for the [4+3] cyclization on the basis of isocyanoacetates. Based on our group’s 
continuous interest and efforts in isocyanoacetate chemistry,[26, 42] we became 
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interested in the exploration of new reaction partners of isocyanoacetates to realize the 
construction of seven-membered ring structures. Various α,β-unsaturated carbonyl 
compounds or imines were evaluated. To our disappointment, no desired product was 
formed; only [3+2] cyclization by-product was obtained. After many attempts, we 
chose 3-formylchromones[89] in which the conjugate addition pathway should be 
encouraged due to the presence of two electron-withdrawing groups. We envisioned 
that seven-membered 1,3-diazepines 4.4 could be obtained from the reaction of 
3-formylchromones 4.1, amines 4.2 and isocyanoacetates 4.3 through a sequence of 
imine condensation, [4+3] cyclization[90] and subsequent elimination[90b] (Scheme 4.2). 
This sequential approach seemed feasible and could generate complex structures from 
simple starting materials in a cascade fashion. The resulting products may have some 
interesting bioactivities as they are synthetic analogues of 1,4-benzodiazepines which 
are well known for their psychotropic effects.[91] Thus, we started to explore the 
possibility of this three-component reaction. 
 




4.3 Results and Discussion 
4.3.1 Observation of Unexpected Pyrrole Formation 
Initial studies were performed by using the commercially available 
3-formylchromone 4.1a, p-anisidine 4.2a and methyl isocyanoacetate 4.3a as the 
model substrates. Based on our previous studies of isocyanoacetate chemistry,[26, 42] 
we first attempted the use of Ag2O as the catalyst to promote this reaction. 
Intriguingly, we did not observe any formation of 1,3-diazepine 4.4a under these 
conditions; instead, an unexpected five-membered ring product of polysubstituted 
pyrrole 4.5a was obtained, albeit in a moderate yield of 27% (Table 4.1, entry 1). The 
failure of 4.4a formation may be due to the high strain and instability of this 
seven-membered ring structure. In fact, the access to such architecture is still elusive 
in isocyanoacetate chemistry. From the viewpoint of product structure, as shown in 
Scheme 4.1, it is worth noting that conventional isocyanide-based MCRs led to the 
formation of imidazolines or oxazoles, while our method provided the access to 
polysubstituted pyrroles; in addition, activated isocyanide typically serves as three- or 
five-atom unit in the five-membered ring structure, whereas in our case, it serves as 
two-atom unit. Moreover, the resulted 1,2,4-trisubstituted pyrroles are important 
heterocycles due to their remarkable biological activities, such as synthetic histone 
deacetylase inhibitors,[92] while synthetic approaches toward them are quite limited.[93] 
Consequently, the efficient preparation of this class of molecules is undoubtedly a 
significant goal in organic synthesis. The novelty of the mechanism coupled with the 
importance of the products encouraged us for further investigation of this reaction. 
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Table 4.1 Optimization of Reaction Conditions[a-d] 
 
entry metal ligand solvent yield (%)[b] 
1 Ag2O / THF 27 
2 Ag2CO3 / THF 17 
3 Cu2O / THF 6 
4 Cu(OAc)2 / THF 16 
5 Ag2O PPh3 THF 37 
6 Ag2O dppf THF 21 
7 Ag2O dppe THF 17 
8 Ag2O PPh3 1,4-dioxane 35 
9 Ag2O PPh3 Et2O 14 
10 Ag2O PPh3 toluene 23 
11 Ag2O PPh3 CHCl3 19 
12 Ag2O PPh3 CH2Cl2 19 
13[c] Ag2O PPh3 THF 53 
14[c-d] Ag2O PPh3 THF 70 
[a] Carried out with 0.1 mmol 4.1a, 0.12 mmol 4.2a and 0.12 mmol 4.3a in 1 mL 
solvent. [b] Isolated yields. [c] 2 mL THF was used. [d] 0.2 mmol 4.2a was used. 
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4.3.2 Optimization of Reaction Conditions 
With the aim of improving the efficiency of this unusual transformation, many 
other silver or copper salts with different levels of basicity or Lewis acidity were 
evaluated (Table 4.1, entries 2-4), suggesting that Ag2O was still the optimal choice. 
In an effort to improve the yield further, various commercially available phosphine 
ligands were tested (entries 5-7), which to our delight the use of simple PPh3 led to a 
higher yield of 37% (entry 5). Further optimization of reaction conditions with the use 
of Ag2O-PPh3 system was carried out. While solvent screening showed THF was still 
the best solvent (entries 8-12), lowering the concentration led to an obvious increase 
in the yield (entry 13, 53%). Finally, the use of 2.0 equiv of 4.2a resulted in the 
efficient formation of 4.5a with 70% isolated yield (entry 14). 
 
4.3.3 Substrate Scope 
With the optimal reaction conditions in hand, we turned our attention to explore 
the scope of this silver-catalyzed pyrrole synthesis (Scheme 4.3). 3-Formylchromones 
bearing different substituents (electron-withdrawing, electron-donating and 
electron-neutral) with diverse substitution patterns (para-, meta-, and ortho-) on the 
aryl ring could be well-tolerated to produce highly functionalized pyrroles with 
different phenol units in moderate to good yields (30-70%, 4.5a-4.5i). 
Isocyanoacetates possessing different ester groups were all suitable substrates, thus 
producing 4.5j and 4.5k in uniformly high yields. Anilines with different 
electron-donating groups on the para-position turned out to be good substrates to 
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generate 4.5l-4.5n in good yields (48%-69%). To further extend the substrate scope, 
aliphatic amine was examined under the standard conditions. To our delight, the 
desired product 4.5o was obtained, albeit with a lower yield of 23%. The structure of 
4.5a was unambiguously determined by single crystal X-ray analysis and those of 
other polysubstituted pyrroles were assigned by analogy. 
It is noteworthy that the current catalytic system is simple to perform with a “mix 
and go” procedure using commercially available and cheap Ag2O and PPh3 as 
catalysts. The reactions were carried out under ambient atmosphere with no need for 
exclusion of air or moisture. Moreover, it is an environmentally friendly procedure as 
water is the only waste generated during the reaction. The combination of all these 
characters makes it an attractive method for polysubstituted pyrrole synthesis. The 
related 1,2,4-trisubstituted pyrroles such as Apricoxib[94] are important target 
compounds in medicinal chemistry, and this protocol provides a rapid access to the 
core structure of those compounds. 
 





[a] The reactions were carried out with 0.1 mmol 4.1a, 0.2 mmol 4.2a and 0.12 mmol 
4.3a in 2 mL THF at ambient temperature for 18 h. [b] Isolated yields. 
 
4.3.4 Gram-Scale Reaction 
To test the robustness and efficiency of this method in preparative synthesis, a 
gram-scale three-component reaction of 4.1a, 4.2a and 4.3a was investigated under 
the standard reaction conditions (eq. 4.1). To our delight, the desired product 4.5a 





4.3.5 Mechanistic Study 
In an effort to shed some light on the mechanism of this unusual transformation, 
the kinetics of the reaction between 4.1a, 4.2a and 4.3a under silver catalysis was 
monitored by NMR. Intriguingly, two unexpected intermediates A and B (as a mixture, 
tautomers to each other) were detected once we mixed 4.1a and 4.2a together, which 
were determined by NMR analysis to be the 1,4-conjugate addition products of 4.1a 
and 4.2a and could be converted to the final product 4.5a by the treatment with 4.3a 
under silver catalysis (Scheme 4.4a). In contrast, the expected imine intermediate 4.6 
(Scheme 4.4b) was not observed during the reaction, suggesting that the formation of 
4.5a does not proceed through imine condensation. To prove this, 4.6 was prepared in 
a pure form.[90a] When 4.6 was subjected to the standard reaction conditions with 4.3a, 
as expected, we did not observe any formation of 4.5a (Scheme 4.4b). It is worth 
noting that conventional isocyanide-based MCRs are all initiated by imine 
condensation, our method represents a new reaction mode on this topic. 
 






4.3.6 Proposed Mechanism 
On the basis of the above experimental results and related reports, a possible 
reaction pathway for the synthesis of polysubstituted pyrroles is proposed with the 
reaction of 4.1a, 4.2a and 4.3a as an example (Scheme 4.5). 
 




The reaction starts with the formation of 1,4-conjugate addition products A and B 
from 4.1a and 4.2a. It is noteworthy that for this step, there is no imine formation 
probably because the β-carbon in 4.1a is more electrophilic than the carbonyl carbon 
in the absence of Brønsted acid[90a]. After that, 1,4-conjuagte addition of enolate C 
(derived from the deprotonation of 4.3a) to B happens to give the key intermediate D. 
Subsequent intramolecular 1,4-migration[95] follwed by cyclization generates F, which, 
upon dehydration then produces 4.5a as the final product. 
 
4.4 Conclusion 
In conclusion, we have developed, for the first time, a mechanistically intriguing 
three-component reaction of 3-formylchromones, amines and isocyanoacetates. Under 
silver catalysis, a wide range of highly functionalized pyrroles could be obtained. 
Current efforts in our laboratory are focused on the application of this current catalytic 
system to the preparation of other types of heterocycles. 
 
4.5 Experimental Section 
4.5.1. General Information 
1H and 13C NMR spectra were recorded on a Bruker AFC 300 (300 MHz) or 
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference: 1H 
(chloroform δ 7.26; Acetone δ 2.05), 13C (chloroform δ 77.0; Acetone δ 29.8, 206.3). 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
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triplet, q = quartet, m = multiplet, br = broad, dd = doublet of doublets), coupling 
constants (Hz) and integration. For thin layer chromatography (TLC), Merck 
pre-coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. High resolution mass spectra (HRMS) were obtained on a 
Finnigan/MAT 95XL-T spectrometer. 
Unless otherwise noted, all the reactions were carried out open to air. 
Dichloromethane, diethyl ether (Et2O), tetrahydrofuran (THF), and toluene were dried 
over a Pure Solv solvent purification system. Deuterated solvents were purchased 
from Cambridge Isotope Laboratories and used as received without further 
purification. Methyl isocyanoacetate, ethyl isocyanoacetate were purchased from Alfa 
Aesar company and used without further purification. Isopropyl isocyanoacetate was 
prepared according to literature procedure.[67] Other chemicals were purchased from 
commercial suppliers and used as received without further purification. 
 
4.5.2 Ag-Catalyzed Three-Component Reaction 
 
General procedure. To a 10 mL vial charged with Ag2O (2.3 mg, 0.010 mmol), 
PPh3 (5.2 mg, 0.020 mmol) and 4 Å MS (30 mg) was added anhydrous THF (2.0 mL). 
The mixture was allowed to stir at ambient temperature for 5 min, then amine 4.2 
(0.20 mmol) was added in one portion, followed by isocyanoacetate 4.3 (0.12 mmol) 
and 3-formylchromone 4.1 (0.10 mmol). The reaction mixture was allowed to stirred 
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at ambient temperature for 18 h, concentrated and purified by flash chromatography 
(hexanes/ethyl acetate) to afford the product 4.5. 
 




Yellow wax, 70% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.88 (s, 1H), 9.52 (s, 
1H), 8.50 (d, J = 1.8 Hz, 1H), 8.02 (dd, J = 8.2, 1.6 Hz, 1H), 7.62-7.56 (m, 1H), 7.50 
(d, J = 1.9 Hz, 1H), 7.34-7.24 (m, 2H), 7.07-6.96 (m, 4H), 3.91 (s, 3H), 3.83 (s, 3H). 
13C NMR (126 MHz, Acetone-d6): δ 194.0, 163.3, 161.5, 159.7, 144.0, 141.3, 137.0, 
132.7, 127.7, 125.2, 125.1, 123.6, 121.7, 120.9, 120.1, 118.9 115.5, 55.8, 52.5. 
HRMS (ESI): m/z Calcd. for [C21H17N2O5, M-H]





Yellow wax, 55% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.66 (s, 1H), 9.52 (s, 
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1H), 8.50 (d, J = 1.8 Hz, 1H), 7.79 (d, J = 1.4 Hz, 1H), 7.50 (d, J = 1.9 Hz, 1H), 
7.44-7.39 (m, 1H), 7.32-7.26 (m, 2H), 7.03-6.98 (m, 2H), 6.94 (d, J = 8.5 Hz, 1H), 
3.91 (s, 3H), 3.83 (s, 3H), 2.33 (s, 3H). 13C NMR (126 MHz, Acetone-d6): δ 194.0, 
161.5, 161.2, 159.7, 144.1, 141.3, 137.9, 132.3, 129.2, 127.6, 125.3, 125.1, 123.6, 
121.7, 120.7, 118.7, 115.5, 55.8, 52.5, 20.5. HRMS (ESI): m/z Calcd. for 
[C22H19N2O5, M-H]





Yellow wax, 49% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.65 (s, 1H), 9.53 (s, 
1H), 8.51 (d, J = 1.6 Hz, 1H), 7.82 (d, J = 2.1 Hz, 1H), 7.50 (d, J = 1.9 Hz, 1H), 7.46 
(dd, J = 8.5, 2.2 Hz, 1H), 7.32-7.27 (m, 2H), 7.04-6.99 (m, 2H), 6.97 (d, J = 8.5 Hz, 
1H), 3.92 (s, 3H), 3.83 (s, 3H), 2.66 (q, J = 7.6 Hz, 2H), 1.23 (t, J = 7.6 Hz, 3H). 13C 
NMR (126 MHz, Acetone-d6): δ 194.0, 161.5, 161.3, 159.7, 144.0, 141.3, 136.8, 
135.7, 131.2, 127.7, 125.3, 125.1, 123.6, 121.6, 120.8, 118.8, 115.5, 55.8, 52.5, 28.5, 
16.2. HRMS (ESI): m/z Calcd. for [C23H21N2O5, M-H]







Yellow wax, 45% yield. 1H NMR (500 MHz, CDCl3): δ 11.73 (s, 1H), 9.56 (s, 1H), 
8.56 (d, J = 1.8 Hz, 1H), 7.74 (d, J = 2.2 Hz, 1H), 7.54 (d, J = 1.9 Hz, 1H), 7.41 (dd, J 
= 8.6, 2.2 Hz, 1H), 7.25-7.18 (m, 2H), 7.00 (d, J = 8.5 Hz, 1H), 6.96-6.90 (m, 2H), 
3.92 (s, 3H), 3.84 (s, 3H), 2.92 (dt, J = 13.8, 6.9 Hz, 1H), 1.27 (d, J = 6.9 Hz, 6H). 13C 
NMR (126 MHz, CDCl3): δ 193.3, 161.0, 160.7, 158.6, 142.7, 140.2, 139.3, 134.5, 
129.0, 127.2, 124.6, 123.7, 122.7, 121.7, 119.6, 118.2, 114.6, 55.5, 52.1, 33.2, 24.0. 
HRMS (ESI): m/z Calcd. for [C24H23N2O5, M-H]





Yellow solid, 46% yield. 1H NMR (500 MHz, CDCl3): δ 11.68 (s, 1H), 9.54 (s, 1H), 
8.55 (d, J = 1.8 Hz, 1H), 7.60 (dd, J = 8.9, 3.1 Hz, 1H), 7.53 (d, J = 1.9 Hz, 1H), 
7.28-7.20 (m, 3H), 7.03 (dd, J = 9.1, 4.5 Hz, 1H), 6.96-6.90 (m, 2H), 3.92 (s, 3H), 
3.84 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 192.3, 160.9, 158.8 (d, J = 1.3 Hz), 
158.7, 154.9 (d, J = 238.6 Hz), 142.6, 140.1, 127.0, 124.0, 123.9, 123.5 (d, J = 23.6 
Hz), 122.7, 121.5, 119.7 (d, J = 7.3 Hz), 119.4 (d, J = 6.3 Hz), 116.6 (d, J = 23.7 Hz), 
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Yellow wax, 52% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.58 (s, 1H), 9.52 (s, 
1H), 8.52 (d, J = 1.8 Hz, 1H), 8.04 (d, J = 2.5 Hz, 1H), 7.70 (dd, J = 8.9, 2.5 Hz, 1H), 
7.50 (d, J = 1.9 Hz, 1H), 7.33-7.24 (m, 2H), 7.06-6.98 (m, 3H), 3.92 (s, 3H), 3.83 (s, 
3H). 13C NMR (126 MHz, Acetone-d6): δ 192.8, 161.7, 161.4, 159.8, 144.0, 141.3, 
139.2, 134.5, 127.9, 125.3, 124.9, 123.7, 123.1, 121.4, 121.1, 115.5, 111.2, 55.8, 52.6. 
HRMS (ESI): m/z Calcd. for [C21H16BrN2O5, M-H]





Yellow wax, 60% yield. 1H NMR (500 MHz, CDCl3): δ 12.16 (s, 1H), 9.54 (s, 1H), 
8.52 (s, 1H), 7.86 (d, J = 8.6 Hz, 1H), 7.52 (d, J = 1.7 Hz, 1H), 7.24-7.18 (m, 2H), 
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7.07 (s, 1H), 6.98-6.90 (m, 3H), 3.92 (s, 3H), 3.83 (s, 3H). 13C NMR (126 MHz, 
CDCl3): δ 192.5, 163.4, 160.9, 158.7, 142.6, 141.9, 140.1, 132.6, 126.9, 124.2, 123.9, 
122.7, 121.5, 119.7, 118.6, 118.4, 114.6, 55.5, 52.1. 
 
Methyl (E)-4-(3,5-dibromo-2-hydroxybenzoyl)-1-(((4-methoxyphenyl)imino)meth 
yl)-1H-pyrrole -2-carboxylate (4.5h) 
 
Yellow solid, 30% yield. 1H NMR (500 MHz, CDCl3): δ 12.53 (s, 1H), 9.54 (s, 1H), 
8.55 (s, 1H), 7.99 (d, J = 1.2 Hz, 1H), 7.90 (s, 1H), 7.50 (s, 1H), 7.23 (d, J = 8.5 Hz, 
2H), 6.94 (d, J = 8.5 Hz, 2H), 3.93 (s, 3H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3): 
δ 191.8, 160.8, 158.8, 158.3, 142.4, 141.0, 139.9, 132.9, 127.4, 124.2, 123.4, 122.8, 
121.5, 121.3, 114.6, 113.3, 110.5, 55.5, 52.2. HRMS (ESI): m/z Calcd. for 
[C21H15Br2N2O5, M-H]





Yellow solid, 50% yield. 1H NMR (500 MHz, CDCl3): δ 11.88 (s, 1H), 9.54 (s, 1H), 
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8.54 (d, J = 1.7 Hz, 1H), 7.86 (s, 1H), 7.51 (d, J = 1.8 Hz, 1H), 7.25-7.19 (m, 2H), 
6.97-6.90 (m, 3H), 3.92 (s, 3H), 3.84 (s, 3H), 2.41 (s, 3H). 13C NMR (126 MHz, 
CDCl3): δ 192.0, 161.2, 160.9, 158.7, 145.3, 142.6, 140.2, 131.1, 126.9, 124.3, 124.1, 
123.9, 122.8, 121.4, 120.5, 118.8, 114.6, 55.5, 52.1, 20.8. HRMS (ESI): m/z Calcd. 
for [C22H18ClN2O5, M-H]





Yellow wax, 69% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.87 (s, 1H), 9.53 (s, 
1H), 8.50 (s, 1H), 8.02 (d, J = 8.1 Hz, 1H), 7.59 (dd, J = 11.2, 4.3 Hz, 1H), 7.51 (d, J 
= 1.8 Hz, 1H), 7.32-7.22 (m, 2H), 7.08-6.96 (m, 4H), 4.38 (q, J = 7.1 Hz, 2H), 3.83 (s, 
3H), 1.38 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, Acetone-d6): δ 194.1, 163.3, 161.0, 
159.7, 144.1, 141.3, 136.9, 132.7, 127.6, 125.5, 125.1, 123.6, 121.6, 121.0, 120.1, 
118.9, 115.5, 61.9, 55.8, 14.5. HRMS (ESI): m/z Calcd. for [C22H21N2O5, M+H]
+: 







Yellow wax, 62% yield. 1H NMR (500 MHz, Acetone-d6): δ 11.87 (s, 1H), 9.55 (s, 
1H), 8.50 (d, J = 1.6 Hz, 1H), 8.02 (dd, J = 8.2, 1.5 Hz, 1H), 7.67-7.57 (m, 1H), 7.50 
(d, J = 1.8 Hz, 1H), 7.32-7.24 (m, 2H), 7.12-6.93 (m, 4H), 5.23 (dt, J = 12.5, 6.2 Hz, 
1H), 3.83 (s, 3H), 1.38 (d, J = 6.3 Hz, 6H). 13C NMR (126 MHz, Acetone-d6): δ 194.1, 
163.3, 160.6, 159.7, 144.2, 141.4, 136.9, 132.7, 127.6, 125.8, 125.1, 123.6, 121.5, 
121.0, 120.1, 118.9, 115.5, 69.8, 55.8, 22.1. HRMS (ESI): m/z Calcd. for 
[C23H23N2O5, M+H]





Yellow wax, 48% yield. 1H NMR (500 MHz, CDCl3): δ 11.96 (s, 1H), 9.56 (s, 1H), 
8.55 (d, J = 1.5 Hz, 1H), 8.00-7.84 (m, 1H), 7.57 (d, J = 1.6 Hz, 1H), 7.55-7.49 (m, 
1H), 7.36 (t, J = 7.9 Hz, 2H), 7.23 (d, J = 8.7 Hz, 2H), 7.12 (t, J = 7.4 Hz, 1H), 
7.09-7.00 (m, 5H), 6.98 (t, J = 7.6 Hz, 1H), 3.92 (s, 3H). 13C NMR (126 MHz, 
CDCl3): δ 193.3, 162.7, 161.0, 157.2, 156.1, 143.7, 142.6, 136.1, 131.7, 129.8, 127.0, 
124.6, 123.8, 123.4, 122.8, 121.9, 119.9, 119.7, 119.0, 118.8, 118.5, 52.1. HRMS 
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(ESI): m/z Calcd. for [C26H21N2O5, M+H]





Brown solid, 69% yield. 1H NMR (500 MHz, CDCl3): δ 12.00 (s, 1H), 9.56 (s, 1H), 
8.56 (d, J = 1.8 Hz, 1H), 7.95 (dd, J = 7.9, 1.2 Hz, 1H), 7.55 (d, J = 1.6 Hz, 1H), 
7.53-7.49 (m, 1H), 7.26-7.20 (m, 2H), 7.06 (d, J = 8.3 Hz, 1H), 6.98 (q, J = 7.4 Hz, 
1H), 6.75 (d, J = 8.4 Hz, 2H), 3.92 (s, 3H), 2.99 (s, 6H). 13C NMR (126 MHz, CDCl3): 
δ 193.4, 162.7, 161.0, 140.9, 135.9, 131.7, 127.0, 124.2, 123.6, 122.8, 121.6, 120.0, 
119.0, 118.4, 113.0, 52.0, 40.7. HRMS (ESI): m/z Calcd. for [C22H22N3O4, M+H]
+: 





Yellow wax, 65% yield. 1H NMR (500 MHz, CDCl3): δ 11.98 (s, 1H), 9.56 (s, 1H), 
8.55 (d, J = 1.7 Hz, 1H), 7.93 (dd, J = 8.0, 1.4 Hz, 1H), 7.55 (d, J = 1.8 Hz, 1H), 7.51 
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(dd, J = 11.3, 4.2 Hz, 1H), 7.23 (d, J = 8.8 Hz, 2H), 7.06 (d, J = 8.4 Hz, 1H), 
7.01-6.90 (m, 3H), 3.92 (s, 3H), 3.90-3.82 (m, 4H), 3.24-3.12 (m, 4H). 13C NMR 
(126 MHz, CDCl3): δ 193.3, 162.7, 161.0, 142.3, 136.0, 131.7, 127.0, 124.4, 123.7, 
122.6, 121.7, 119.9, 119.0, 118.4, 116.2, 66.8, 52.0, 49.3. HRMS (ESI): m/z Calcd. 
for [C24H22N3O5, M-H]





Pale yellow wax, 23% yield. 1H NMR (300 MHz, CDCl3): δ 11.97 (s, 1H), 9.41 (s, 
1H), 8.27 (d, J = 1.9 Hz, 1H), 7.87 (dd, J = 8.0, 1.6 Hz, 1H), 7.60-7.39 (m, 2H), 7.04 
(dd, J = 8.4, 0.8 Hz, 1H), 6.99-6.88 (m, 1H), 3.90 (s, 3H), 3.21-2.98 (m, 1H), 
0.96-0.80 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 193.4, 162.6, 161.0, 143.3, 135.9, 
131.7, 127.1, 123.9, 123.0, 121.1, 119.9, 118.9, 118.4, 52.0, 37.1, 8.5. 
 
4.5.4 X-Ray Crystallographic Analysis of 4.5a 
The conformation of 4.5a was determined by X-ray crystallographic analysis of a 
single crystal of 4.5a (Figure 4.1). The crystal was prepared from the solution of 4.5a 




Figure 4.1 X-ray Structure of 4.5a 
 
 
Table 4.2 Crystal Data and Structure Refinement for 4.5a 
Identification code 4.5a  
Empirical formula C25H27N2O5.25  
Formula weight 439.48  
Temperature 100(2) K  
Wavelength 1.54178 Å  
Crystal system Monoclinic  
Space group P21/c  
Unit cell dimensions a = 3.8268(2) Å α = 90° 
 b = 31.4297(12) Å β = 92.2510(10)° 
 c = 17.1304(7) Å γ = 90° 
Volume 2058.77(16) Å3  
Z 4  
Density (calculated) 1.418 Mg/m3  
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Absorption coefficient 0.817 mm-1  
F(000) 932  
Crystal size 0.360 x 0.260 x 0.160 mm3  
Theta range for data collection 2.812 to 68.231°  
Index ranges -4<=h<=4, -37<=k<=37, -20<=l<=20 
Reflections collected 31351  
Independent reflections 3774 [R(int) = 0.0382]  
Completeness to theta = 67.679° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.6531  
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 3774 / 9 / 288  
Goodness-of-fit on F2 1.086  
Final R indices [I>2sigma(I)] R1 = 0.0819, wR2 = 0.2745  
R indices (all data) R1 = 0.0870, wR2 = 0.2815  
Extinction coefficient n/a  
Largest diff. peak and hole 1.013 and -0.653 e.Å-3  
 




Figure 4.2 NOESY Spectrum of Intermediates A and B 
 
 
The intermediates A and B were formed immediately when we mixed 4.1a and 
4.2a together. The structure of A was determined by the NOE correlation between H1 
and H2, H3 and H4 (Figure 4.2, in red), while the structure of B was determined by the 
















Chapter 5 Divergent Synthesis of Tricyclic Ketals and 














The efficient access to structurally complex compounds and especially those with 
scaffold diversity is a crucial requirement for biological screening in drug discovery, 
which calls for the development of versatile and effective complexity-generating 
transformations in synthetic chemistry.[96] Diversity-oriented synthesis, in particular, 
has been practised successfully to generate skeletally diverse molecule libraries 
through stepwise, divergent chemical transformations of central core intermediates.[51, 
97] In the field of natural product synthesis, the strategy of collective synthesis has also 
proven to be highly powerful in accessing natural products of different families from 
a common advanced intermediate.[98] In catalytic method development, the realization 
of catalyst-enabled divergent reactivities has attracted much attention in recent years 
as well.[82] The adoption of different catalytic conditions could lead to chemo-,[99] 
regio-[56a, 100] or stereoselective transformations[101] of the starting materials leading to 
isomeric products that are structurally related. More importantly, elegant reports on 
“product-selective catalysis”[82] were also documented in the literature, in which 
processes skeletally unrelated products could be accessed using different catalysts or 
reaction conditions.[102] Despite of these important advancements on this topic, 
however, the implementation of a general strategy of catalytic transformations to 
achieve scaffold diversity remains a significant challenge in organic synthesis. 
 
5.2 Project Design 
We were attracted to an intriguing and general strategy of generating a common 
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intermediate bearing multiple functionalities (depicted as I, Scheme 5.1a) that may 
undergo chemo-divergent intramolecular couplings to produce different structures II, 
for which further coupling can in principle take place to generate complex and diverse 
molecular structures in a cascade catalysis fashion.[52] Such a seemingly simple 
strategy possesses formidable challenges in the efficient formation of I from readily 
available building blocks as well as the chemo-selective transformation of I 
afterwards. We report herein our initial progress made towards such a goal in catalytic 
method development. 
Activated isocyanides such as isocyanoacetates (5.4 in Scheme 5.1b) are 
intriguing molecules bearing multiple reactive sites, which have found wide 
application in multicomponent reactions (MCRs) as well as heterocycle synthesis.[2, 
53a, 54] The combination of these reactions with further functionalization of the 
products in a tandem fashion has also been extensively studied, in particular by the 
Zhu Group to produce more complex structures.[57] Based on our group’s continuous 
interest and efforts in isocyanoacetate chemistry,[26, 42] we reasoned that 
isocyanoacetate 5.4 could serve as a perfect building block to introduce multiple 
functionalities (isocyanide and the ester as electrophiles for divergent reactions) if 
conjugate addition of isocyanoacetate 5.4 to para-quinone methide-aryl ester 5.3 
could be realized. 
para-Quinone methides (p-QMs) have proven to be a powerful Michael acceptor 
for 1,6-conjuagte addition reactions with a wide range of carbon-,[103] sulfur-,[104] 
boron-[105] or silane-based[106] nucleophiles. In all of these reactions, aromatization of 
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the substrate served as the strong driving force. We therefore proposed that the 
addition of the enolate derived from isocyanoacetate 5.4 to p-QM-containing ester 5.3 
should proceed efficiently to yield the phenol intermediate 5.2, in which step the 
p-QM moiety in 5.3 should serve only as the Michael acceptor while undesired [3+2] 
cyclization reaction with isocyanoacetate 5.4 should not take place. Based on our 
previous discovery of oxazole formation from aryl esters and isocyanoacetates,[26] we 
expected that further deprotonation of the isocyanoacetate moiety in 5.2 followed by 
addition to the aryl ester should result in an acyl transfer to yield the key intermediate 
5.1, in which three different electrophiles (isocyanide, ketone and ester) are attached 
on the same carbon, while the phenol unit may serve as the nucleophile to undergo 
reaction with any one of the three. If chemo-selectivity could be achieved under 
different reaction conditions, this initial step would be followed by further cascade 
intramolecular couplings leading to the formation of diverse skeletons (Scheme 5.1b). 
 





As possible product structures, we envisioned that the addition of phenol to the 
isocyanide may lead to the formation of 1,3-oxazepines 5.5 (pathway i), although the 
construction of seven-membered ring structures still remains elusive in this field. 
Alternatively, if the phenol attacks the ketone moiety, the resultant hemiacetal may 
undergo further addition to the isocyanide to produce tricyclic ketals 5.6 bearing three 
continuous stereogenic centres (pathway ii); this should take place in preference over 
the addition to the ester moiety to form a more strained β-lactone. Another possibility 
is the generation of δ-lactones 5.7 through the addition of phenol to the ester group 
(pathway iii). The focus of this study was whether efficient catalytic methods could be 
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developed to realize such divergent transformations leading to skeletally diverse 
products, ideally in a cascade fashion. We report herein the realization of this strategy 
to deliver two classes of highly complex and valuable compounds in the forms of 
tricyclic ketals 5.6 and triarylmethanes 5.8. 
 
5.3 Results and Discussion 
5.3.1 Investigation on Cascade Divergent Synthesis 
We initiated our investigation using 5.3a and 5.4a as the model substrates. 
Various metal salts possessing different basicity or Lewis acidity were systematically 
screened for this reaction. The selected key results of extensive studies are 
summarized in Table 5.1. Based on our previous studies of isocyanoacetate 
chemistry,[26, 42] we first attempted the use of Ag2O in combination with PPh3 as the 
catalyst. To our excitement, an exclusive conversion to the complex tricyclic ketal 
5.6a could be achieved under these conditions, with excellent efficiency as well as 
exquisite stereoselectivity (entry 1, 95% yield, >20:1 d.r.). While no intermediate was 
observed, the formation of 5.6a clearly suggested the formation of 5.1 and the 
feasibility of pathway ii initiated by phenol addition to the ketone moiety. The catalyst 
loading could be further reduced to 5 mol% without any loss of selectivity and 
efficiency (entry 2, 94% yield, >20:1 d.r.). 
When the catalyst was switched to Cu(OAc)2, intriguingly, an unexpected 
rearrangement product triarylmethane 5.8a was observed, albeit in a mixture with 
5.6a (entry 3, 5.6a:5.8a = 1.3:1). From the viewpoint of molecular structure, this type 
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of compound is clearly formed through pathway iii. However, instead of the expected 
C-O bond cleavage to produce δ-lactone 5.7 (Scheme 5.1b), an unexpected C-C bond 
cleavage occurred exclusively to generate the carbonate moiety followed by 
cyclization to give the triarylmethane scaffold. We argued that aromatization in 
oxazole formation served as the driven force for such an unusual transformation. This 
observation of switching of chemo-selectivity with Ag- or Cu-catalysis proved that 
the proposed divergent synthesis using this system could be realized, which also 
represents an interesting example of catalyst-controlled chemo-divergent reactions[82]. 
Recognizing that this unexpected reactivity catalyzed by copper provides a new entry 
to the difficult-to-access oxazole-containing triarylmethanes,[107] we screened various 
readily available bisphosphine ligands in order to improve the efficiency of 5.8a 
formation. Although many ligands including dppm led to similarly low selectivity 
(entry 4, 5.6a:5.8a = 1.4:1), the use of dppp resulted in exclusive formation of 5.8a 
with >98% isolated yield (entry 5). With the efficient formation of 5.6a or 5.8a in 
hand, we further screened many other metal salts in an attempt to achieve the 
formation of pathway i product 5.5a. Unfortunately, no reactivity was obtained for the 
use of Co, Zn, Fe, Ni or Au salts (entries 6-10). The failure of 5.5a formation may be 
due to the high strain and instability of this seven-membered ring structure. In fact, 
the access to such architecture is still elusive in isocyanoacetate chemistry. 
 










1 Ag2O PPh3 >98 >20:1 95 / 
2[c] Ag2O PPh3 >98 >20:1 94 / 
3 Cu(OAc)2 PPh3 >98 1.3:1 n.d. n.d. 
4 Cu(OAc)2 dppm >98 1.4:1 n.d. n.d. 
5 Cu(OAc)2 dppp >98 1:>20 / >98 
6 Co(OAc)2 PPh3 <2 / / / 
7 Zn(OAc)2 PPh3 <2 / / / 
8 Fe(OAc)2 PPh3 <2 / / / 
9 NiCl2 PPh3 <2 / / / 
10 AuCl3 PPh3 <2 / / / 
[a] The reactions were carried out under ambient atmosphere for 24 h. We did not 
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observe any formation of 5.5a or 5.7a in all reactions. The d.r. of 5.6a and ratio of 
5.6a:5.8a were determined by crude 1H NMR analysis. In all cases 5.6a was obtained 
with >20:1 d.r. [b] Isolated yields. [c] 5 mol% Ag2O and 10 mol% PPh3 were used. 
 
5.3.2 Tricyclic Ketal Synthesis 
With the optimal conditions in hand, we moved on to explore the scope of this 
silver-catalyzed cascade reaction for tricyclic ketal synthesis first (Scheme 5.2). It is 
noteworthy that the current catalytic system is simple to perform with a “mix and go” 
procedure using commercially available and cheap Ag2O and PPh3 as catalysts. The 
reactions were set up open to air with no need for exclusion of air or moisture. In 
addition, this process is entirely atom-economical as the product incorporates all 
portions from the starting materials.  
As shown, in all cases perfect diastereoselectivity (>20:1 d.r.) was obtained for 
product 5.6. Different substitution patterns on the aryl ring (para-, meta- and ortho-) 
could be well adopted to form 5.6a-5.6h in excellent selectivities and yields (87% 
to >98%). The variation on the ester moiety in 5.3 (bearing both alkyl and aryl 
substituents) was also tolerated to produce 5.6i-5.6l in uniformly excellent yields with 
excellent selectivities. Different isocyanoacetates could also be used to produce 5.6m 
and 5.6n in excellent yields and selectivities. The relative configuration of 5.6a was 
unambiguously assigned by single crystal X-ray analysis and those of other tricyclic 
ketals were assigned by analogy. To further extend the substrate scope, 
isocyanoacetamide was examined under the standard conditions. To our delight, the 
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desired product 5.6o was obtained in 75% yield, although a small amount of the 
corresponding triarylmethane was formed in this case. The relative configuration of 
5.6o proved to be the same as assigned by single crystal X-ray analysis. 
 





[a] The d.r. of 5.6 and ratio of 5.6:5.8 were determined by crude 1H NMR analysis. [b] 
Isolated yields. [c] The reaction was carried out for 48 h. [d] In this case 5.6o and the 
corresponding triarylmenthane were obtained as a mixture in a ratio of 9:1. 
 
Figure 5.1 Natural Products Containing Tricyclic Ketal Moiety 
 
 
It is important to note that tricyclic ketals are important structural motif in 
medicinal chemistry. Related compounds such as xyloketal A and D (Figure 5.1) are 
known to inhibit acetylcholinesterase (AChE)[108] and are considered as potential lead 
compounds for the treatment of neurological disorders such as Alzheimer’s disease. 
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The simple catalytic system developed in our studies delivers such highly 
functionalized tricyclic ketals for the first time. Further biological screening of these 
compounds is ongoing. 
 
5.3.3 Triarylmethane Synthesis 
The scope of the copper-catalyzed synthesis of triarylmethanes was examined 
next (Scheme 5.3). In almost all cases excellent chemo-selectivity and yield were 
obtained for product 5.8. Different substituents (electron-donating, electron-neutral, 
and electron-withdrawing) with diverse substitution patterns (para-, meta- and ortho-) 
on the aryl ring could be well tolerated to give triarylmethanes in uniformly excellent 
chemo-selectivity and efficiency (>98% yield for 5.8a-5.8h). Different ester 
substituents on 5.3 were all suitable to produce 5.8i and 5.8j in excellent yields with 
excellent selectivities. Isocyanoacetates possessing different ester groups could also 
be used to produce 5.8k and 5.8l in good to excellent yields and selectivities. The high 
efficiency of this process, coupled with the operational simplicity (use of cheap 
Cu(OAc)2 and dppp as catalysts and running reactions open to air), makes it an 
attractive method for triarylmethane synthesis. The related heteroaryl-substituted 
triarylmethanes such as Letrozole has proven to be an effective commercial drug for 
the treatment of cancer and the current approach provides a rapid access to the 





Scheme 5.3 Triarylmethane Synthesis by Copper Catalysis[a-d] 
 
[a] The ratio of 5.8:5.6 were determined by crude 1H NMR analysis. [b] Isolated 
yields. [c] The reaction was carried out for 48 h. [d] In this case 5.8l and the 
corresponding tricyclic ketal were obtained as a mixture in a ratio of 14:1. 
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5.3.4 Large-Scale Preparation and Derivatization 
To test the robustness and efficiency of our method in preparative synthesis, 
gram-scale reactions of 5.3f and 5.4a were investigated under the standard reaction 
conditions (Scheme 5.4a). To our delight, the desired products 5.6f and 5.8f were 
obtained with no loss of efficiency or selectivity.  
 




Moreover, cleavage of the carbonate moiety in triarylmethane 5.8i took place 
smoothly by the treatment with potassium carbonate to generate bisphenol 5.9 in 84% 
yield (Scheme 5.4b). The structure of 5.9 was unambiguously determined by single 
crystal X-ray analysis, and the structures of triarylmethanes 5.8 were assigned by 
analogy. 
It is worth mentioning that the bulky tert-butyl substituents in the substrates were 
necessary for the reactions to proceed with high efficiency and chemo-selectivity, 
although such groups may be redundant in the product structure. Gratifyingly, the 
tert-butyl groups on 5.8 could be efficiently removed partially or completely to yield 
5.10 or 5.11 by following the previously established procedure (Scheme 5.4c).[104] 
 
5.3.5 Mechanistic Studies 
The kinetics of the reaction between 5.3a and 5.4a under silver or copper 
catalysis was monitored by NMR respectively to shed some light on the mechanism 
of this chemo-divergent cascade reaction. A common intermediate 5.2a (Scheme 5.5a) 
was detected in both cases, which was determined by NMR analysis to be the 
1,6-conjugate addition product of 5.4a and 5.3a. In either case, however, the key 
intermediate 5.1a was not observed, which is believed to be highly reactive and 
undergo the following steps spontaneously. We envisioned that the chemo-selectivity 
between the formation of tricyclic ketal and triarylmethane is independent of the 
1,6-conjugate addition step, as the stereoselectivity of 5.2a will be lost upon 
deprotonation in the following steps. To probe this, 5.2a was isolated in a pure form 
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as a mixture of diastereomers (1.4:1 d.r.). When 5.2a was subjected to the standard 
silver or copper catalysis conditions, as expected, the desired products 5.6a or 5.8a 
were obtained with the same level of chemo- and stereoselectivity, respectively 
(Scheme 5.5a). 
 
Scheme 5.5 Experiments on Mechanistic Study 
 
 
Moreover, as cyclic ketals are known to undergo fragmentation-rearrangement 
reactions, a control reaction of the interconversion of 5.6f to 5.8f was also carried out. 
Under the copper catalysis conditions, 5.6f was stable and did not undergo conversion 





5.3.6 Proposed Mechanism 
On the basis of the above experimental results and related reports, a possible 
reaction pathway for the divergent synthesis of tricyclic ketals and triarylmethanes is 
proposed with the reaction of 5.3a and 5.4a as an example (Scheme 5.6). The reaction 
starts with the formation of 1,6-conjugate addition adduct 5.2a. After that, the 
deprotonation of 5.2a takes place to give enolate A, from which Ag and Cu catalysis 
lead to the generation of different scaffolds. As shown in the left part, under Ag 
catalysis, enolate A will undergo an acyl transfer process to afford complex B. Based 
on the nearly perfect yield and diastereoselectivity for 5.6a formation, intermediate B 
is believed to be formed as a single diastereomer (ester trans to the 2,6-di-tert-butyl 
phenol). Then, nucleophilic addition of the silver phenoxide to the ketone generates 
intermediate C, which will cyclize to form the oxazolyl-silver intermediate D. 
Subsequent protonation affords 5.6a as the final product with the regeneration of the 
catalyst to complete this catalytic cycle. Similar to Ag catalysis, phenoxide E is 
generated through an acyl transfer process under Cu catalysis (right part of the 
proposed reaction pathway). The relative configuration of E is inconsequential in the 
following step. In contrast to the Ag system, the nucleophilic addition of phenoxide to 
the ester takes place next followed by the exclusive C-C bond cleavage to yield a new 
enolate F. Cyclization of F generates the oxazolyl-copper intermediate G, which, 
upon protonation produces triarylmethane 5.8a. 
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We have developed, for the first time, an interesting and effective divergent 
cascade reaction using para-quinone methide-aryl esters and activated isocyanides as 
the starting materials. By the judicious choice of substrate structure, a common 
intermediate bearing multiple reactive sites could be accessed, which undergo 
different reaction pathways to realize divergent synthesis of either tricyclic ketals or 
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triarylmethanes under silver or copper catalysis. Current efforts in our laboratory are 
focused on the understanding of the origin of the divergent reactivity as well as the 
application of this concept to the preparation of other types of valuable heterocyclic 
structures. 
 
5.5 Experimental Section 
5.5.1. General Information 
1H and 13C NMR spectra were recorded on a Bruker AV 300 or AV 500 or DPX 
400 spectrometer. Chemical shifts were reported in parts per million (ppm), and the 
residual solvent peak was used as an internal reference: 1H (chloroform δ 7.26; 
Acetone δ 2.05), 13C (chloroform δ 77.0; Acetone δ 29.8, 206.3). Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, dd = doublet of doublets, dt = doublet of triplets, dq = doublet of quartets, 
td = triplet of doublets), coupling constants (Hz) and integration. Melting point (MP) 
was obtained on Büchi B-540. For thin layer chromatography (TLC), Merck 
pre-coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. High resolution mass spectra (HRMS) were obtained on a 
Finnigan/MAT 95XL-T spectrometer. Diastereomeric ratio (d.r.) of 5.6, and the ratio 
of 5.6 to 5.8 were determined by crude 1H NMR analysis. 
Unless otherwise noted, all the reactions were carried out open to air. 
Dichloromethane (DCM), tetrahydrofuran (THF), and toluene were dried over a Pure 
Solv solvent purification system. Deuterated solvents were purchased from 
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Cambridge Isotope Laboratories and used as received without further purification. 
Methyl isocyanoacetate (5.4a) and ethyl isocyanoacetate (5.4b) were purchased from 
Alfa Aesar company. Isopropyl isocyanoacetate (5.4c)[109] and 2-isocyano-1-(piperidin 
-1-yl)ethan-1-one (5.4d)[110] were prepared according to literature procedures. Other 
chemicals were purchased from commercial suppliers and used as received without 
further purification. 
 
5.5.2 Synthesis of para-Quinone Methide-Aryl Esters 5.3[111] 
 
General procedure. In a Dean-Stark apparatus, a solution of 2,6-di-tert- 
butylphenol (10 mmol, 2.06 g) and the corresponding salicylaldehyde (10 mmol) in 
toluene (40 mL) was heated to reflux. Piperidine (20 mmol, 1.97 mL) was dropwise 
added within 1 h. The reaction mixture was continued to reflux for overnight. After 
cooling just below the boiling point of the reaction mixture, the corresponding 
anhydride (30 mmol) was added and stirring was continued for 15 min. Then the 
reaction mixture was poured on ice-water (200 mL) and extracted with CH2Cl2 (4×80 
mL). The combined organic phases were dried over anhydrous Na2SO4, and the 
solvent of the filtrate was removed under reduced pressure. The crude products were 







Yellow solid, 34% yield. 1H NMR (500 MHz, CDCl3): δ 7.49-7.39 (m, 2H), 7.33-7.31 
(m, 2H), 7.24-7.14 (m, 1H), 7.06 (s, 1H), 6.99 (d, J = 2.4 Hz, 1H), 2.30 (s, 3H), 1.33 
(s, 9H), 1.28 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 186.6, 168.9, 149.6, 149.3, 
148.2, 136.0, 134.5, 133.2, 131.8, 130.2, 128.8, 127.9, 126.0, 122.9, 35.4, 35.1, 29.5, 
20.9; MP: 111-112 °C; HRMS (ESI): m/z calcd. for [C23H28NaO3, M+Na]
+: 





Yellow solid, 19% yield. 1H NMR (500 MHz, CDCl3): δ 7.39 (d, J = 2.3 Hz, 1H), 
7.08 (d, J = 8.5 Hz, 1H), 7.04-6.88 (m, 4H), 3.82 (s, 3H), 2.28 (s, 3H), 1.33 (s, 9H), 
1.28 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 186.6, 169.4, 157.1, 149.6, 148.2, 142.8, 
136.0, 134.5, 133.3, 129.3, 127.8, 123.6, 116.2, 116.0, 55.7, 35.5, 35.1, 29.6, 29.5, 
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20.9; MP: 170-172 °C; HRMS (ESI): m/z calcd. for [C24H30NaO4, M+Na]
+: 





Yellow solid, 42% yield. 1H NMR (300 MHz, CDCl3): δ 7.39-7.32 (m, 1H), 7.25-7.19 
(m, 2H), 7.10-6.96 (m, 3H), 2.39 (s, 3H), 2.28 (s, 3H), 1.33 (s, 9H), 1.28 (s, 9H); 13C 
NMR (75 MHz, CDCl3): δ 186.6, 169.1, 149.3, 148.1, 147.1, 136.3, 135.7, 134.5, 
133.1, 132.3, 130.9, 128.4, 128.1, 122.6, 35.4, 35.0, 29.5, 20.9, 20.8; MP: 113-115 °C; 
HRMS (ESI): m/z calcd. for [C24H30NaO3, M+Na]





Yellow solid, 16% yield. 1H NMR (300 MHz, CDCl3): δ 7.41-7.36 (m, 2H), 7.26 (d, J 
= 2.1 Hz, 1H), 7.13 (d, J = 8.5 Hz, 1H), 7.00-6.90 (m, 2H), 2.28 (s, 3H), 1.33 (s, 9H), 
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1.28 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 186.5, 168.7, 150.0, 148.6, 147.6, 134.1, 
134.0, 133.9, 131.5, 131.3, 130.3, 129.9, 127.3, 124.2, 35.5, 35.1, 29.5, 20.9; MP: 
158-160 °C; HRMS (ESI): m/z calcd. for [C23H27ClNaO3, M+Na]






Yellow solid, 11% yield. 1H NMR (500 MHz, CDCl3): δ 7.72-7.46 (m, 2H), 7.27 (d, J 
= 2.4 Hz, 1H), 7.08 (d, J = 8.6 Hz, 1H), 7.01-6.89 (m, 2H), 2.29 (s, 3H), 1.32 (s, 9H), 
1.28 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 186.5, 168.6, 150.0, 148.6, 148.1, 134.3, 
134.1, 134.0, 133.8, 132.8, 130.7, 127.3, 124.5, 119.0, 35.5, 35.1, 29.5, 20.9; MP: 
165-166 °C; HRMS (ESI): m/z calcd. for [C23H27BrNaO3, M+Na]








Yellow solid, 48% yield. 1H NMR (500 MHz, CDCl3): δ 7.36-7.32 (m, 2H), 7.14 (d, J 
= 7.9 Hz, 1H), 7.04-6.98 (m, 3H), 2.41 (s, 3H), 2.30 (s, 3H), 1.33 (s, 9H), 1.28 (s, 9H); 
13C NMR (126 MHz, CDCl3): δ 186.6, 169.1, 149.3, 149.2, 147.8, 141.2, 136.3, 
134.7, 132.7, 131.5, 128.0, 127.0, 125.8, 123.4, 35.4, 35.0, 29.5, 29.4, 21.3, 20.9; MP: 
94-96 °C; HRMS (ESI): m/z calcd. for [C24H30NaO3, M+Na]






Yellow solid, 28% yield. 1H NMR (300 MHz, CDCl3): δ 7.33-7.17 (m, 4H), 7.03-6.93 
(m, 2H), 2.35 (s, 3H), 1.33 (s, 9H), 1.27 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 186.6, 
167.7, 154.7 (d, J = 250.3 Hz), 149.9, 148.5, 137.0 (d, J = 13.6 Hz), 134.3, 134.2 (d, J 
= 3.1 Hz), 134.0, 131.3, 127.5, 126.7, 126.6 (d, J = 10.3 Hz), 117.1 (d, J = 19.1 Hz), 
35.5, 35.1, 29.5, 20.4; MP: 143-145 °C; HRMS (ESI): m/z calcd. for [C23H27FNaO3, 




yl acetate (5.3h) 
 
Yellow solid, 12% yield. 1H NMR (500 MHz, CDCl3): δ 7.49 (d, J = 2.4 Hz, 1H), 
7.32 (d, J = 2.4 Hz, 1H), 7.23 (d, J = 2.3 Hz, 1H), 6.94 (d, J = 2.4 Hz, 1H), 6.85 (s, 
1H), 2.35 (s, 3H), 1.32 (s, 9H), 1.28 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 186.5, 
167.6, 150.4, 149.0, 144.4, 134.7, 133.9, 132.7, 132.2, 131.8, 130.1, 129.8, 129.1, 
126.9, 35.5, 35.2, 29.5, 20.4; MP: 153-154 °C; HRMS (ESI): m/z calcd. for 
[C23H26Cl2NaO3, M+Na]





Yellow solid, 23% yield. 1H NMR (500 MHz, CDCl3): δ 7.47-7.39 (m, 2H), 7.33-7.30 
(m, 2H), 7.24-7.13 (m, 1H), 7.06 (s, 1H), 6.98 (d, J = 2.4 Hz, 1H), 2.59 (q, J = 7.6 Hz, 
2H), 1.33 (s, 9H), 1.27 (s, 9H), 1.24 (t, J = 7.6 Hz, 3H); 13C NMR (126 MHz, CDCl3): 
δ 186.6, 172.4, 149.4, 149.3, 148.1, 136.2, 134.5, 133.1, 131.6, 130.2, 128.7, 128.0, 
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125.9, 122.9, 35.4, 35.0, 29.5, 27.7, 9.1; MP: 108-110 °C; HRMS (ESI): m/z calcd. 
for [C24H30NaO3, M+Na]





Yellow solid, 34% yield. 1H NMR (500 MHz, CDCl3): δ 7.47-7.38 (m, 2H), 7.35-7.29 
(m, 2H), 7.23-7.11 (m, 1H), 7.05 (s, 1H), 6.97 (d, J = 2.3 Hz, 1H), 2.54 (t, J = 7.6 Hz, 
2H), 1.80-1.72 (m, 2H), 1.32 (s, 9H), 1.27 (s, 9H), 1.01 (t, J = 7.3 Hz, 3H); 13C NMR 
(126 MHz, CDCl3): δ 186.6, 171.6, 149.4, 149.3, 148.1, 136.3, 134.5, 133.1, 131.6, 
130.2, 128.8, 128.0, 126.0, 122.9, 36.1, 35.4, 35.0, 29.5, 18.4, 13.6; MP: 95-97 °C; 
HRMS (ESI): m/z calcd. for [C25H32NaO3, M+Na]





Yellow solid, 29% yield. 1H NMR (300 MHz, CDCl3): δ 7.48-7.36 (m, 2H), 7.35-7.27 
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(m, 2H), 7.17-7.14 (m, 1H), 7.04 (s, 1H), 6.96 (d, J = 2.4 Hz, 1H), 2.89-2.71 (m, 1H), 
1.34-1.24 (m, 24H); 13C NMR (75 MHz, CDCl3): δ 186.6, 175.0, 149.5, 149.3, 148.2, 
136.2, 134.4, 133.2, 131.5, 130.2, 128.9, 128.0, 125.9, 122.8, 35.4, 35.0, 34.2, 29.5, 







Yellow solid, 28% yield. 1H NMR (300 MHz, CDCl3): δ 8.19 (dd, J = 8.4, 1.3 Hz, 
2H), 7.70-7.61 (m, 1H), 7.59-7.45 (m, 4H), 7.41-7.29 (m, 3H), 7.13 (s, 1H), 6.93 (d, J 
= 2.2 Hz, 1H), 1.28 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 186.6, 164.7, 149.5, 
149.4, 148.0, 136.1, 134.6, 133.9, 133.3, 131.8, 130.3, 130.2, 129.0, 128.7, 128.0, 
126.1, 123.0, 35.4, 35.0, 29.5, 29.4; MP: 142-144 °C; HRMS (ESI): m/z calcd. for 
[C28H30NaO3, M+Na]
+: 437.2087; found: 437.2080. 
 
5.5.3 X-Ray Crystallographic Analysis of 5.3a 
The conformation of 5.3a was determined by X-ray crystallographic analysis of a 
single crystal of 5.3a (Figure 5.2). The crystal was prepared from the solution of 5.3a 
in hexane at 0 oC. 
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Figure 5.2 X-Ray Structure of 5.3a 
 
 
Table 5.2 Crystal Data and Structure Refinement for 5.3a 
Identification code 5.3a  
Empirical formula C46H56O6  
Formula weight 704.90  
Temperature 100(2) K  
Wavelength 1.54178 Å  
Crystal system Triclinic  
Space group P -1  
Unit cell dimensions a = 11.8989(4) Å α = 97.562(2)° 
 b = 13.6819(4) Å β = 112.950(2)° 
 c = 14.7054(5) Å γ = 93.820(2)° 
Volume 2167.04(13) Å3  
Z 2  
Density (calculated) 1.080 Mg/m3  
Absorption coefficient 0.553 mm-1  
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F(000) 760  
Crystal size 0.204 x 0.157 x 0.106 mm3  
Theta range for data collection 3.286 to 68.235°  
Index ranges -14<=h<=14, -16<=k<=15, -17<=l<=17 
Reflections collected 23256  
Independent reflections 7717 [R(int) = 0.0538]  
Completeness to theta = 67.679° 97.2 %  
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 7717 / 0 / 483  
Goodness-of-fit on F2 1.046  
Final R indices [I>2sigma(I)] R1 = 0.0480, wR2 = 0.1060  
R indices (all data) R1 = 0.0745, wR2 = 0.1145  
Largest diff. peak and hole 1.013 and -0.653 e.Å-3  
 
5.5.4 Diastereoselective Synthesis of Tricyclic Ketals  
 
General procedure. To a 10 mL vial charged with PPh3 (2.6 mg, 0.010 mmol) 
and Ag2O (1.2 mg, 0.005 mmol) was added anhydrous THF (1.0 mL). The mixture 
was allowed to stir at ambient temperature for 5 min, then para-quinone methide-aryl 
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ester 5.3 (0.10 mmol) and activated isocyanide 5.4 (0.13 mmol) were added in one 
portion. The reaction mixture was allowed to stir at ambient temperature for 24 h, 
concentrated and purified by flash chromatography (silica gel or neutral Al2O3, 
hexanes/ethyl acetate) to afford the product 5.6. 
In all cases, the d.r. of 5.6 is >20:1. Unless otherwise noted, the ratio of 5.6 and 
the corresponding triarylmethane is >20:1. 
 




The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow solid, 
94% yield. 1H NMR (300 MHz, CDCl3): δ 7.79-7.08 (m, 3H), 7.04-6.94 (m, 2H), 
6.88 (s, 1H), 6.78 (d, J = 7.6 Hz, 1H), 5.18 (s, 1H), 4.68 (s, 1H), 3.64 (s, 3H), 1.83 (s, 
3H), 1.44 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 170.0, 155.0, 153.1, 151.9, 135.3, 
129.9, 127.9, 127.5, 125.3, 123.8, 118.1, 111.6, 85.0, 77.2, 52.4, 47.1, 34.4, 30.5, 22.7; 








The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.74-7.07 (m, 2H), 6.97-6.84 (m, 
2H), 6.69 (dd, J = 8.7, 2.6 Hz, 1H), 6.34 (dd, J = 2.9, 1.0 Hz, 1H), 5.17 (s, 1H), 4.66 
(s, 1H), 3.63 (s, 6H), 1.81 (s, 3H), 1.44 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 170.0, 
156.0, 155.0, 153.1, 145.3, 135.4, 131.1, 125.2, 118.7, 113.9, 112.2, 111.7, 84.8, 77.2, 
55.3, 52.4, 47.4, 34.4, 30.5, 22.6; HRMS (ESI): m/z calcd. for [C28H35NNaO6, 





The general procedure outlined above was followed. The crude reaction mixture was 
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purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.72-7.08 (m, 2H), 6.98 (d, J = 8.1 
Hz, 1H), 6.90 (d, J = 7.3 Hz, 2H), 6.60 (s, 1H), 5.18 (s, 1H), 4.66 (s, 1H), 3.63 (s, 3H), 
2.20 (s, 3H), 1.82 (s, 3H), 1.46 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 170.0, 155.0, 
153.1, 149.6, 135.3, 133.2, 129.4, 128.5, 127.9, 125.3, 117.8, 111.6, 84.9, 77.2, 52.4, 
47.1, 34.4, 30.5, 22.7, 21.1; HRMS (ESI): m/z calcd. for [C28H35NNaO5, M+Na]
+: 





The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.78-7.04 (m, 3H), 6.98-6.86 (m, 
2H), 6.77 (dd, J = 2.4, 1.1 Hz, 1H), 5.21 (s, 1H), 4.63 (s, 1H), 3.63 (s, 3H), 1.82 (s, 
3H), 1.45 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 169.6, 155.1, 153.3, 150.4, 135.5, 
131.8, 129.2, 128.1, 127.5, 124.5, 119.4, 111.6, 84.7, 77.2, 52.5, 47.1, 34.4, 30.4, 22.5; 
HRMS (ESI): m/z calcd. for [C27H32ClNNaO5, M+Na]







The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 7:1). Colorless wax, >98% 
yield. 1H NMR (500 MHz, CDCl3): δ 7.84-6.78 (m, 6H), 5.21 (s, 1H), 4.64 (s, 1H), 
3.63 (s, 3H), 1.82 (s, 3H), 1.45 (s, 18H); 13C NMR (126 MHz, CDCl3): δ 169.6, 155.1, 
153.3, 150.9, 135.5, 132.2, 131.0, 130.5, 124.4, 119.9, 116.8, 111.6, 84.8, 77.2, 52.52, 
47.0, 34.4, 30.4, 22.5; HRMS (ESI): m/z calcd. for [C27H32BrNNaO5, M+Na]
+: 





The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 7:1). Pale yellow 
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solid, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.72-6.99 (m, 2H), 6.90 (s, 1H), 
6.84 (s, 1H), 6.79 (d, J = 7.8 Hz, 1H), 6.66 (d, J = 7.7 Hz, 1H), 5.17 (s, 1H), 4.64 (s, 
1H), 3.63 (s, 3H), 2.30 (s, 3H), 1.82 (s, 3H), 1.44 (s, 18H); 13C NMR (126 MHz, 
CDCl3): δ 170.0, 154.9, 153.0, 151.7, 137.6, 135.2, 127.6, 126.5, 125.4, 124.4, 118.8, 
111.5, 84.9, 77.2, 52.4, 46.9, 34.3, 30.5, 22.7, 21.0; MP: 164-166 °C; HRMS (ESI): 
m/z calcd. for [C28H35NNaO5, M+Na]





The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 5:1). Pale 
yellow wax, 98% yield. 1H NMR (300 MHz, CDCl3): δ 7.77-6.82 (m, 5H), 6.55 (d, J 
= 7.5 Hz, 1H), 5.19 (s, 1H), 4.67 (s, 1H), 3.64 (s, 3H), 1.88 (s, 3H), 1.44 (s, 18H); 13C 
NMR (75 MHz, CDCl3): δ 169.6, 155.1, 153.2, 152.3 (d, J = 248.8 Hz), 139.1 (d, J = 
11.5 Hz), 135.4, 132.9, 125.0, 123.6 (d, J = 7.0 Hz), 123.1 (d, J = 3.3 Hz), 114.7 (d, J 
= 18.1 Hz), 111.8, 85.1, 77.2, 52.5, 47.1 (d, J = 2.5 Hz), 34.4, 30.5, 22.4; HRMS 
(ESI): m/z calcd. for [C27H32FNNaO5, M+Na]







The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 6:1). Pale 
yellow wax, 87% yield. 1H NMR (300 MHz, CDCl3): δ 7.66-6.98 (m, 3H), 6.91 (s, 
1H), 6.74-6.60 (m, 1H), 5.22 (s, 1H), 4.61 (s, 1H), 3.63 (s, 3H), 1.87 (s, 3H), 1.44 (s, 
18H); 13C NMR (75 MHz, CDCl3): δ 169.3, 155.2, 153.5, 146.4, 135.7, 133.5, 129.1, 
127.9, 126.7, 124.3, 124.1, 112.1, 84.8, 77.2, 52.6, 47.5, 34.4, 30.4, 22.3; HRMS 
(ESI): m/z calcd. for [C27H31Cl2NNaO5, M+Na]





The general procedure outlined above was followed (48 h). The crude reaction 
mixture was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 
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10:1). Pale yellow wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.91-7.10 (m, 
3H), 6.98 (dd, J = 16.1, 7.9 Hz, 2H), 6.89 (s, 1H), 6.68 (d, J = 7.5 Hz, 1H), 5.15 (s, 
1H), 4.90 (dt, J = 12.5, 6.2 Hz, 1H), 4.62 (s, 1H), 2.37 (dq, J = 14.6, 7.3 Hz, 1H), 1.94 
(td, J = 14.4, 7.2 Hz, 1H), 1.44 (s, 18H), 1.22 (t, J = 7.3 Hz, 3H), 1.05 (d, J = 6.3 Hz, 
3H), 0.92 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 168.9, 154.7, 153.0, 
151.8, 135.4, 130.9, 127.7, 127.4, 125.9, 123.7, 118.0, 113.4, 84.7, 77.2, 69.4, 47.7, 
34.3, 30.4, 28.9, 21.4, 21.1, 7.5; HRMS (ESI): m/z calcd. for [C30H39NNaO5, M+Na]
+: 





The general procedure outlined above was followed (48 h). The crude reaction 
mixture was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 
10:1). Pale yellow wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.76-6.93 (m, 
5H), 6.89 (s, 1H), 6.68 (d, J = 7.5 Hz, 1H), 5.16 (s, 1H), 4.92 (dt, J = 12.5, 6.3 Hz, 
1H), 4.63 (s, 1H), 2.41-2.22 (m, 1H), 2.01-1.76 (m, 2H), 1.70-1.58 (m, 1H), 1.44 (s, 
18H), 1.06 (d, J = 6.3 Hz, 3H), 1.01 (t, J = 7.2 Hz, 3H), 0.93 (d, J = 6.3 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 168.9, 154.7, 153.0, 151.8, 135.4, 130.9, 127.7, 127.3, 
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125.9, 123.7, 118.0, 113.1, 84.8, 77.2, 69.3, 47.6, 37.8, 34.3, 30.4, 21.4, 21.1, 16.4, 
14.2; HRMS (ESI): m/z calcd. for [C31H41NNaO5, M+Na]






The general procedure outlined above was followed (48 h). The crude reaction 
mixture was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 
10:1). Pale yellow wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.79 (s, 1H), 
7.20-6.80 (m, 5H), 6.68 (d, J = 7.4 Hz, 1H), 5.15 (s, 1H), 4.87 (dt, J = 12.5, 6.2 Hz, 
1H), 4.58 (s, 1H), 2.54 (dt, J = 13.2, 6.6 Hz, 1H), 1.44 (s, 18H), 1.32 (d, J = 6.7 Hz, 
3H), 1.07 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 6.3 Hz, 3H), 0.90 (d, J = 6.2 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 169.2, 154.7, 153.0, 151.9, 135.4, 130.7, 127.7, 127.4, 
126.1, 123.6, 118.0, 115.4, 84.6, 77.2, 69.3, 48.8, 34.3, 33.4, 30.4, 21.2, 20.9, 17.6, 
17.3; HRMS (ESI): m/z calcd. for [C31H41NNaO5, M+Na]








The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow solid, 
97% yield. 1H NMR (300 MHz, CDCl3): δ 7.70-7.55 (m, 3H), 7.48-7.36 (m, 3H), 
7.30-7.00 (m, 5H), 6.84 (d, J = 7.5 Hz, 1H), 5.17 (s, 1H), 4.87 (s, 1H), 2.99 (s, 3H), 
1.44 (s, 9H), 1.43 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 168.9, 155.3, 153.1, 151.8, 
136.4, 135.3, 135.2, 129.8, 129.4, 128.7, 128.0, 127.9, 127.7, 127.3, 126.2, 125.2, 
124.1, 118.5, 112.7, 88.4, 77.2, 51.8, 46.6, 34.4, 34.3, 30.5; MP: 244-246 °C; HRMS 
(ESI): m/z calcd. for [C32H35NNaO5, M+Na]





The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 7:1). Pale yellow 
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wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.82-7.05 (m, 3H), 7.04-6.94 (m, 
2H), 6.89 (s, 1H), 6.75 (d, J = 7.5 Hz, 1H), 5.17 (s, 1H), 4.67 (s, 1H), 4.23-3.92 (m, 
2H), 1.86 (s, 3H), 1.44 (s, 18H), 1.04 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3): δ 169.4, 154.8, 153.1, 151.9, 135.3, 130.2, 127.8, 127.5, 125.4, 123.8, 118.0, 
111.6, 84.7, 77.2, 61.6, 47.3, 34.3, 30.4, 22.6, 13.9; HRMS (ESI): m/z calcd. for 
[C28H35NNaO5, M+Na]





The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 9:1). Pale yellow 
wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.90-7.04 (m, 3H), 7.02-6.94 (m, 
2H), 6.88 (s, 1H), 6.68 (d, J = 7.5 Hz, 1H), 5.16 (s, 1H), 4.93 (dt, J = 12.5, 6.2 Hz, 
1H), 4.65 (s, 1H), 1.87 (s, 3H), 1.44 (s, 18H), 1.09 (d, J = 6.3 Hz, 3H), 0.94 (d, J = 6.2 
Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 168.9, 154.8, 153.0, 151.8, 135.4, 130.7, 
127.7, 127.4, 125.9, 123.8, 117.9, 111.7, 84.4, 77.2, 69.4, 47.1, 34.3, 30.4, 22.5, 21.5, 
21.2; HRMS (ESI): m/z calcd. for [C29H37NNaO5, M+Na]







The general procedure outlined above was followed (48 h). In this case, the ratio of 5o 
and the corresponding triarylmethane is 9:1 (of crude). The crude reaction mixture 
was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 10:1). 
Pale yellow solid, 75% yield. 1H NMR (300 MHz, CDCl3): δ 7.52 (s, 1H), 7.35-6.85 
(m, 5H), 6.72 (s, 1H), 5.16 (s, 1H), 4.86 (s, 1H), 4.25-4.00 (m, 1H), 3.95-3.70 (m, 1H), 
3.22-2.93 (m, 1H), 2.90-2.60 (m, 1H), 1.85 (s, 3H), 1.75-1.55 (m, 1H), 1.50-1.25 (m, 
21H), 1.15-1.00 (m, 1H), 0.42-0.10 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 168.8, 
153.2, 152.6, 152.2, 135.1, 129.9, 127.8, 127.2, 125.3, 123.4, 118.4, 113.5, 87.9, 77.2, 
50.7, 46.9, 46.2, 30.5, 29.7, 26.6, 25.7, 24.5, 24.3; MP: 182-184 °C; HRMS (ESI): 
m/z calcd. for [C31H40N2NaO4, M+Na]
+: 527.2880; found: 527.2882. 
 
5.5.6 X-Ray Crystallographic Analysis of 5.6a 
The conformation of 5.6a was determined by X-ray crystallographic analysis of a 
single crystal of 5.6a (Figure 5.3). The crystal was prepared from the solution of 5.6a 




Figure 5.3 X-Ray Structure of 5.6a 
 
 
Table 5.3 Crystal Data and Structure Refinement for 5.6a 
Identification code 5.6a  
Empirical formula C27H33NO5  
Formula weight 451.54  
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic  
Space group C 2/c  
Unit cell dimensions a = 25.0398(15) Å α = 90° 
 b = 10.8136(5) Å β = 104.572(2)° 
 c = 18.7266(12) Å γ = 90° 
Volume 4907.5(5) Å3  
Z 8  
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Density (calculated) 1.222 Mg/m3  
Absorption coefficient 0.084 mm-1  
F(000) 1936  
Crystal size 0.307 x 0.107 x 0.024 mm3  
Theta range for data collection 2.245 to 29.173°  
Index ranges -34<=h<=33, -13<=k<=14, -25<=l<=25 
Reflections collected 20967  
Independent reflections 6578 [R(int) = 0.0552]  
Completeness to theta = 25.242° 99.9 %  
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 6578 / 0 / 307  
Goodness-of-fit on F2 1.017  
Final R indices [I>2sigma(I)] R1 = 0.0539, wR2 = 0.1255  
R indices (all data) R1 = 0.0821, wR2 = 0.1431  
Largest diff. peak and hole 0.450 and -0.359 e.Å-3  
 
5.5.7 X-Ray Crystallographic Analysis of 5.6o 
The conformation of 5.6o was determined by X-ray crystallographic analysis of a 
single crystal of 5.6o (Figure 5.4). The crystal was prepared from the solution of 5.6o 





Figure 5.4 X-Ray Structure of 5.6o 
 
 
Table 5.4 Crystal Data and Structure Refinement for 5.6o 
Identification code 5.6o  
Chemical formula C31H40N2O4  
Formula weight 504.65 g/mol  
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal size 0.300 x 0.400 x 0.600 mm3  
Crystal system Monoclinic  
Space group P 1 21/n 1  
Unit cell dimensions a = 10.640(3) Å α = 90° 
 b = 14.112(4) Å β = 95.021(4)° 
 c = 18.010(5) Å γ = 90° 
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Volume 2693.9(14) Å3  
Z 4  
Density (calculated) 1.244 Mg/m3  
Absorption coefficient 0.082 mm-1  
F(000) 1088  
Theta range for data collection 1.84 to 28.36°  
Index ranges -14<=h<=14, -18<=k<=18, -24<=l<=23 
Reflections collected 37277  
Independent reflections 6736 [R(int) = 0.0358]  
Coverage of independent reflections 99.9%  
Absorption correction Multi-Scan 
Max. and min. transmission 0.7457 and 0.6711  
Structure solution technique direct methods  
Structure solution program SHELXS-97 (Sheldrick 2008) 
Refinement method Full-matrix least-squares on F
2
 
Refinement program SHELXL-2014/7 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 6736 / 0 / 345  
Goodness-of-fit on F2 1.028  
Δ/σmax 0.001  
Final R indices [6124 data; I>2σ(I)] R1 = 0.0421, wR2 = 0.1052  
R indices (all data) R1 = 0.0459, wR2 = 0.1082  
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Largest diff. peak and hole 0.442 and -0.239 eÅ-3  
R.M.S. deviation from mean 0.052 eÅ-3  
 
5.5.8 Triarylmethane Synthesis by Copper Catalysis 
 
General procedure. To a 10 mL vial charged with dppp (8.2 mg, 0.020 mmol) 
and Cu(OAc)2 (1.8 mg, 0.010 mmol) was added anhydrous THF (1.0 mL). The 
mixture was allowed to stir at ambient temperature for 5 min, then para-quinone 
methide-aryl ester 5.3 (0.10 mmol) and isocyanoacetate 5.4 (0.13 mmol) were added 
in one portion. The reaction mixture was allowed to stir at ambient temperature for 24 
h, concentrated and purified by flash chromatography (silica gel or neutral Al2O3, 
hexanes/ethyl acetate) to afford the product 5.8. 
Unless otherwise noted, the ratio of 5.8 and the corresponding tricyclic ketal 
is >20:1. 
 




yl carbonate (5.8a) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.71 (s, 1H), 7.33-7.10 (m, 4H), 
7.05 (s, 2H), 5.49 (s, 1H), 5.11 (s, 1H), 3.74 (s, 3H), 2.12 (s, 3H), 1.38 (s, 18H); 13C 
NMR (75 MHz, CDCl3): δ 153.7, 152.4, 148.8, 144.8, 135.6, 135.0, 134.9, 131.2, 
130.3, 127.5, 126.1, 125.6, 121.9, 55.2, 41.3, 34.3, 30.2, 10.1; HRMS (ESI): m/z 
calcd. for [C27H33NNaO5, M+Na]
+: 474.2251; found: 474.2247. 
 
2-((3,5-Di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)-4-methoxyp
henyl methyl carbonate (5.8b) 
 
The general procedure outlined above was followed (48 h). The crude reaction 
mixture was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 
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4:1). Pale yellow wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.71 (s, 1H), 7.07 
(s, 2H), 7.04 (d, J = 8.8 Hz, 1H), 6.82 (d, J = 3.0 Hz, 1H), 6.76 (dd, J = 8.8, 3.1 Hz, 
1H), 5.42 (s, 1H), 5.10 (s, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 2.12 (s, 3H), 1.39 (s, 18H); 
13C NMR (75 MHz, CDCl3): δ 157.2, 154.1, 152.4, 148.8, 144.8, 142.6, 136.0, 135.6, 
134.8, 131.0, 125.6, 122.6, 115.7, 112.3, 55.4, 55.1, 41.6, 34.3, 30.2, 10.1; HRMS 
(ESI): m/z calcd. for [C28H35NNaO6, M+Na]
+: 504.2357; found: 504.2357. 
 
2-((3,5-Di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)-4-methylphe
nyl methyl carbonate (5.8c) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.71 (s, 1H), 7.14-6.96 (m, 5H), 
5.44 (s, 1H), 5.09 (s, 1H), 3.73 (s, 3H), 2.28 (s, 3H), 2.13 (s, 3H), 1.39 (s, 18H); 13C 
NMR (75 MHz, CDCl3): δ 153.9, 152.3, 148.8, 146.8, 144.7, 135.7, 135.5, 135.0, 
134.4, 131.3, 130.7, 128.1, 125.6, 121.6, 55.1, 41.2, 34.3, 30.2, 21.1, 10.1; HRMS 
(ESI): m/z calcd. for [C28H35NNaO5, M+Na]





nyl methyl carbonate (5.8d) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.73 (s, 1H), 7.29 (d, J = 2.5 Hz, 
1H), 7.22 (dd, J = 8.6, 2.5 Hz, 1H), 7.08 (d, J = 8.6 Hz, 1H), 7.04 (s, 2H), 5.42 (s, 1H), 
5.14 (s, 1H), 3.73 (s, 3H), 2.12 (s, 3H), 1.39 (s, 18H); 13C NMR (126 MHz, CDCl3): δ 
153.5, 152.6, 149.0, 147.3, 144.9, 136.9, 135.8, 134.3, 131.5, 130.5, 130.2, 127.6, 
125.5, 123.3, 55.4, 41.4, 34.3, 30.2, 10.1; HRMS (ESI): m/z calcd. for 
[C27H32ClNNaO5, M+Na]
+: 508.1861; found: 508.1868. 
 
4-Bromo-2-((3,5-di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)phe
nyl methyl carbonate (5.8e) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
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purified by flash column chromatography (hexanes/EtOAc 7:1). Pale yellow 
wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.74 (s, 1H), 7.45 (d, J = 2.2 Hz, 
1H), 7.37 (dd, J = 8.6, 2.2 Hz, 1H), 7.06-6.98 (m, 3H), 5.42 (s, 1H), 5.13 (s, 1H), 3.73 
(s, 3H), 2.12 (s, 3H), 1.39 (s, 18H); 13C NMR (126 MHz, CDCl3): δ 153.4, 152.6, 
149.0, 147.9, 145.0, 137.2, 135.8, 134.3, 133.2, 130.6, 130.5, 125.5, 123.7, 119.4, 
55.4, 41.4, 34.3, 30.2, 10.1; HRMS (ESI): m/z calcd. for [C27H32BrNNaO5, M+Na]
+: 
552.1356; found: 552.1358. 
 
2-((3,5-Di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)-5-methylphe
nyl methyl carbonate (5.8f) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 7:1). Pale yellow 
wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.71 (s, 1H), 7.15 (d, J = 7.9 Hz, 
1H), 7.06 (s, 2H), 7.00 (d, J = 7.9 Hz, 1H), 6.94 (s, 1H), 5.43 (s, 1H), 5.10 (s, 1H), 
3.75 (s, 3H), 2.32 (s, 3H), 2.12 (s, 3H), 1.39 (s, 18H); 13C NMR (126 MHz, CDCl3): δ 
153.9, 152.3, 148.8, 148.6, 144.6, 137.6, 135.5, 135.0, 131.9, 131.4, 130.0, 127.0, 
125.6, 122.4, 55.2, 41.0, 34.3, 30.2, 20.9, 10.1; HRMS (ESI): m/z calcd. for 
[C28H35NNaO5, M+Na]




yl methyl carbonate (5.8g) 
 
The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 5:1). Yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.72 (s, 1H), 7.19-7.11 (m, 1H), 
7.10-6.98 (m, 4H), 5.47 (s, 1H), 5.13 (s, 1H), 3.75 (s, 3H), 2.13 (s, 3H), 1.39 (s, 18H); 
13C NMR (75 MHz, CDCl3): δ 154.4 (d, J = 249.3 Hz), 152.53, 152.48, 148.9, 144.9, 
137.8, 136.8 (d, J = 13.1 Hz), 135.7, 134.5, 130.7, 126.5 (d, J = 7.8 Hz), 125.6, 125.2 
(d, J = 3.3 Hz), 114.7 (d, J = 18.6 Hz), 55.6, 41.3 (d, J = 2.2 Hz), 34.3, 30.2, 10.1; 
HRMS (ESI): m/z calcd. for [C27H32FNNaO5, M+Na]
+: 492.2157; found: 492.2167. 
 
2,4-Dichloro-6-((3,5-di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)




The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 6:1). Yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.73 (s, 1H), 7.32 (d, J = 2.4 Hz, 
1H), 7.24 (d, J = 2.5 Hz, 1H), 7.06 (s, 2H), 5.39 (s, 1H), 5.16 (s, 1H), 3.75 (s, 3H), 
2.16 (s, 3H), 1.40 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 152.8, 151.9, 149.1, 145.0, 
143.9, 139.1, 135.9, 133.9, 131.9, 130.0, 129.0, 128.2, 125.6, 55.8, 41.6, 34.3, 30.2, 
10.1; HRMS (ESI): m/z calcd. for [C27H31Cl2NNaO5, M+Na]






The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 5:1). Pale yellow 
wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.73 (s, 1H), 7.33 (dd, J = 7.5, 1.9 
Hz, 1H), 7.27-7.10 (m, 3H), 7.00 (s, 2H), 5.52 (s, 1H), 5.08 (s, 1H), 3.72 (s, 3H), 
2.52-2.39 (m, 2H), 1.37 (s, 18H), 1.10 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 153.7, 152.3, 149.8, 148.9, 148.9, 135.5, 135.0, 134.1, 131.5, 130.3, 127.5, 




+: 488.2407; found: 488.2403. 
 
2-((3,5-Di-tert-butyl-4-hydroxyphenyl)(5-propyloxazol-4-yl)methyl)phenyl meth 
yl carbonate (5.8j) 
 
The general procedure outlined above was followed (48 h). The crude reaction 
mixture was purified by flash column chromatography (neutral Al2O3, hexanes/EtOAc 
6:1). Pale yellow wax, >98% yield. 1H NMR (300 MHz, CDCl3): δ 7.73 (s, 1H), 
7.37-7.10 (m, 4H), 6.98 (s, 2H), 5.52 (s, 1H), 5.08 (s, 1H), 3.71 (s, 3H), 2.55-2.26 (m, 
2H), 1.60-1.45 (m, 2H), 1.37 (s, 18H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 153.7, 152.3, 149.0, 148.9, 148.8, 135.4, 135.0, 134.8, 131.6, 130.3, 127.5, 
126.0, 125.5, 121.9, 55.2, 41.3, 34.3, 30.2, 26.5, 21.5, 13.6; HRMS (ESI): m/z calcd. 
for [C29H37NNaO5, M+Na]







The general procedure outlined above was followed. The crude reaction mixture was 
purified by flash column chromatography (hexanes/EtOAc 8:1). Pale yellow 
wax, >98% yield. 1H NMR (500 MHz, CDCl3): δ 7.71 (s, 1H), 7.28-7.23 (m, 2H), 
7.21-7.11 (m, 2H), 7.05 (s, 2H), 5.50 (s, 1H), 5.10 (s, 1H), 4.17 (q, J = 7.1 Hz, 2H), 
2.11 (s, 3H), 1.38 (s, 18H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 
153.2, 152.4, 148.8, 144.8, 135.6, 135.0, 134.9, 131.3, 130.3, 127.5, 126.0, 125.6, 
121.9, 64.6, 41.2, 34.3, 30.2, 14.1, 10.1; HRMS (ESI): m/z calcd. for [C28H35NNaO5, 
M+Na]+: 488.2407; found: 488.2406. 
 
2-((3,5-Di-tert-butyl-4-hydroxyphenyl)(5-methyloxazol-4-yl)methyl)phenyl 
isopropyl carbonate (5.8l) 
 
The general procedure outlined above was followed (48 h). In this case, the ratio of 7l 
and the corresponding tricyclic ketal is 14:1 (of crude). The crude reaction mixture 
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was purified by flash column chromatography (hexanes/EtOAc 8:1). Pale yellow wax, 
90% yield. 1H NMR (300 MHz, CDCl3): δ 7.70 (s, 1H), 7.28-7.10 (m, 4H), 7.04 (s, 
2H), 5.51 (s, 1H), 5.09 (s, 1H), 4.85 (dt, J = 12.4, 6.2 Hz, 1H), 2.10 (s, 3H), 1.38 (s, 
18H), 1.30 (d, J = 6.3 Hz, 3H), 1.26 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): 
δ 152.8, 152.4, 148.83, 148.77, 144.8, 135.6, 135.1, 134.9, 131.3, 130.3, 127.4, 126.0, 
125.6, 122.0, 72.8, 41.2, 34.3, 30.2, 21.64, 21.61, 10.1; HRMS (ESI): m/z calcd. for 
[C29H37NNaO5, M+Na]
+: 502.2564; found: 502.2557. 
 
5.5.10 Cleavage of the Carbonate Moiety in 5.8i[112] 
 
Potassium carbonate (69 mg, 0.5 mmol) was added to the mixture of 5.8i (46.5 
mg, 0.1 mmol), CH2Cl2 (0.5 mL), MeOH (0.5 mL) and H2O (0.5 mL). The reaction 
mixture was allowed to stir at 60 oC for 24 h, concentrated and purified by flash 






Yellow solid, 84% yield. 1H NMR (500 MHz, CDCl3): δ 9.87 (s, 1H), 7.84 (s, 1H), 
7.24-7.13 (m, 2H), 6.96 (d, J = 7.9 Hz, 1H), 6.93-6.81 (m, 3H), 5.15 (s, 1H), 5.09 (s, 
1H), 2.88-2.68 (m, 2H), 1.34 (s, 18H), 1.29 (t, J = 7.6 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 155.6, 152.4, 149.7, 148.7, 135.5, 134.6, 131.5, 130.8, 129.0, 127.9, 124.3, 
120.1, 119.2, 46.4, 34.3, 30.2, 18.0, 13.0; MP: 156-157 oC; HRMS (ESI): m/z calcd. 
for [C26H33NNaO3, M+Na]
+: 430.2353; found: 430.2344. 
 
5.5.11 X-Ray Crystallographic Analysis of 5.9 
The conformation of 5.9 was determined by X-ray crystallographic analysis of a 
single crystal of 5.9 (Figure 5.5). The crystal was prepared from the solution of 5.9 in 
hexanes/CH2Cl2 at ambient temperature. 
 




Table 5.5 Crystal Data and Structure Refinement for 5.9 
Identification code 5.9  
Chemical formula C26H33NO3  
Formula weight 407.53 g/mol  
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal size 0.300 x 0.360 x 0.560 mm3  
Crystal system Monoclinic  
Space group P 1 21/n 1  
Unit cell dimensions a = 13.873(2) Å α = 90° 
 b = 10.0086(16) Å β = 95.084(2)° 
 c = 16.516(3) Å γ = 90° 
Volume 2284.2(6) Å3  
Z 4  
Density (calculated) 1.185 g/cm3  
Absorption coefficient 0.076 mm-1  
F(000) 880  
Theta range for data collection 1.84 to 28.28°  
Index ranges -18<=h<=18, -13<=k<=13, -22<=l<=22 
Reflections collected 30529  
Independent reflections 5670 [R(int) = 0.0406]  
Coverage of independent reflections 100.0%  
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Absorption correction Multi-Scan 
Max. and min. transmission 0.7459 and 0.6423  
Structure solution technique direct methods  
Structure solution program SHELXS-97 (Sheldrick 2008) 
Refinement method Full-matrix least-squares on F
2
 
Refinement program SHELXL-2014/7 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 5670 / 0 / 308  
Goodness-of-fit on F2 1.044  
Final R indices [4888 data; I>2σ(I)] R1 = 0.0443, wR2 = 0.1105  
R indices (all data) R1 = 0.0521, wR2 = 0.1155  




Largest diff. peak and hole 0.414 and -0.233 eÅ-3  
R.M.S. deviation from mean 0.049 e.Å-3  
 
5.5.12 De-tert-butylation of 5.8a[104] 
 
Under nitrogen atmosphere, the compound 5.8a (43.3 mg, 0.096 mmol) was 
250 
 
dissolved in 4 mL dry toluene. The resulting mixture was cooled to 0 oC, then AlCl3 
(63.8 mg, 0.48 mmol) was added. The reaction was stirred for 15 h at 0 oC and 4 mL 
H2O was added and extracted with ethyl acetate for three times. The combined 
extracts were dried over anhydrous Na2SO4. The solvent was concentrated under 
reduced pressure. The residue obtained was purified by flash column chromatography 





Pale yellow wax, 84% yield. 1H NMR (400 MHz, CDCl3): δ 7.74 (s, 1H), 7.29-7.21 
(m, 2H), 7.20-7.10 (m, 2H), 7.07 (d, J = 2.0 Hz, 1H), 6.80 (dd, J = 8.1, 2.1 Hz, 1H), 
6.48-6.28 (m, 1H), 5.97 (s, 1H), 5.49 (s, 1H), 3.74 (s, 3H), 2.11 (s, 3H), 1.33 (s, 9H); 
13C NMR (101 MHz, CDCl3): δ 153.8, 153.3, 149.1, 148.8, 144.9, 135.9, 134.8, 
131.9, 130.2, 127.7, 127.5, 127.2, 126.2, 121.9, 116.5, 55.3, 41.0, 34.5, 29.5, 10.0; 
HRMS (ESI): m/z calcd. for [C23H26NO5, M+H]





Under nitrogen atmosphere, the compound 5.8a (45.1 mg, 0.1 mmol) was 
dissolved in 4 mL dry toluene and AlCl3 (133 mg, 1.0 mmol) was added. The resulting 
mixture was warmed to 35 oC and stirred for 16 h. Then the reaction was cooled to 
room temperature and 4 mL H2O was added and extracted with ethyl acetate for three 
times. The combined extracts were dried over anhydrous Na2SO4. The solvent was 
concentrated under reduced pressure. The residue obtained was purified by flash 
column chromatography on silica gel eluting with hexanes/ethyl acetate (2:1) to 
afford 23 mg of 5.11. 
 
2-((4-Hydroxyphenyl) (5-methyloxazol-4-yl)methyl)phenyl methyl carbonate 
(5.11) 
 
Pale yellow wax, 68% yield. 1H NMR (400 MHz, Acetone-d6): δ 8.21 (s, 1H), 7.91 (s, 
1H), 7.37 (dd, J = 7.7, 1.8 Hz, 1H), 7.30-7.24 (m, 1H), 7.24-7.13 (m, 2H), 7.13-7.06 
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(m, 2H), 6.80-6.66 (m, 2H), 5.49 (s, 1H), 3.78 (s, 3H), 2.16 (s, 3H); 13C NMR (101 
MHz, Acetone-d6): δ 157.0, 154.6, 150.2, 150.0, 145.4, 136.3, 135.7, 133.2, 131.3, 
130.8, 128.3, 126.8, 123.0, 115.9, 55.7, 41.1, 10.0; HRMS (ESI): m/z calcd. for 
[C19H18NO5, M+H]
+: 340.1179; found: 340.1175. 
 
5.5.13 Synthesis of Intermediate 5.2a and Subjection to Ag or Cu Catalysis 
 
To a 10 mL vial charged with dppp (8.2 mg, 0.020 mmol) and Cu(OAc)2 (1.8 mg, 
0.010 mmol) was added anhydrous toluene (1.0 mL). The mixture was allowed to stir 
at ambient temperature for 5 min, then para-quinone methide-aryl ester 5.3a (0.10 
mmol) and methyl isocyanoacetate 5.4a (0.13 mmol) were added in one portion. The 
reaction mixture was allowed to stir at 0 oC for 72 h, concentrated and purified by 







Intermediate 5.2a was obtained in a pure form as a mixture of two diastereomers (d.r. 
= 1.4:1). Pale yellow wax, 78% yield. 1H NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.6 
Hz, 0.7H), 7.42 (d, J = 7.7 Hz, 1H), 7.35-7.20 (m, 3.4H), 7.10-7.05 (m, 1.7H), 7.03 (s, 
2H), 6.98 (s, 1.4H), 5.18 (s, 1.7H), 4.94-4.86 (m, 1.7H), 4.83-4.73 (m, 1.7H), 3.70 (s, 
3H), 3.65 (s, 2.1H), 2.17 (s, 3H), 2.14 (s, 2.1H), 1.39 (s, 18H), 1.38 (s, 12.6H). 13C 
NMR (126 MHz, CDCl3): δ 168.62, 168.37, 166.25, 166.21, 162.63, 162.57, 153.15, 
153.10, 148.71, 148.25, 136.03, 135.82, 131.51, 130.37, 128.74, 128.43, 128.40, 
128.36, 127.17, 126.11, 125.94, 125.13, 124.65, 123.09, 123.02, 60.34, 60.21, 53.32, 
53.26, 46.43, 46.36, 34.31, 34.30, 30.16, 30.11, 20.73, 20.68; HRMS (ESI): m/z calcd. 
for [C27H 33NNaO5, M+Na]
+: 474.2251; found: 474.2255. 
 
 
To a 10 mL vial charged with PPh3 (2.1 mg, 0.0078 mmol) and Ag2O (0.9 mg, 
0.0039 mmol) was added anhydrous THF (0.8 mL). The mixture was allowed to stir at 
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ambient temperature for 5 min, then intermediate 5.2a (35 mg, 0.078 mmol) was 
added in one portion. The reaction mixture was allowed to stir at ambient temperature 
for 24 h, concentrated and purified by flash chromatography (hexanes/ethyl acetate 
5:1) to afford 29 mg of 5.6a. 
 
 
To a 10 mL vial charged with dppp (6.4 mg, 0.0156 mmol) and Cu(OAc)2 (1.4 
mg, 0.0078 mmol) was added anhydrous THF (0.8 mL). The mixture was allowed to 
stir at ambient temperature for 5 min, then intermediate 5.2a (35 mg, 0.078 mmol) 
was added in one portion. The reaction mixture was allowed to stir at ambient 
temperature for 24 h, concentrated and purified by flash chromatography 
(hexanes/ethyl acetate 5:1) to afford 32 mg of 5.8a. 
 




To a 10 mL vial charged with dppp (8.2 mg, 0.020 mmol) and Cu(OAc)2 (1.8 mg, 
0.010 mmol) was added anhydrous toluene (1.0 mL). The mixture was allowed to stir 
at ambient temperature for 5 min, then tricyclic ketal 5.6f (46.5 mg, 0.10 mmol) was 
added in one portion. The reaction mixture was allowed to stir at ambient temperature 
for 24 h. 
Under the copper catalysis conditions, 5.6f was stable and didn’t undergo 
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NMR Spectra of the Compounds 
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